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SUMMARY 
 
A fundamental understanding of how biological systems work requires knowledge of 
the proteins and interactions of biomolecules. The role of proteins as well as small 
molecules participating in interactions can be interpreted as their functions. This is
becoming an increasingly important means for better understanding of biological 
process and for facilitating modern drug discoveries. This thesis presents the predicting
 of protein functional families and protein inhibitors by statistical machine learning
 approach. 
 
Development of methods and computational tools for the prediction of functional
 
families of protein is one of the main objectives of this study. Protein function 
classification systems were designed to assign functional families from proteins’ 
primary sequence irrespective of sequence similarity. In this work, a number of protein 
classification problems such as enzyme families, transporter families and RNA-binding 
proteins were studied and the classification models were further evaluated by using 
independent evaluation sets. The independent evaluation results showed a prediction 
accuracy above 70% for 53 out of 72 protein functional families in this study. 
 
In order to evaluate the capability of the prediction system for assigning functional 
class of proteins without any sequence similarity in protein sequence databases and 
proteins with similar sequence but different functions, novel proteins from bacterial, 
viral and plant species were selected and tested to examine to us what extent, their 
function can be predicted by using our prediction systems.  It was shown that the 
IV 
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accuracy for predicting their function is in an acceptable range of 67% ~ 85%, whereas 
other approaches solely based sequence similarity approach may not suitable for this 
task. These results suggest that an SVM-based prediction system is useful for 
facilitating the prediction of the function of novel proteins in the genomes of bacteria, 
virus, plants as well as other organisms and major functional groups, such as enzymes. 
 
Another aim of this work is to predict protein inhibitors by statistical learning approach 
in order to cope with an increasing need of the discovery of inhibitors of therapeutically 
important proteins, particularly those with crystal 3D structures available. These 
inhibitors can be used as potential leads for drug development. Prediction of 
HIV-protease inhibitors (PIs) is used as an example, as it is of relevance of drug 
discovery and there are substantial structures and inhibitors to develop a statistical 
machine learning system. In the current use of HIV-1 protease inhibitors for anti-HIV 
therapies, the main concerns are the rapid emergence of drug resistance and many 
physiological side effects. Thus it is in high demand for speeding up drug discovery in 
the fight against with HIV infections by properly choosing HIV PIs candidates. In this 
study, a set of 4291 inhibitors and 10000 non-inhibitors were selected to develop a 
SVM classifier, which gave a prediction accuracy of 97.05% for a random selection of 
independent evaluation set composed of 3424 compounds. This result suggests that the 
classification model is self-consistent and has certain capability in the selection of 
probable HIV-1 PI candidates. Recursive feature selection has been employed to select 
significant molecular descriptors and it was shown that molecular connectivity and 
shape, flexibility, and hydrogen bond interactions are among the most distinguishing 
features for discriminating HIV-1 protease inhibitors. The results of this study indicate 
that the statistical learning approach is useful for PIs prediction, the methods 
V 
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Chapter 1 Introduction 
1. Introduction 
Knowledge of proteins is essential in the understanding of biological processes such as 
gene regulation and disease pathology1, 2. The demand and possibility for probing 
protein function and interactions with other biomolecules have been increasing along 
with the progress of genomics and proteomics. Resulting from large-scale genome 
sequencing projects, the gap between the large amounts of sequences information and 
their function characterization is continuously increasing3, 4. Thus, the understanding of 
protein function is important for facilitating drug target search, drug discovery and 
systematically study of biological events. The availability of the flood of biological 
information brings us both the chance and the challenge to probe the knowledge of the 
biomolecules interactions, proteins function and biological process, which not only 
helps us to understand and interpret the biological events in the molecular level but also 
enables us to study regions which are not accessible experimentally or which would 
imply very expensive experiments. Prediction of protein functions and protein 
inhibitors (normally protein inhibitors are referring to molecules that can inhibit the 
protein functions ) are two challenges in biology and drug discovery,  that  are 
investigated by a statistical learning method – Support Vector Machines in this thesis.  
1.1. Introduction to protein function prediction 
Increasing effort has been directed for predicting protein functions from their sequence. 
Various methods have been used for protein function prediction from their sequence, 
such as sequence similarity searching5-7, evolutionary analysis8, 9, structure-based 
approach10, protein/gene fusion11, 12, protein interaction13, 14 and family classification 
by sequence clustering15, 16.  
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Methods based on sequence similarity, such as FASTA17, BLAST18, Motifs19 and 
Prosite20, have frequently been used for protein function prediction. However, with 
decreasing in sequence similarities, the criteria for comparison of distantly-related 
proteins become increasingly difficult to formulate 16. Moreover, not all homologous 
proteins have similar functions 8.  Even a shared domain within a group of proteins 
does not necessarily imply that these proteins have the same function21. These 
problems often hinder some of the sequence similarity based methods 15.  
Unlike sequence similarity based approach, structure-based methods can determine 
protein function from the structure function relationship without solely relying on 
sequence similarities. Although the structure information may provide insights into 
protein function22, a hypothetical function obtained by identifying the similar 3D folds 
in the absence of clear sequence identity does not reflect the real function with high 
confidence23-26. Structure-based approaches are not limited in finding clues between 
function and similar 3D folds. Several other approaches, such as structure descriptors27, 
patterns in non-homologous tertiary structures28 and geometric hashing29, have been 
successfully implemented by using 3D templates known to be associated with functions 
to scan new structures against the profile library. However, the limited ability to locate 
3D profiles automatically and the restriction of sequence variation of 3D templates 
methods30 are the practical drawbacks of these methods.  
Apart from the methods for determining specific protein function on the basis of 
similarities either in structure or in sequence, another approach to predict protein 
function is to classify proteins into their functional families on the basis of their 
sequences, which is expected to be particularly useful in the cases described above. To 
fulfill the task of protein functional families classification for facilitating protein 
function prediction, artificial intelligence statistical learning methods, such as support 
2 
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vector machine (SVM)31-33 and neural network34, have been reported. The strategy 
normally used is that samples of proteins in a functional family and those outside the 
family are used to train a system for protein classification. And the preliminary 
results31-34 suggest that Support Vector Machine  can be trained and used to recognize 
proteins with characteristics for a particular function if there are sufficient samples of 
proteins with specific function. 
In summary, there are three principal strategies, sequence similarity based, structure 
based and statistical learning based methods relying on sequence or structures, to 
estimate function of a protein by using bioinformatics approaches. 
 
1.1.1. Sequence similarity based approaches 
As introduced in the previous section, various approaches have been implemented for 
facilitating the protein function assignment for the primary sequence, such as sequence 
alignment, clustering and pattern identification, remote homology searching, statistical 
methods and artificial intelligence. The most prominent and commonly used one 
among them is sequence alignment method. Based on sequence-structure-function 
relationship, proteins with high similarity in sequence are more likely to have the 
similarity in structure and function.  This method normally starts by aligning the 
sequences of proteins with unknown function and proteins with known function 
together with a certain level of sequence similarities. By determining the level of 
sequence similarity, one can predict the potential functions.  
As early in 1970, Needleman-Wunsch algorithm was proposed by Saul Needleman and 
Christian Wunsch35 for solving the global pairwise sequence alignment problem where 
all the characters in both sequences participate in the alignment. Another famous 
3 
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algorithm, Smith-Waterman algorithm was first proposed by Temple Smith and 
Michael Waterman in 198136 for performing local sequence alignment to find related 
regions within sequences. 
Pairwise sequence alignment methods are concerned with finding the best-matching 
piecewise local or global alignments of protein (DNA) sequences, however, it could be 
time consuming to perform a large sequence database scan in order to identify the 
sequences homologous.  
In order to cope with the task of large-scale sequence database searching, FASTA17 was 
proposed by David J. Lipman and William R. Pearson in 1985, which was latter 
superseded by BLAST18 proposed by Stephen Altschul etc in 1990. BLAST became the 
most widely used bioinformatics programs because it addresse a fundamental problem 
and the algorithm emphasizes the balance between the speed and sensitivity. It is an 
important fact that biomolecules could share the similar structures and functions even if 
their sequences have low level of similarity or if they are dissimilar.  In order to find 
distant relatives of a protein and identify weak but biologically relevant similarities,  
PSI-BLAST37 has been introduced by Altschul and Koonin in 1998. It iteratively 
searches protein databases for sequences similar to one or more protein query 
sequences. PSI-BLAST is similar to BLAST except that it uses position-specific scoring 
matrices derived during the search. In addition to the usual PSI-blast criteria for 
matching, Pattern-Hit Initiated BLAST38 (PHI-BLAST) is introduced to enforce the 
presence of a pattern in database searching for protein sequences that also contain the 
input pattern and have significant similarity to the query sequence near the pattern 
occurrences. 
In many cases, a protein can perform certain functional activity if it contains a 
conserved sequence20, thus motif based methods, such as Motifs19 , Prosite20 and 
4 
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Sequence Clustering15 that have been developed in recent years, also show certain 
capability of identifying proteins with weak similarities by using patterns, rules and 
profiles search.  
However, identification of protein functions solely based on the sequence similarities is 
impractical for proteins without any homology in sequence16. In addition, proteins with 
similar sequences may not have similar functions8. Although the motif/pattern based 
methods could cluster proteins by identifying shared domains within a functional group, 
it does not necessarily imply that clustered proteins have the same function21.  
1.1.2. Structure based approaches 
Unlike sequence-based approaches, structure–based approaches rely on the analysis of 
the protein 2D/3D structures. Based on assumption that proteins with similar structure 
have similar functions, one can predict the protein function or get clues on protein 
function from its structure. 
Based on the knowledge of structure-function relationship, one can infer function from 
the corresponding protein structure22. Homology modeling approaches27-29, 39 have 
been successfully implemented by using 3D templates known to be associated with 
functions to scan new structures against the profile library. However, the restriction of 
sequence variation in the templates30 is the main limitation. 
By studying the relationships between protein fold and functions, one is able to analyze 
the protein functions from the shared protein folds40. However, there are two concerns. 
Firstly, function identification that solely relies on the homologous fold identification 
without considering sequence similarity is of low confidence23-26. Secondly, the 
relationship between the 3D folds and protein function is usually very complex, and 
even ambiguous in many cases41.  
5 
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The gap between the amount of protein sequences and solved protein structures is 
increasing rapidly. Although a combination of techniques such as comparative protein 
modeling and experimental protein structure determination techniques42 are widely 
used to determine protein structures, only about 15% of sequenced protein have 3D 
structures. The lack of solved structures limits the application of structure-based 
methods for predicting protein functions. 
1.1.3. Statistical learning based approach 
The sequence similarity based approaches and structure based approaches require 
certain similarities in their sequences or their structures. Thus it is necessary to look for 
alternative approaches to predict the protein function without considering similarities 
in either structures or sequences. Statistical learning based approach is one potential 
solution to address this problem. 
Various statistical learning approaches have been developed to explore protein 
functions from its primary sequence by using statistical learning methods including 
discretized naïve Bayes, C4.5 decision trees, and instance-based leaning33, neural 
networks34 and support vector machines (SVM)31-33, 43-46. These methods rely on the 
model generated by training the protein examples from a specific functional class and 
negative examples outside the functional class. The features representing the protein 
sequence information have been obtained by several methods such as binary coding, 
amino acid composition, hydrophobicity, normalized Van der Waals volume, polarity, 
polarizability or their combinations14, 31, 43, 47-49. Some of these methods, use sequence 
derived features without considering sequence similarities, are capable of facilitating 
protein function prediction without considering sequence similarities. 
The statistical learning approaches require certain number of representative examples 
6 
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for learning. Thus the effective data collection and negative examples selection are very 
important to obtain pre-classified functional protein examples and representative 
negative examples. However, the problem of effective examples remains unsolved. 
 
1.2. Introduction to protein inhibitor prediction 
Many drugs target on enzymatic proteins and act as competitive inhibitor of the 
enzymes, are commonly referred to as inhibitors50. Interactions between inhibitors and 
proteins such as enzymes and carrier proteins can be either reversible or irreversible. 
One of the common roles for inhibitors’ activity is to hinder its target protein’s normal 
reaction or to regulate the function of its target. For example, the cyclo-oxygenase 
inhibition by aspirin that irreversible acetylates a serine residue at the top of the main 
cytoclooxygenase site51; HIV-1 protease inhibition by indinavir, which block its 
peptide binding, site to prevent the binding of its peptide51. While not all inhibitors can 
be used as valid drugs due to the unwanted effects and poor pharmacokinetic properties, 
prediction of protein inhibitors is important for finding drug leads, probing protein 
inhibition mechanisms and designing better drugs and for protein enginering. Intensive 
efforts on designing inhibitors have lead to the advent of computer aided drug 
design52-55, that aims to help the rapid and efficient discovery of drug leads.  
 
Many existing computational approaches focused on the improvement of interaction 
between target proteins and their inhibitors. One approach studies the relationship 
between protein and its inhibitors to simulate the interactions and binding activities of 
protein-substrate system by finding if there is a stable energy minimum by 
protein-ligand docking approach56, which requires 3D structures of both proteins and 
7 
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substrates.  Other methods widely used to speed up the inhibitors identification in the 
early stage of drug discovery are statistical learning methods57-60 and Quantitative 
Structure Activity Relationship(QSAR)61-64 study. These approaches can be used to 
speed up the drug development circle by eliminating false drug leads in earlier stage. 
Various approaches have their requirements for achieving the study objective. Thus, it 
is necessary to have a close look on these approaches for facilitating protein inhibitor 
research. 
1.2.1. Quantitative Structure Activity Relationship (QSAR) 
It has been a century since Crum-Brown and Fraser proposed the idea that the 
physiological action of a substance is a function of its chemical composition and 
constitution17 and about 40 years since the quantitative structure-activity relationship 
(QSAR) paradigm was practically used in chemistry and pharmacology65.  
Quantitative Structure Activity Relationship (QSAR) stands for the quantitative study 
of relationships between molecules’ physical-chemical properties and their biological 
activities. In other words, QSAR is to study molecule behaviors in a biological event. 
QSAR can be used to identify chemical structures that have good inhibitory effects on 
specific protein target. Optimal molecular properties are considered to develop the 
relationship between a list of compounds structure and their quantitative activities. And 
this relationship can be used to predict quantitative activities of new compounds from 
their structures. Unlike the docking and other molecular modeling approaches, the 3D 
structure of the protein target is not required. 
QSAR process provids the usefully clues of which descriptors are important for the 
biological response. For example, the LogP is an important measure used in identifying 
"drug-likeness" according to Lipinski's Rule of Five66, the LogP of 2.77-3.76 was 
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found to be ideal for LOX inhibitors67; a logP value of 2.92 or higher, 18-atom-long or 
longer molecular length and a high Ehomo value etc are required for an effective p- 
glycoprotein inhibitor68; other important measures like chi (first-order Randic 
connectivity index) is for identification of carbonic anhydrase inhibitors69. The 
proposed important descriptor during the QSAR analysis can be used as a rule for 
virtual screening the new inhibitors that are likely to produce the desired activities.  
Normally the development of QSAR model is based on a group of compounds with 
certain common structure, the diversity of the studied compounds is not enough for 
predicting novel inhibitors without the common structure. Thus, the use of QSAR for 
novel inhibitors design might not adequate as it requires a large number of compounds 
with experimental activity data to develop many QSAR models. 
1.2.2. Molecular Docking Approach 
Molecular docking is a widely used technique for screening and rapid testing of large 
amount of compounds to identify new binders of a selected protein target56. The 
identified new binders are candidates of new drug leads. It is an advance for docking 
brought by the development of empirical force fields. The automated docking 
techniques allow de novo drug design with the capacity of allowing assessment of 
relative binding strength and drug specificity70.  
This approach has been used widely in probing new inhibitor candidates. DesJarlais 
71suggested that the Targeted-DOCK can be used for the design of a novel non-peptide 
inhibitor of HIV-1 protease. Benzylamino acetylcholinesterase inhibitor-like 
compound screening is another successful application of docking approach by 
Yamamoto72. Other studies of protein inhibitors, such as human rhinovirus-14 
inhibitors73, glucoamylase inhibitors74, thrombin inhibitors 75, 76 etc, especially the 
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study of HIV protease inhibitors70, 71, 77-79 which attracts a lot of interests,   show that 
docking approach can be used for inhibitor screening.  
However, the use of molecular docking approach requires 3D structure of the target 
proteins, which is essential for calculating the binding affinity from molecular 
mechanics/modeling. Because there are only limited number of proteins with 3D 
structures available, the molecular docking approach is not applicable in many other 
cases. Moreover, molecular docking normally prefers the conformation of the binding 
site of the protein target is rigid other than flexible, thus the flexibility of the protein 
structure can affect the screening accuracy.  
1.2.3. Statistical learning approaches for protein inhibitor prediction 
Statistical leaning methods have been applied in QSAR studies for facilitating 
inhibitors identification as the implementation of relationship analytical mothods80-83. 
On the other hand, the direct use of statistical learning methods for this purpose mainly 
focused on classification, such as distinguishing between inhibitors and non-inhibitors, 
or regression analysis between the molecular structure and the measurement of 
inhibition57-60. One of the advantages is that the direct use of statistical learning 
methods do not require the 3D structure of protein target, thus these methods are 
potentially applicable to the case that the target structure is unknown or very flexible. 
Another advantage of statistical learning methods for protein inhibitor prediction is the 
diversity in training samples, which allows us to predict diversified compounds.  
Douali et al 80 approach the prediction of anti-HIV activity of HEPT by use of neural 
networks. Daszykowski et al 57 analysis of biological activity of Non-Nucleoside 
Reverse Transcriptase Inhibitors (NNRTIs) by using tree based approach - 
Classification And Regression Trees. Mager82 overview the work for using the neural 
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approach to optimize the desired actions and to lower the side effects of non-nucleoside 
HIV-1 reverse transcriptase inhibitors. 
However, a well-trained statistical learning model requires more inhibitor samples that 
QSAR approach to construct the decision function. Moreover, the proper selection of 
non-inhibitors is also very important because the decision function of statistical 
learning methods is usually determined by both positive and negative samples. 
Unfortunately, this problem remains unsolved because the compounds are enormous in 
numbers and they are very diverse. In work, we are going to approach this problem as 
well as other important issues such as data unbalance problem, predominant feature 
selections. 
One of the well-known examples in the field of rational drug design is the discovery 
and development of drugs for the treatment of AIDS84. The major targets for the 
development of new chemotherapeutic agents are Protease, Intergrease, and Reverse 
Transcriptase. Protease inhibitors are known as effective antiviral agents in increasing 
the effectiveness of antiretroviral therapy and prolonging the survival of patients with 
HIV infection/AIDS. Thus, development of new HIV PIs is also in high demand for 
anti-HIV therapy. However, due to the poor pharmacokinetic properties and side 
effects, the discovery of novel PIs is a difficult task. In this study, the prediction of HIV 
PIs is taken as an example to illustrate our approach for protein inhibitors predictions. 
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1.3. Introduction to HIV protease inhibitors prediction 
As of December 2004, an estimated 39.4 million ~ 37.2 million adults and 2.2 million 
children younger than 15 years – are infected with Human Immunodeficiency Virus 
(HIV) or living with AIDS. The rate of increase of the new infection is alarming. An 
estimation of 4.9 million new HIV infections occurred worldwide during 2004, 
amounting to about 14,000 infections each day85. In view of the huge worldwide impact 
of AIDS and the spreading speed of the AIDS pandemic, there have been intense global 
efforts towards understanding the biology and life cycle of HIV-1 and the host response 
to HIV-1 infection. These advances have led to the development of several new drugs 
that target the viral life cycle which are effective against HIV-1.  
Currently, there are 20 approved antiretroviral agents for anti-HIV-1 clinical therapy86, 
and each of those drugs could target one of the two viral enzymes protease or reverse 
transcriptase. Although the cocktail method87 is introduced, the success of treatment is 
still limited due to the HIV-1 target drug resistant mutations88, 89 which is the main 
cause of anti-HIV drug failure. Besides the drug resistant mutations that occurred in 
long term therapy, protease inhibitors are known as effective antiviral agents to 
increase the effectiveness in antiretroviral therapy and to prolong the survival of 
patients with HIV infection/AIDS. Efforts have been directed to development of new 
HIV protease inhibitors that could be potentially used for anti-HIV therapy. 
Development of new HIV PIs is also in high demand for anti-HIV therapy because the 
appearance of drug-resistant mutants and even multi-drug-resistance mutants is the 
main cause of the drug failure. Thus, it is time to have a clear look on HIV protease and 
its inhibitors. 
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1.3.1. HIV protease and protease inhibitors 
The HIV-1 protease is responsible for the maturation of new infectious HIV particles. It 
cleaves the Gag protein to yield the functional core proteins, i.e. the capsid protein, 
matrix protein, and nucleocapsid protein. It also synthesizes the polymerase protein 
(Pol) of HIV-1 as a Gag-pol (Pr160Gag-Pol) fusion polyprotein90, 91.  
HIV-1 PI inhibits the protease from properly cleaving Gag-pol polyprotein into its 
smaller functional units. The currently available HIV-1 protease inhibitors (PIs) can be 
classified into two broad classes85, 86: 1) Peptide-based inhibitors, which can be 
subdivided into peptides, peptidomimetics and symmetry-based inhibitors; and 2) 
non-peptide based inhibitors.  
Peptides are short amino acid polymers in which the individual amino acid residues are 
linked by amide bonds (CO-NH). In this study, amino acids, amines and amides are 
categorized under peptides. Amines are compounds containing one or more 
substituents that are organic bonded to a nitrogen atom, i.e. RNH2, R2NH or R3N. 
Examples of amines among the positive samples are aminoglycosides, benzimidazole, 
indoles, pyrroles and decahydroisoquinolines. Amides are compounds containing 
–CONR2 functional groups, such as carboxyamides and sulfonamides92. 
Peptidomimetics are protease substrate analogues that have a non-hydrolysable amino 
acid at the scissile bond. They have been designed to mimic the tetrahedral 
transition-state intermediate formed during the HIV-1 PR catalysis event. The 
transition state of the aspartic proteinase-catalyzed reaction occurs with the addition of 
a water molecule, coordinated by the active site of aspartates, to the peptide bond. 
These substrate-based inhibitors have many chemical forms, but they assume similar 
conformations in the substrate-binding cleft of the protease93. Examples of 
peptidomimetic drugs approved by FDA, are Saquinavir (Ro 31-8959) and Indinavir 
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(L-735, 524).  
C2 symmetry and pseudo-symmetry drugs are also peptide-based, they have less 
peptidic nature and they exploit protease-specific symmetry of the active site. Although 
symmetry is not thought to be an absolute requirement for the design of HIV PIs, these 
drugs were designed as an improvement of peptidic drugs with the expectation that the 
less peptidic nature of inhibitors might enhance stability. An example of 
symmetry-based drug is Ritonavir (ABT-538). 
Non-peptidic inhibitors are inhibitors with moieties to displace water molecules in the 
active site cleft. Specifically, the binding features of the surrounded water are 
incorporated into the inhibitor. These classes of compounds have proved to be quite 
promising, and their discovery has provided a new starting point for designing of 
HIV-1 PR inhibitors. However, no inhibitor from this group is in clinical use yet.  
The United States Food and Drug Administration (FDA) has approved nine protease 
inhibitors for marketing in the United States since the release of Saquinavir in 1995. As 
a part of the Highly Active Antiretroviral Therapy (HAART), all of the HIV-PIs are 
used in combination with other antiretroviral agents for the treatment of HIV-1 
infection. 
1.3.2. Current problems with the use of HIV-1 PIs 
While existing HIV-1 PIs show promising results in antiretroviral therapy and 
prolonging the survival of patients with HIV infection/AIDS, most patients taking 
protease inhibitors alone show an increase in plasma viral RNA to near baseline levels 
by the end of the year of drug administration94 and the occurrence of PI-resistance HIV. 
It has been discovered that there are two major problems related to the use of HIV-1 PIs, 
drug resistance and side effects due to drug toxicity.  
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Resistance mutations in the protease gene may result from amino acid substitutions at 
or near the active site. This interferes with inhibitor binding because of conformational 
perturbations and the properties change around the active binding site. Substitution of 
amino acids lying outside the active region compensates for the deleterious effects of 
primary mutations95, 96.  
Resistance to PIs can emerge rapidly when these inhibitors are administered at 
inadequate doses or as part of suboptimal regimens97. The interpretation of protease 
mutants is further complicated by the extensive polymorphisms found in the protease 
gene of HIV-1 isolates from untreated patients. In one study, variation was noted in 
nearly 48% of protease codons compared with the consensus (wild-type) sequence98. 
The significance of these polymorphisms in determining treatment outcome remains 
uncertain, since most studies have not found any correlation between the presence of 
these polymorphisms and virologic response, or the rate at which PI resistance 
emerges.  
One other shortcoming of the present treatment involving protease inhibitors is the 
adverse effects, drug interactions, and other risks associated with their use. Generally, 
all protease inhibitors may cause hyperglycemia, diabetes mellitus and redistribution or 
accumulation of body fat and may increase the risk of bleeding in patients with 
hemophilia. They are also the causes of gastrointestinal adverse events such as nausea 
and diarrhea. 
Other adverse reactions occur less commonly, and some are primarily associated with 
the use of a particular protease inhibitor. The widely used HIV-PI Saquinavir was 
found to be the most toxic in majority of cell types99. Atazanavir causes asymptomatic 
hyperbilirubinemia, which may be accompanied by jaundice in many patients, although 
it is reversible upon discontinuation of treatment. The use of Ritonavir and 
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Lopinavir/Ritonavir has been associated with large increases in total cholesterol and 
triglyceride concentrations, and in some cases, pancreatitis. Some patients treated with 
Amprenavir have experienced severe and life-threatening skin reactions, including 
Stevens-Johnson syndrome. Thus the development of new effective PIs for 
antiretroviral therapy with less toxicity and improved enzyme-inhibitor interaction is in 
high demand. 
 
1.4. Introduction to Statistical learning methods 
The key concepts of the learning methods are data and hypotheses100. As such, 
statistical learning methods are capable of learning from the evidence and predicting 
the new observations. The mathematical analysis of the learning process began when 
the first learning machine, Perceptron, was suggested by F.Rosenblatt in 1960s101. The 
Perceptron addressed the pattern reorganization problem by generalizing rules from 
given examples for recognizing their specific patterns. The Perceptron was soon widely 
known as it brought a general model of learning phenomenon. Over the past 50 years, a 
number of machine learning methods have been introduced for solving real-life 
problems, for examples, Decision Trees, Hidden Markov Model, Neural Networks and 
Support Vector Machines.  
From the conceptual point of view, statistical learning methods are carried out in two 
flavors: supervised learning and unsupervised learning.  During supervised learning, 
the observations are divided into two groups: explanatory part and one (or more) 
dependent part that was treated as the consequence of the explanatory part. The purpose 
of the learning process is to specify a relationship between the explanatory part and the 
dependent part. The application of supervised learning requires a sufficiently large 
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number of data. Approaches under this category such as K-Nearest neighbor, Linear 
Learning Machines, Support Vector Machines, Probalistic Neural Networks, etc. were 
widely applied in the field of pattern reorganization.    During unsupervised learning, 
all data under investigation are allowed to speak for themselves and they are treated 
evenly. They are forming naturally without any interference, i.e. the unsupervised 
learning methods do not happen to have advanced indication of correct or incorrect 
answers; instead, they adjust through direct confrontation with new experiences. This 
learning process is called self-organization. Many machine learning methods, such as 
Self Organization Map, clustering methods including both hierarchal clustering and 
partitional clustering, are implemented in the unsupervised manner. 
Many statistical learning algorithms have been successfully applied in the pattern 
reorganization problems such as text reorganization and protein function classifications. 
In the following several sections, we will focus on some of the machines learning 
algorithms that have been employed in solving biological problems. 
1.4.1. K- Nearest Neighbor 
Learning from the observations is the centre of machine leaning system. KNN is an 
intuitional approach to demonstrate such learning process. An important feature of 
KNN is instance orientation. The decision procedure of KNN is very simple and 
intuitional by assuming that observations that are close together will share the same 
domain. The learned observations are pre-labeled while the new observation will be 
evaluated based on a similarity measure. The conclusions are based on the rule of 
“majority wins” voted by the K nearest neighbors closest to the new observation, 
whereas the remaining pre-labeled observations will not be considered for making 
decisions. The K, number of nearest neighbors, is a manageable variable optimized 
during the model training.  Practically, K should be smaller with respect to the number 
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of observations in order to make the data points close enough to produce an accurate 
estimate of the new observations. On the other hand, the K should be large enough to 
minimize the misclassification error due to biased examples involved in 
decision-making process. 
Various forms of K-nearest neighbor methods have been applied widely in dealing with 
biological information. Because of its conceptual simplicity and good performance in 
particular problems, it has become a basic method for solving information centric 
problems such as pattern reorganization problems in bioinformatics. Moreover, it is 
usually selected as a benchmark tool for comparison.  
The problem setup of KNN in the analysis of biology data is mostly for pattern 
recognitions, such as the detection of ventricular arrhythmia102, the study of 
Quantitative Structure-Activity Relationship(QSAR)62, 103-106,  the classification of 
protein families based on certain characteristics such as protein function107 and protein 
allergenicities108.   
The similarity measure used in KNN could be a drawback, because it treats all features 
equally based on computational similarities of distances. Since the nature of KNN is 
that only K nearest neighbors is considered for decision-making, this probably can lead 
to poor classification accuracy.  
1.4.2. Clustering Methods 
No matter how the learning problem is complicated, the information that the machine 
are learning could be enormous. Clustering method is one of the statistical learning 
approaches to reduce the amount of data by categorizing or grouping similar data items 
together.  
Clustering methods109-115 come in two basic types: hierarchical and partitional 
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clustering. There exist a wealth of subtypes and different algorithms across a wide 
variety of communities for these two basic types of clustering methods.  
Hierarchical clustering is implemented either by merging small clusters into larger ones, 
or by splitting large clusters into small ones. The clustering methods differ in the 
strategies on deciding which two small clusters should be merged together or which 
large cluster should be further divided. The end of the clustering procedure is a tree of 
clusters, which is also called a dendrogram. The obtained clusters are related together 
by sharing the root, which is like a tree with many branches and leafs. By cutting the 
dendrogram at a desired level, one can obtain a clustering of the data items into disjoint 
groups. Partitional clustering, on the other hand, attempts to decompose the data set 
into a set of disjoint clusters. The clustering algorithm tries to minimize the objective 
function by assigning clusters to the peaks in the probability density function. One of 
the partitional clustering algorithms is K-means clustering which is minimizing 
dissimilarity in the samples within each cluster and meanwhile maximizing the 
dissimilarity between clusters. 
Many biological problems require the information categorizing to extract hints or clues 
for interpreting biological phenomenon. Such as the study of genotypic and phenotypic 
relationships116, 117, Clustering receptors118, 119, disease feature clustering116, 120 etc. 
Although it is useful to abstract the flood of biological information for extracting easy 
understandable rules, it should be used with caution when the problem domain is very 
complex. The knowledge exploration of clustering approach requires little or no prior 
knowledge and start from the understanding of the whole data set, which makes the 
clusters very difficult to maintain. Grouped clusters based on the distance similarity can 
be easily affected by the input data with poor similarity measure.  
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1.4.3. Decision Trees 
The Decision Tree is a popular machine learning algorithms in the application of data 
mining and pattern reorganization. Compared with many other machine learning 
approaches, such as neural networks, support vector machines and instance centric 
methods, Decision Tree is simple to construct efficient in decision making. It can 
produce human readable and interpretable rules. These rules provide an insight into the 
problem domains. 
Decision Trees generate a series of rules from the input examples and then apply these 
rules to new examples for prediction. These rules are linked together and are shaped in 
a tree structure. The working flow starts from the topmost node and every decision of 
the node determines the direction of next node movement until the end of the tree 
branch node is reached. Therefore, the topmost node is the root of the decision tree, the 
variable playing this role is evaluated first as everything should start from the root of 
the tree. The variable on the root of the decision tree is one of the highest information 
gains. That is where the constriction of Decision tree starts form. Branches nodes of 
Decision trees can be calculated in the same way as a recursive procedure.  Many 
elegant algorithms for building decision trees with the desirable quality have been 
introduced and applied in many real life problems, for example, C4.5121(derived from 
ID3),CART122, CHAID123 are well known programs for decision trees construction. 
Decision Tree has been demonstrated useful for common medical clinical problems 
where uncertainties are unlikely124-128.  The logic flow of constructed Decision Trees 
can be an aid for the physician choosing a clinical strategy that offers the patient with 
the greatest expected value124, 129. Various application of Decision Trees in medical 
applications126-128, 130, 131 are shown. The wise designed tree logic with wise 
administrative and flexibly understanding of the decision could benefit both economy 
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and patients. Decision tree also has been applied in some biological information 
analysis problems, such as motif identification approach to explain T cell responses132, 
leiomyomatous tumors characterizations133,  exons and introns identification in DNA 
sequences134.  
The construction of the decision trees usually requires large number of samples to 
produce a meaningful classifier in biological problems. Additionally, Decision trees 
may not perform well than other methods when the problem is complex. Because it is 
difficult or even impossible find enough samples to describe the problem, the rules 
generated by Decision trees may be biased or even misleading 125.  
1.4.4. Neural Networks 
It has been a long time we understand about how the human brain working differ from 
the traditional data analysis methods either in performance or in learning process. From 
the basic conceptual point of view, mathematical methods designed to mimic the way 
of information processing and the knowledge acquisition in human brain are neural 
networks. As its name indicated, neural networks consist of group of neurons that are 
linked together into a network. Increasing efforts were directed to the study of the 
learning problem by various neural networks since the so-called back propagation 
method was proposed to simultaneously compute the weight coefficient of neurons 
within the networks135, 136 in 1986. The use of neural networks is still a hot research area 
in current machine learning research, such as pattern reorganization, association, and 
transformation to modeling in process control or expert system. 
A neural network trains a hidden-layer-containing network and uses the output of this 
layer to recognize patterns from the input feature vectors 137, 138, where each vector 
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where j0  is the output weight of a hidden node j  to an output node; w g  is the 
output function; jh  is the value of a hidden layer n do e: ∑ += jjjij wxw(δ , jiw  is 
j
h
the input weight from an input node i to a hidden node j, wj is the threshold weight from 
an input node of value 1 to a hidden node j, and δ  
on in m
is a sigmoid function. The learning 
process is to optimize the weight vectors of all the neurons. The knowledge is gained 
from the learning and acquired by these weight vectors. Therefore, the optimized 
network that could act as a classifier can be used for determining whether or not a new 
input data of an observation response to a specific pattern. 
The most widely used transfer active functi any neural network applications is 
the sigmoid function, ( ) xexf −+= 1
1 .  Other alternative activation f e 
Gaussian have also been used widely in neural networks, e.g. probabilistic neural 
networks . Although the underlying principle of every kind of neural networks start 
from the human neurons simulation, different approaches may have different 
performance for different problems. In the study of anesthesia, intensive care, and 
emergency medicine by neural network, it has been shown that “complex, non-linear, 
and time depending relationships can be modeled and forecasted” . The encouraging 
results obtained in drug lead discovery and development also demonstrate it as a robust 
tool . The successfully implementation of NN approaches bioinformatics problem 
have been demonstrated in protein structure prediction 14 , protein f
protein-protein interaction prediciton 150.  
Unfortunately, there are still several concerns  138 for using neural networks to solve 
our problems. Firstly, it requires a great deal of computational effort to minimize 
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output variables are not developed without analytical basis so that the model tends to be 
a black box. Thirdly, neural networks have a number of weight parameters that are 
consequently increasing the computation costs for model training.  
the 
1.4.5. Support Vector Machines 
The basis of Support Vector Machine (SVM) learning theory had been brought forth by 
Vapnik151 in 1979. It receives increasing attention since it was officially introduced by 
Vapnik152 in 1995 and further explained by Dr. Burges153 in 1998. Because of the 
successful fundamental construction of the theory and the prominent learning power, 
much more efforts have been directed into both the study of its theoretical aspects and 
the potential of its applications. SVM has been applied to a wide range of problems 
including text categorization154-156, hand-written digit recognition152, tone 
recognition157, image classification and object detection158-161; flood stage 
forecasting162; cancer diagnosis163-165, microarray gene expression data analysis166, 
inhibitor classification167, prediction of protein solvent accessibility48, protein fold 
recognition47, protein secondary structure prediction49, prediction of protein-protein 
interaction14 and protein functional class classification31, 43, 45. These studies have 
demonstrated that SVM is consistently superior to other supervised learning methods 
including classification methods43, 166, 167. Thus in this study, we selected SVM as 
main statistical learning approach for predicting protein functions and inhibitors.  
SVM is based on the structural risk minimization (SRM) principle from statistical 
learning theory152. In linearly separable cases, SVM constructs a hyperplane that 
separates two different classes of vectors with a maximum margin. Examples are tested 
by placing them onto this input space to recognize the classification label based on their 
relative positions to the hyperplane. As real world problems are most likely in 
non-linear forms, SVM can be extended by introducing kernel mappings that are able to 
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project the samples from non-separable space onto a high-dimensional feature space in 
which the training examples can be linearly separated. The optimal separation 
hyperplane obtained in this high-dimensional feature space corresponds to the 
nonlinear decision boundary in the input space. 
 in a wide range of real 
. A function 
m  
nding class label. 
Every data point is under the same pro y),  
1.4.5.1. Theory and algorithm 
The beauty of SVM is not only in its successful applications
world classification problems, but also from where it starts.  
Support vector machine aims to recognize patterns by learning process
apping is described by training data set (xi, yi) for pattern recognition: 
}1{: ±→NRf                                          (1) 
where xi are the n-dimensional feature vectors and yi are the correspo
bability distribution P(x, 
}1{),),...(,(),,( 2221 ±∈ XRyxyxyx Nll                     (2) 
The function f is well generalized so that the training dataset (xi, yi), i = 1, 2, …, l, 
satisfy f (xi) = yi. Through the learning, the function f is usually able to correctly 
recognize new examples (xj, yj), by satisfying f (xj) = yj. However, the fact is that the 
generalized function f from the training dataset may have the poor performance on 
predicting new samples. That is, for any test dataset (xj, yj) ∈ RN X {±1} and  ∩ {x1, 
x2, …, xi} = { }, there exists another function f* such that f* (xi) = f (xi) for all i and f* 
(xj) ≠ f (xj) for all j.  
Thus, there no way to decide which decision function is better than the other. In order to 
minimize the testing error, the statistical learning theory or the Vapnik-Chervonenkis 
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(VC) theory101 is thus introduced to add the bounds on the test error. The minimization 
of these bounds, which depend on both the empirical risk (training error) and the 
capacity of the function class, leads to the principle of structural risk minimization151. 
The best-known capacity concept of VC theory is the VC dimension, defined as the 
largest number h of points that can be separated in all possible ways using functions of 
given class. If the h < l is the VC dimension of the class of functions that the machine 
le  all functions of that class, the bound with a probability 
of at least 1- η will be 




ηφαα +≤                           (3) 









ηφ =                   (4) 
h )log()1(log −+
From the above function, in order to increase the capacity, a large VC dimension h 
The aim of SVM learning is to find the optimal separation hyperplane (OSH) that can 
separate the positive and negative samples by achieving maximum margins as shown in 
Figure 1-1. 
should be considered; the increase of h is accompanied by the increase of the 
confidence term φ. 
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Figure 1-1. The binary classification and the hyperplane. Hyperplanes 1±=+• bxw  
are boundaries of two classes of examples denoted by circles and squares. The OSH 
 is decision hyperplane to separate the positive and negative samples. 0=+• bxw
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Any hyperplane that can separate the input samples in the n-dimensions space can be 
described as follows: 
0) +⋅ bxw RbR N ∈∈ , )               ( =       (         (5) 
                (6) 
w
where w is the weight vector and the corresponding decision functions 
))(()( bxwsignx +⋅=                    f
It has been proved that the OSH is a unique one among the hyperplanes described in 
equation (5) which could yield the maximum margin of separation between the 
classes152, 
bw,
max },...,2,1,0)(,R||:min{|| N libxwxxx i ==+⋅∈−      (7) 
The construction of the Optimal Hyperplane is achieved by solving the following 
optimization problem: 
minimize 2||||1) ww =                               (
2
(τ 8) 
subject to libxwy ii ,...,2,1,1))(( =≥+⋅⋅                (9) 
ization problem, the Langrangian and the Lagrange 
multiplier αi is introduced, 










2 )1))(((||||,,( α           (10) 
Where 0≥iα . The Lagrangian L has to be minimized with respect to the primal 
expansion 
variables w and b and maximized with respect to the dual variables αi. w here has an 
∑= i iii xyw α in terms of a subset of t  patters, called Support he training
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where b is calculated by 
∑l xysignx (()( α=
=
+⋅⋅
.,...,2,1,0]1))(([ libwxy iii ==−+⋅⋅α                   (12) 
ension space where the 
problem can function non-linearly maps 
ase when the relation 
between class labels and attributes is nonlinear: 
                                        (13) 
This requires the evaluation of dot products by a simple kernel function,  
1.4.5.2. Feature Spaces and Kernels 
When the examples is inseparable by linear SVM, the SVM OSH is developed by 
mapping data from input dimension space into higher dim
 be solved by linear approach. The kernel 
samples into a higher dimensional space, so it can handle the c
FRN →:φ
F is the hyperspace where the original problem becomes linear. 
))()((:),( yxyxk φφ ⋅=                               (14) 
ernel,  
k                         (15) 
s N le, d = 2 and x, y ∈ R2, then 
If F is high-dimensional, then kernel function, polynomial k
dyxyx )(),( ⋅=             
can be shown to correspond to a map φ into the space spanned by all products of exactly 
d dimen ions of R . For examp
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defining ),2,()( 2211 xxxxx =φ . For every kernel that gives rise to a positive 
matrix ijji xxk )),(( , a map 
22
φ  can be constructed.  
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The RBF function is chosen in this study because it has few numbers of parameters that 
fluence the complexity of model selection. Furthermore, it reduces computation cost 
compared with polynomial kernels that kernel values may go to infinity or zero while 
the degree is large. In addition, RBF kernel has been commonly used in other SVM 
protein studies with consistently better performance than other kernels such as linear 
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2. Scope and Research Objective 
One of the main purposes of this study is to develop a classification system for 
predicting protein functions from their primary sequences. There are four focuses for 
this objective. Firstly, the features vectors are constructed from protein primary 
sequence. Our designed physico-chemical properties derived from sequence are 
independent to sequence similarities. Secondly, the strategy employed in this work is to 
classify proteins according to their functional families from their primary sequences by 
using Support Vector Machines (SVM). SVM is a relatively new and promising 
algorithm for binary classification by means of supervised learning. Although the 
studies of SVM used to solve various problems have demonstrated that SVM is 
consistently superior to other supervised learning methods including classification 
methods166, 167, problems, such as data unbalance and over fitting are still critical when 
the optimal separation problem is addressed. Thirdly, the prediction system based on 
the well established SVM models are developed for solving the multiple-class 
classification problem. Various protein functional classes’ classification problems are 
properly solved before their use for protein function prediction. Lastly, the potential of 
our designed protein function prediction system for predicting novel proteins’ function 
are evaluated.  
Because the problems of resistance development and physiological side effects remain 
in current HIV-1 protease inhibitors, methods for facilitating early elimination of 
potential HIV-1 protease inhibitors are useful for speeding up new drug discovery. 
Another main objective of this study is to predict HIV protease inhibitors by statistical 
learning approach. In order to fulfill this task, four important components are brought 
forward.  Firstly, thousands of HIV-1 protease inhibitors are manually collected and 
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checked to ensure the data quality. Secondly, the non-protease inhibitors used as 
negative control are representatively selected by distribution analysis. In order to 
diversify the negative control data set, compounds database containing large number of 
compound structures is constructed for diversity analysis. Thirdly, feature selection is 
considered to select distinguishing features for identification of HIV-1 protease 
inhibitors. Lastly, the prediction system is developed for protease inhibitor prediction 
and novel HIV-Protease inhibitor design. 
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3. Methods used in this study 
3.1. Protein functional family classification and prediction 
3.1.1. Feature vector construction 
Construction of the feature vector for each protein is based on the formula used for the 
prediction of protein-protein interaction 14, protein fold recognition47, and protein 
family classification31, 43, 45, 46. Each feature vector is constructed from the encoded 
representations of tabulated residue properties including amino acids composition, 
hydrophobicity, normalized van der Waals volume, polarity, polarizability, charge, 
surface tension, secondary structure and solvent accessibility14, 43.  
Amino acid composition can be computed directly. Some of the methods for computing 
each of the other properties can be found from the literature14, 31, 43, 47, 49. For calculating 
each group of properties, amino acids are divided into three groups such that those in a 
particular group are considered to have the same property. For instance, amino acids 
can be divided into hydrophobic (CVLIMFW * ), neutral (GASTPHY), and polar 
(RKEDQN) groups. The groupings of amino acids for each of the properties are given 
in Table 3-1. Three descriptors, composition (C), transition (T), and distribution (D), 
are used to describe global composition of each of the properties. C is the number of 
amino acids of a particular property divided by the total number of amino acids in a 
protein sequence. T characterizes the percent frequency with which amino acids of a 
particular property is followed by amino acids of a different property. D measures the 
chain length within which the first, 25%, 50%, 75% and 100% of the amino acids of a 
particular property is located respectively.  
A hypothetical protein sequence AEAAAEAEEAAAAAEAEEEAAEEAEEEAAE, as 
                                                        
* List of amino acid in standard one letter amino acid codes 
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shown in Figure 3-1 , has 16 alanines (n1=16) and 14 glutamic acids (n2=14). The 
composition for these two amino acids are n1×100.00/(n1+n2)=53.33 and 
n2×100.00/(n1+n2)=46.67 respectively. There are 15 transitions from A to E or from E 
to A in this sequence and the percent frequency of these transitions is 
(15/29)×100.00=51.72. The first, 25%, 50%, 75% and 100% of alanines  are located 
within the first 1, 5, 12, 20, and 29 residues respectively. The D descriptor for alanines 
is thus 1/30 ×100.00=3.33, 5/30×100.00=16.67, 12/30×100.00=40.0, 
20/30×100.00=66.67, 29/30×100.00=96.67. Likewise, the D descriptor for glutamic is 
6.67, 26.67, 60.0, 76.67, 100.0. Overall, the amino acid composition descriptors for this 
sequence are C=(53.33, 46.67), T=(51.72), and D=(3.33, 16.67, 40.0, 66.67, 96.67, 
6.67, 26.67, 60.0, 76.67, 100.0) respectively. Descriptors for other properties can be 
computed by a similar procedure.  
Overall, there are 21 elements representing these three descriptors: 3 for C, 3 for T and 
15 for D. The feature vector of a protein is constructed by combining the 21 elements of 
all of these properties and the 20 elements of amino acid composition in sequential 
order. Table 3-2 gives the computed descriptors of the Purinergic receptor (Swiss-Prot 
AC O70397) with 474 amino acids. The feature vector of a protein is commutated by 
combining all of the descriptors in sequential order. 
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Figure 3-1 The sequence of a hypothetic protein and the illustration of feature vector 
derivation from its sequence. Sequence index indicates the position of an amino acid in 
the sequence. The index for each type of amino acids in the sequence (A or E) indicates 
the position of the first, second, third, … of that type of amino acid (The position of the 
first, second, third, …, A is at 1, 3, 4, …). A/E transition indicates the position of AE or 




Chapter 3 Methods 
Table 3-1 Division of amino acids into 3 different groups for different 
physicochemical properties 
 
Property   Group 1 Group 2 Group 3 
Type Polar Neutral Hydrophobic Hydrophobicity Amino Acids in Group RKEDQN GASTPHY CVLIMFW 
Value 0~2.78 2.95~4.0 4.43~8.08 van der Waals 
volume Amino Acids in Group GASCTPD NVEQIL MHKFRYW 
Value 4.9~6.2 8.0~9.2 10.4~13.0 Polarity Amino Acids in Group LIFWCMVY PATGS HQRKNED 




Table 3-2 Characteristic descriptors of Purinergic Receptor (Swiss-Prot AC O70397). 
The feature vector of this protein is constructed by combining all of the descriptors in 
sequential order. 
Property Elements of Descriptors of Purinergic Receptor (Swiss-Prot AC O70397) 
6.54 2.95 4.43 4.01 4.43 7.38 3.16 6.33 5.06 8.02 Amino acid 
composition 1.05 3.16 7.81 4.22 5.06 7.17 6.54 6.96 1.89 3.80 
25.95 42.41 31.65 23.04 18.39 25.16 1.48 23.00 47.68 75.11
99.79 0.42 27.00 53.16 79.96 99.58 0.21 22.57 48.10 71.52Hydrophobicity
100.0  
42.83 32.70 24.47 28.12 20.51 14.80 0.42 28.48 53.80 80.38
99.58 2.53 20.04 49.36 73.42 100.0 0.21 21.94 46.41 66.46Van der waals volume 98.95  
35.44 35.44 29.11 23.47 23.04 21.35 0.21 22.36 47.26 70.68
100.0 0.42 27.00 54.01 81.22 99.58 1.05 24.47 48.31 75.11Polarity 
99.79  
32.07 43.46 24.47 30.66 15.01 20.30 0.42 28.48 53.16 76.16
99.58 1.27 23.42 50.63 76.79 100.0 0.21 21.94 46.41 66.46Polarizability 
98.95  
 
3.1.2. Effective selection of examples 
Statistical learning process of binary classification SVM requires both positive 
examples and negative samples, for example, proteins examples from a particular 
functional family and those outside of this family. The positive samples of a family 
include all of the known distinct proteins in that family. Ideally, the negative samples of 
the given family should include all of the proteins outside of the family. Because the 
proteins are enormous, it is impractical to include all of the proteins outside of the 
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family as negative examples for statistical learning. Thus, the negative samples selected 
statistical learning should be restricted to a manageable level by using a minimum set of 
representative proteins.  
Our approach to select effective proteins examples is to choose a few distinct proteins 
from each protein family. The negative samples of a family can be selected from seed 
proteins of the curated protein families in the Pfam database169 excluding those families 
that have at least one member belongs to the Pfam family. The purpose of using Pfam 
families to generate negative protein examples is to ensure that the negative examples 
are more evenly distributed in the protein space than random selection. However, only 
the selection of negative examples is involved in using of Pfam families that are based 
on sequence similarity; the positive examples are collected without any consideration 
of sequence similarity. Thus, our approach for protein functional family classification 
is to some extent independent of sequence similarity.  
3.1.3. Support Vector Machine classification 
As the theory of SVM has been described in the previous section, only a brief 
description of our strategy of the implementation is given here. 
In nonlinearly separable cases, SVM maps feature vectors into a high dimensional 
feature space using a kernel function ),( ji xx . The kernel function employed in this 
work is the Gaussian kernel, which has been extensively used in a number of protein 
classification studies
K
14, 31, 44, 47-49, 153: 
2 2/ 2( , ) j iei jK
σ− −= x xx x                                                  (1) 
The linear SVM procedure is then applied to the feature vectors in this feature space 
and the decision function for their classification is given by:  
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f sign y K bα
=
= ∑x x +x                                           (2) 
Where the coefficients αi0 and b are determined by maximizing the following 
Langrangian expression:  
1 1 1
1 ( , )
l l l
y y Kα α α− ∑ x x2i i j i j i ji i j= = =∑ ∑                                         (3) 
Under conditions:  
ia yα≥ =∑                                                (4) 
hard margin SVM with threshold instead of soft margin SVM is used in our 
ss) and negative prediction (proteins that do not 
47: 
1i=
A positive or negative value from Equation (2) determines whether the vector x belongs 
to the positive or negative group. In order to reduce the complexity of parameter 
selection, 




As in the case of all discriminative methods170, 171, the performance of SVM 
classification can be measured by the quantity of true positive TP (correctly predicted 
members), false negative FN (incorrectly predicted as non-members), true negative TN 
(correctly predicted non-members), and false positive FP (non-members incorrectly 
predicted as members). In this work, protein functional family classification is a 
one-against-other multi-class prediction problem, thus the unique accuracy47 
specifically designed for evaluation of multi-class prediction is used. Due to the 
imbalanced number of positive and negative samples for each sub-class, two unique 
accuracies Qp and Qn are used to measure the accuracy of positive prediction (proteins 
that belong to a specific functional cla
belong to a given functional class) 
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FNTP
TPQp +=                                              (5) 
FPTN
TNQn +=                                              (6) 
uantity suitable for evaluating the classification accuracy of imbalanced 








A reliability index of SVM protein family p n introduced in 




lue, is introduced to indicate the expected 
classification accuracy. P-value is derived from the statistical relationship between the 
R-value and actual classification accuracy based on the analysis of 9,932 positive and 
45,999 negative samples of proteins 43. 
=                   (7) 


















dvalueR                       (8) 
Where d is the distance between the position of the vector of a classified protein and the 
optimal separating hyperplane in the hyperspace. A statistical correlation between 
R-value and expected classification accuracy or probability of correct classification  
as show in Figure 3-2. Another quantity, P-va
<≤
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Figure 3-2 Expected classification accuracy P-value (probability of correct 
classification) versus R-value. It is derived from the statistical relationship between 
the R-value and actual classification accuracy based on the analysis of 9,932 positive 







3.1.4. Protein functional family classification systems-SVMProt  
In this work, we have developed a protein functional family classification systems, 
SVMProt153, based on support vector machines (SVM) for protein functional family 
prediction. The construction of SVMProt protein function prediction system is 
currently containing 97 protein functional classes as listed in Appendix A. The 97 
protein functional classes include 46 enzyme families, 9 channel/transporter families, 
21 transporter families, 4 RNA-binding protein families, DNA-binding proteins, 5 
G-protein coupled receptors, nuclear receptors, tyrosine receptor kinases, cell adhesion 
proteins, coat proteins, envelope proteins, outer membrane proteins, structural proteins, 
and growth factors. Two broadly defined families of antigens and transmembrane 
proteins are also included.  
Every protein function classification model in SVMProt has been trained and tested by 
using a large number of proteins. A training set contains positive examples those 
proteins belong to a functional family, and negative examples referring to those outside 
a family. The negative examples of a protein family are collected from representative 
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proteins of the Pfam families without a member in that class A training set needs to be 
both diverse and kept as small as possible in order to ensure adequate representation 
and to reduce un-necessary noise generated from data redundancy.  
 
The numbers of member and non-member protein sequences in the training sets are in 
the range of 14~3,892 and 513~7,299 respectively, and those of the independent 
evaluation sets are in the range of 7~4,841 and 986~7,291 respectively. For examples, 
945 glycosyltransferases proteins and 1,896 non- glycosyltransferases are used for 
training glycosyltransferases (EC2.4) family, and there are 288 glycosyltransferases 
proteins and 4,926 non- glycosyltransferases are used for independent evaluation of 
glycosyltransferases (EC2.4) family. The number of sequences in all classes can be 
found in the Appendix A. 
We develop the protein classification model in the following manner. First, every 
protein sequence is represented by specific feature vectors assembled from encoded 
representations of tabulated residue properties including amino acid composition, 
hydrophobicity, normalized van der Waals volume, polarity, polarizability, charge, 
surface tension, secondary structure and solvent accessibility for each residue in the 
sequence. The feature vectors of the positive and negative samples are used to train a 
SVMProt classifier. The trained SVMProt classifier is used to determine whether a 
protein belongs to this protein functional class or not. 
The SVMProt training system for each family is optimized and tested using separate 
testing sets of both positive and negative samples. Those proteins outside of the training 
set for each functional family are positive examples of the testing set, and all the 
representative seed proteins in Pfam curated families not used for model training are 
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negative examples of the testing set. The performance of SVMProt classification is 
further evaluated by using independent sets consisted of both positive and negative 
examples. There is no overlap in each training, testing or independent evaluation set. 
Not all of the protein functional classes in SVMProt are at the same hierarchical level. 
These protein functional classes are mixtures of subfamilies, families and 
super-families. Some classes, such as antigen, are superfamily. While it is desirable to 
define all of the classes at the same level, this is not yet possible because of 
insufficiency of data for the sub-hierarchies of some families and super-families. 
Because of independency of SVMProt classifiers, different classification models can 
work simultaneously. 
3.2. Methods for protein inhibitor prediction 
3.2.1. Molecular descriptors 
As shown in Table 3-3, a set of 159 molecular descriptors were used for quantitative 
description of structural and physiochemical properties of molecules in this study. 
There are 18 simple molecular properties, 28 molecular connectivity and shape 
descriptors, 84 descriptors computed from electro-topological state, 13 quantum 
chemical properties and 16 geometrical properties. All of these descriptors are 
calculated from the 3D structure of compound by using our previously published 
molecular descriptor program173. 
Chapter 3 Methods 
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Table 3-3 Molecular Descriptors used in this work 
Descriptor class Number of descriptors Descriptors 
Simple molecular properties 18 Molecular weight, number of ring structures, number of rotatable bonds, number of H-bond donors, number of H-bond acceptors, element counts 
Molecular connectivity and shape 28 Molecular connectivity indices, valence molecular connectivity indices, molecular shape, Kappa indices, Kappa alpha indices, flexibility index 
Electro-topological state 84 Electrotopological state indices and atom type electrotopological state indices 
Quantum chemical properties 13 
Atomic charge on the most positively charged H atom, largest negative charge on an non-H atom, 
polarizability index, hydrogen bond acceptor basicity (covalent BAB), 
hydrogen bond donor acidity (covalent HBDA),   molecular dipole moment, absolute hardness, 
softness, ionization potential, electron affinity, chemical potential, electronegativity index, 
electrophilicity index 
Geometrical properties 16 
Molecular size vectors (distance of the longest separated atom pairs, combined distance of the 
longest separated three atoms, combined distance of the longest separated four atoms), molecular 
van der Waals volume, solvent accessible surface area, molecular surface area, van der Waals 
surface area, polar molecular surface area, sum of solvent accessible surface areas of positively 
charged atoms, sum of solvent accessible surface areas of negatively charged atoms, sum of charge 
weighted solvent accessible surface areas of positively charged atoms, sum of charge weighted 
solvent accessible surface areas of negatively charged atoms, sum of van der Waals surface areas of 
positively charged atoms, sum of van der Waals surface areas of negatively charged atoms, sum of 
charge weighted van der Waals surface areas of positively charged atoms, sum of charge weighted 
van der Waals surface areas of negatively charged atoms. 
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3.2.2. Selection of HIV-1 PI candidates 
4291 HIV-1 PI candidates are selected as positive training samples from the HIV/OI 
Enzyme Inhibition Database†  of the National Institute of Allergy and Infectious 
Diseases, National Institutes of Health. 
Since the quality of input data have a direct effect in the training of the SVM model, the 
positive samples from the database were further examined by checking each of the PIs 
against PubMed Database174 to ascertain that they have been described as HIV-1 
protease inhibitors. Only those with reported IC50‡ (inhibitory concentration 50%) in 
the literature were selected. Meanwhile, since PIs constitute a large chemical space 
(sulfonamides, benzopyrans, piperazines, benzimidazoles, urethanes, symmetry-based 
dihydroxy, epoxies etc.) with varying potencies for uses in different contexts, those 
with reported log (IC50) of log units -7.85 to 3.30 were selected. 
3.2.3. Selection of HIV-1 non-PI candidates 
There are numerous and diversified compounds. Thus, it is impractical to include all 
compounds outside of a specific family as negative examples. It is reliable to use 
experimentally determined negative compound examples, such as those compounds 
with non-inhibition activities to a specific protein target. However, only a small number 
of true negative examples have been report for some protein target. As such, it is 
inadequate to use those compounds to approximate the complete negative compounds 
space.  
Our approach to generate comprehensive negative examples is to choose representative 
compounds from the compound space that is not covered by positive examples.  
In order to analyze the distribution of positive examples within the compounds space, a 
                                                        
† HIV/OI Enzyme Inhibition Database: http://www.niaid.nih.gov/daids/ 
‡ IC50 (or EC50 - effective concentration 50%) is the concentration required for 50% inhibition. 
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chemical database composed of 85,000 is constructed in this study. These compounds 
and their 3D structures are selected from MDDR (MDL Drug Data Report), ACD 
(MDL Available Chemicals Directory) and ChemIDPlus§, ChemFinder** databases. 
Subsequently, we use the hierarchal clustering method to cluster these compounds into 
8,000 subfamilies according to the Euclidean distance of their descriptors.  
By this means, the compound space is condensed into 8,000 subfamilies instead of the 
original 85,000 compounds. The distribution of positive compounds is calculated based 
on the 8,000 subfamilies. Thus the distribution of negative examples could be obtained 
from the compound space that not occupied by positive examples.  
The selection of Non-PIs is based on the distribution of PIs. In this study, 12,453 
negative samples are selected to ensure data balance in the 2-class c-SVM model that is 
used. There are basically two requirements for the selection of negative example: 1) 
their structures are vary from each other, and 2) the distribution of the negative 
examples should be diversified enough to form an effective representation of negative 
compound space.  
The crude 3-dimensional structures collected from the databases are converted into 
accurate, energy-based geometry optimized 3-dimensional structures by using 
commercial software, Concord™††. 
3.2.4. Recursive feature elimination within non-linear SVM 
The purpose of feature or variable selection is to eliminate irrelevant variables to 
enhance the generalization performance of a given learning algorithm. The selected 
predominated variables show some insight about the concept to be learned 175. 
                                                        
§ http://chem.sis.nlm.nih.gov/chemidplus/ 
** http://chemfinder.cambridgesoft.com/ 
†† Tripos product Sheet, 2004 
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In this work, recursive feature elimination (RFE) using SVM-based Criteria has been 
employed to select important features for identifying HIV-protease inhibitors. Linear 
RFE-SVM algorithm has been introduced by Guyon 176 for gene selection on cancer 
classification. In this work, the algorithm is extended to solve non-linear cases. 
As Kohavi and John177 suggested, the ranking criterion for feature selection can be 
computed from feature’s influence on the objective function. In this study, the objective 
function is represented by a cost function for the ith feature in the training set. 
The basic idea of RFE is to find and remove the smallest change in cost function 
resulting from the features. In our case, the cost function to be minimized is: 
LaHaa TT −= 1                               J
2
            (9) 
under the constraints Ci ≤≤α0  and_∑ = 0ii yα ;  
where H is the matrix with elements , K is a RBF kernel function that 
measures the similarity between and , and L is an l dimensional vector of ones. 
),( jiji xxKyy
i j
One can compute change in cost function by assuming no change in the value of the a . 
Thus, one avoids having to retrain a classifier for every candidate feature to be 
eliminated. In order to compute the change in cost function caused by removing input 
component 
x  x
δ  ,  we can leaves the a  unchanged and one re-computes matrix H  
corresponds to calculate 
. This
))(),(( δδ excludexexcludexKyy jiji                         (10) 
yielding matrix )( δexcludeH , where the notation δexclude  means that component δ  
has been removed. The resulting ranking coefficient is:  
                   (11) aexcludeHaHaaDJ YT )(5.05.0)( δδ −=
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The input corresponding to the smallest difference )(δD  is removed. This procedure 
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4. Protein functional family classification based 
on primary sequence by Support Vector 
Machines 
The work in this chapter has been published in: 
I) Enzyme Family Classification by Support Vector Machines. C.Z. Cai, L.Y. Han, 
Z.L. Ji, Y.Z. Chen .Proteins. 55,66-76 (2004). 
II) Prediction of RNA-Binding Proteins from Primary Sequence by Support Vector 
Machine Approach. L.Y. Han, C.Z. Cai, S. L. Lo, Maxey C. M. Chung,Y. Z. 
Chen. RNA. 10(3),355-368. (2004). 
III) Prediction of Transporter Family by Support Vector Machine Approach H. H. 
Lin, L.Y. Han, C.Z. Cai, Z. L. Ji, and Y.Z. Chen. Proteins. 62 (1): 218-31 (2006) 
 
Determination of protein function is essential for understanding biological processes. 
Our approach for predicting protein function is based on the protein functional family 
classification. The method used in our study for protein functional family classification 
starts from the analysis of physicochemical properties of a protein derived from its 
primary sequence. In the coming sections, our results of classification on some specific 
protein functional families, such as enzymes and transporters, are described. 
4.1. Enzyme Family Classification (Paper I) 
Enzymes represent the largest and most diverse group of all proteins, catalyzing 
chemical reactions an organism needs to survive. In addition, enzymes are well 
classified into functional families according to the recommendation by the 
classification of enzyme nomenclature committee of IUBMB178. Therefore, enzymes 
are ideal for comprehensive testing of SVM protein family classification systems. In 
our study for protein family classification, enzymes from protein sequence database 
have been classified into 46 enzyme families and classifier for each enzyme family has 
been further tested by independent evaluation. The optimized enzyme classifiers are 
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also evaluated for their capability in the classification of distantly related enzymes and 
homologous enzymes with different function. 
4.1.1. Methods 
The definitions of enzyme families are obtained from BRENDA database179. As  
sufficient number of samples are required for developing a SVM classification system 
with statistical significance, only 46 enzyme families with more than 100 
non-redundant protein entries for each family in Swiss-Prot Enzyme database180 are 
selected in our study. Appendix A gives the list of enzyme families along with the 
number of enzymes for each family used for training, testing and evaluating SVM 
classification system. 
All distinct members in each enzyme family found in Swiss-Prot database180 are used to 
construct positive samples for training SVM. Based on the definition of enzyme 
families in BRENDA179 and annotations in Pfam database 180, the negative samples for 
each enzyme family are selected from seed proteins of the curated protein families in 
the Pfam database169. Negative samples of one enzyme family include proteins from 
other enzyme families and non-enzyme proteins such as receptors, transporters, 
channels and matrix proteins. The redundancy in the selected datasets has been further 
removed by sequence comparisons. 
Every enzyme sequence is represented by specific feature vectors assembled from 
encoded representations of tabulated residue properties including amino acid 
composition, hydrophobicity, normalized van der Waals volume, polarity, 
polarizability, charge, surface tension, secondary structure and solvent accessibility for 
each residue in the sequence14, 31, 47-49, 181, 182. There is some level of overlap in the 
descriptors for hydrophobicity, polarity, and surface tension. Our study of these 
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descriptors by principle component analysis suggests that the use of the PCA-reduced 
descriptors only moderately improves the accuracy for only some of the families. As it 
is also noted that reasonably accurate results have been obtained in various protein 
classification studies using these overlapping descriptors14, 31, 47-49, 181, 182. Thus, we 
choose the whole set of descriptors for our SVM study.  
The constructed feature vectors of both positive samples  and negative samples are 
then input into SVM classification system to train it to identify features that separate 
positive and negative samples. The trained SVM systems can thus be used to classify an 
enzyme into either the positive group or the negative group of each family. One enzyme 
is predicted to be a member of a family if it is classified into the positive group of that 
family. Likewise, it is predicted to not belong to a family if it is classified into the 
negative group of that family.  
 
The theory of SVM has been earlier described in Chapter 2. Thus, only the method for 
performance measurement is given here. As in the case of all discriminative methods171, 
183,  the performance of SVM classification can be measured by the quantity of true 
positives (TP), true negatives (TN), false positives (FP), and false negatives (FN). 
Enzyme family classification is a one-against-others multi-classes classification 
problem, thus the unique accuracy47, sensitivity and specificity, for evaluation of 
multi-class prediction is used in this study. Because the number of positive and 
negative samples for each family is imbalanced in size, an additional measure,  
Matthews correlation coefficient C172 (appears in Chapter 2),  is used to measure the 
randomness and the performance of SVM prediction. 
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4.1.2. Result and Discussion 
4.1.2.1. Assessment of overall accuracy of SVM enzyme family 
classification  
The results for the classification of the 46 enzyme families are given in Appendix Table 
A. All the computed TP, TN, FP, and FN for the testing sets and independent evaluation 
sets of these families are as shown in the Table. Table A also gives the unique 
classification accuracies Qp and Qn and Matthews correlation coefficient C for every 
family measured by using independent evaluation sets. The computed Qp, Qn and C for 
the 46 enzyme families are in the range of 53.0% to 99.3%, 82.1.0% to 100%, and 
54.1% to 96.1% respectively. These numbers on average are better improved from that 
obtained in other SVM studies of proteins14, 31, 47-49, 181, 182. One possible reason for this 
improvement is the use of representative proteins of Pfam curated families as negative 
samples for SVM classification, they provides a more comprehensive sampling of 
proteins not in an enzyme family.  
Table 4-1 lists a number of randomly selected enzyme entries from Swiss-Prot 
database180 which are not correctly classified into the corresponding family by our 
developed SVM classifiers . Amino acid sequence of each of these enzyme entries is 
examined to find out whether or not the classification error is caused by 
sequence-related problems such as fragment, incomplete chain, and mutations. As 
shown in Table 4-2, the composition of the negative samples for a specific enzyme 
family is diversified, thus these sequence-related problems do not appear to be a 
significant factor for the classification error. BLAST sequence alignment of each of 
these enzymes against other members of its family suggests these substantial portions 
(61.3%) of incorrectly classified enzymes are of low sequence similarity to other 
members in its family. Here, the threshold for sequence similarity score E value is 0.05. 
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The percentage of low sequence similarity proteins in a family is not expected to be 
very high. Therefore, our study seems to suggest that sequence similarity has certain 
level of influence on the accuracy of SVM classification. 
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Table 4-1.Randomly selected enzyme entries from Swiss-Prot database which are not 













EC 1.1 Q8YH79 Alcohol dehydrogenase C L 
EC 1.14 P79078 Delta-9 fatty acid desaturase C S 
EC 1.14 Q8TE42 Truncated steroid 21-hydroxylase IC L 
EC 1.14 P14791 Heme oxygenase C L 
EC 1.2 O67724 N-acetyl-γ-glutamyl-phosphate reductase C L 
EC 1.2 Q57658 Aspartate-semialdehyde dehydrogenase C L 
EC 2.1 Q9ZE37 tRNA (Guanine-N(1)-)-methyltransferase C S 
EC 2.1 Q9PJ28 Methionyl-tRNA formyltransferase C S 
EC 2.1 Q9UX08 Aspartate carbamoyltransferase C L 
EC 2.1 P96111 PyrBI protein C L 
EC 2.7 Q9JR61 Phosphatidylserine synthase C L 
EC 2.7 Q9ZE96 Phosphatidylglycerophosphate synthase C L 
EC 3.1 Q62087 Serum paraoxonase/arylesterase 3 C L 
EC 3.1 Q97VT7 Aryldialkylphosphatase, putative C S 
EC 3.2 Q9EVP3 Stx2fA protein subunit C, subunit L 
EC 3.2 Q9S9E4 rRNA-glycosidase C L 
EC 3.2 Q41216 Trichosanthin C L 
                                                        
∗ C—Complete sequence; IC—Incomplete sequence; C,subunit—Complete sequence of subunit; 
C,chain—Complete sequence of chain; L—Low sequence similarity to other enzymes in a particular 
family; S—Significant sequence similarity to other enzymes in a particular family 
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EC 3.5 P32320 Cytidine deaminase C, subunit L 
EC 3.5 Q01432 AMP deaminase 3 C, subunit L 
EC 3.5 Q49135 Methenyltetrahydrofolate cyclohydrolase C, subunit S 
EC 4.2 P73715 Endonuclease III C S 
EC 4.2 Q8RI68 Cystathionine gamma-synthase C S 
EC 4.3 Q8XMJ8 Argininosuccinate lyase C S 
EC 5.1 Q980W1 UDP-glucose 4-epimerase C S 
EC 5.1 P21955 Aldose 1-epimerase C L 
EC 5.3 P29954 Mannose-6-phosphate isomerase C S 
EC 5.4 Q8Z8D7 UDP-galactopyranose mutase C S 
EC 6.1 Q8YH72 Alanyl-tRNA synthetase C L 
EC 6.1 Q9ZDF8 Lysyl-tRNA synthetase C L 
EC 6.1 Q9HJM5 Glutamyl-tRNA synthetase C L 
EC 6.1 Q55486 Arginyl-tRNA synthetase C L 
EC 6.3 P57245 Carbamoyl-phosphate synthase, small chain C, chain S 
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Table 4-2 Composition of the negative samples for EC2.7 family. Here “other 
proteins” include proteins known to not belong to any of the families listed and those 
enzymes whose EC number is not specified at the time of our data Collection 
 
Family No. of Entries Family No. of Entries 
EC  1.1 10 EC  3.3 2 
EC  1.2 3 EC  3.4 12 
EC  1.3 17 EC  3.5 9 
EC  1.4 6 EC  3.6 33 
EC  1.5 2 EC  4.1 28 
EC  1.6 7 EC  4.2 18 
EC  1.7 2 EC  4.4 7 
EC  1.8 1 EC  4.6 5 
EC  1.9 24 EC  5.1 7 
EC 1.10 8 EC  5.4 3 
EC 1.11 4 EC  5.5 1 
EC 1.13 4 EC 5.99 9 
EC 1.14 1 EC  6.1 1 
EC 1.15 3 EC  6.2 1 
EC 1.18 2 EC  6.3 20 
EC  2.1 11 EC  6.4 6 
EC  2.3 20 EC  6.5 9 
EC  2.4 20 Receptors 17 
EC  2.5 4 Transporters 53 
EC  3.1 30 Channels 11 
EC  3.2 33 Other proteins  1455 
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The quality of each of SVM classifiers trained for classification of a particular enzyme 
family can be further assessed by conducting direct two-way tests. For such a purpose, 
a set of 3000 enzymes in a randomly selected enzyme family EC1.6 is used for testing 
the accuracy of positive classification for that family. It is found that 76.8% of these 
enzymes are correctly classified into the EC1.6 family by our SVM system. A set of 
2850 randomly selected non-enzyme proteins is used for assessing the accuracy of 
negative classification for that enzyme family. It is found that 98.5% of these 
non-enzyme proteins are correctly classified as not belong to the EC1.6 family. This 
result is comparable to the independent evaluation of the EC1.6 family in out study, 
where the sensitivity and specificity are 94.5 and 98.2 respectively. 
4.1.2.2. Independent evaluation and 10-fold cross validation  
In this work, independent evaluation sets were used to determine the accuracy of 
enzyme family classification. To examine whether it can provide sufficiently accurate 
assessment of prediction accuracy, we have conducted 10 fold cross validation on three 
randomly selected families to compare with our results from independent evaluation. 
Table 4-3 show the results of the 10-fold cross validation study for the EC1.9, EC4.4 
and EC5.2 family respectively. For comparison, the results from our study are also 
included in the respective Table. It is found that the computed Qp, Qn, and C for each of 
these families using our method is roughly similar to those obtained by using 10-fold 
cross validation study. This suggests that our method may be used to assess the quality 
of SVM enzyme family classification, with a comparable accuracy as that of n-fold 
cross validation study. 
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Table 4-3 Ten-fold Cross Validation Results of EC1.9, EC4.4 and EC5.2 family. The 
true positive TP means number of correctly predicted members, false negative FN is 
the number of incorrectly predicted as non-members, true negative TN is the number 
of correctly predicted non-members, and false positive FP is the number of 
non-members incorrectly predicted as members. Sensitivity Qp and specificity Qn are 
defined as Qp=TP/(TP+FN), Qn=TN/(TN+FP), Matthews correlation coefficient C172, 
which is given by equation (7) in Chapter 1. 
 
Performance measures EC family 
Qn(%) Qp(%) C 
10 CV 94.2 99.3 0.947 EC1.9 Independent Evaluations 95.7 99.5 0.961 
10 CV 65.7 99.9 0.791 EC4.4 Independent Evaluations 50.0 99.9 0.679 
10 CV 66.7 99.9 0.800 EC5.2 Independent Evaluations 65.3 99.8 0.776 
 
 
4.1.3. Conclusion remark 
Our study suggests the potential usefulness of SVM in classification of enzymes into 
functional families. The developed SVM models by using sequence derived 
physico-chemical properties are able to discriminate enzymes into their functional 
families with comparable accuracies and even better than other protein function 
prediction methods14, 31, 47-49, 181, 182. Moreover, it shows the capability for classification 
of enzymes with very low sequence similarities. The enzyme classification SVM 
models are very useful for classifying an unknown protein. As it is revealed in our study, 
the quality and diversity of enzyme protein samples and proteins as negative samples is 
very important for developing a SVM model with both good sensitivity and specificity. 
Our results also suggest that the developed SVM classification models could be a 
useful tool for facilitating protein function prediction.  
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4.2. Classification of RNA-Binding Proteins (Paper II) 
 
Knowledge about how proteins interact with each other and with other molecules is 
essential in the understanding of cellular processes184-187. With the accumulation of 
sequence information, attention has been paid to the development of methods for 
predicting protein function188 and protein-protein interactions14, 189, 190 from sequence. 
Several computational methods have been developed for the prediction of 
protein-protein interactions using support vector machines14 and for the prediction of 
protein-protein interaction maps by Rosetta/gene fusion12, 191, phylogenetic profile192, 
gene neighbor189, 190, and interacting domain profile pair193 methods.  
 
While progress has been made in the development of predictive methods for 
protein-protein interactions, there is no effort has been made for predicting 
protein-RNA interactions by using machine-learning approach. Most cellular RNAs 
work in concert with protein partners and protein-RNA interactions are critically 
important in regulation of different steps of gene expression186. Moreover, binding of 
proteins to some catalytic RNA molecules are known to activate or enhance the activity 
of these molecules 194. Therefore, prediction of protein-RNA interactions is very 
important for understanding how cellular processes and biological network works.  
 
In this work, the use of SVM for the prediction of RNA-binding proteins from protein 
primary sequence was explored. SVM is used for the prediction of individual classes of 
rRNA-, mRNA-, tRNA-binding proteins as well as all RNA-binding proteins. There 
are other groups of RNA-binding proteins, such as snRNA-binding and 
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snoRNA-binding proteins, with small number of proteins and fewer available 
sequences195, 196. A search of protein family and sequence databases finds a total of 60 
sequences of snRNA-binding proteins and 21 sequences of snoRNA-binding proteins, 
which is fewer than the number of 80~100 sequences typically needed to properly train 
an SVM protein classification system. Non-the-less, to evaluate its performance on 
classification of a small protein class, SVM is used for the prediction of 
snRNA-binding proteins. Proteins of small RNA-binding classes as well as other 
RNA-binding proteins are included in training and testing SVM classification of all 
RNA-binding proteins.  
 
4.2.1. Selection of RNA-binding proteins and non- RNA- binding proteins 
 
All RNA-binding proteins used in this study are from a comprehensive search of 
Swiss-Prot database 180. A total number of 4458 RNA-binding protein sequences are 
obtained, which include 2054 rRNA-, 570 mRNA-, 259 tRNA-, 60 snRNA-, and 21 
snoRNA-binding proteins. The distribution of RNA-binding proteins in different 
kingdoms and in top 10 host species is given in Appendix Table B and that of each 
class of RNA-binding proteins is given in Table 4-4. As shown in the table, these 
RNA-binding proteins are from diverse range of species and all species appear to be 
adequately represented. 
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Table 4-4 Distribution of rRNA-, mRNA-, tRNA- and snRNA-binding proteins in different kingdoms and in top 10 host species. Not all 
protein sequences studied in this work are included because the host species information of some protein sequences is not yet available in 
the protein sequence database. 
 
rRNA-binding   mRNA-binding tRNA-binding snRNA-binding  







Kingdom or species 
No. of 
proteins 
Kingdom or species 
No. of 
proteins 
Eucaryote     493 Eucaryote 310 Eucaryote 19 Eucaryote 50
Eubacteria       1330 Eubacteria 235 Eubacteria 230 Eubacteria -
Protein 
distribution 
in kingdom Archaea     181 Archaea - Archaea 10 Archaea -
Thermus thermophilus 32 Homo sapiens 77 Thermus thermophilus 6 Homo sapiens 18 
Aquifex aeolicus 29 Candida albicans 41 Homo sapiens 5 Candida albicans 15 
Mycobacterium leprae 28 Mus musculus 36 Bacillus subtilis 5 Mus musculus 5 
Chlamydia pneumoniae 28 
Schizosaccharom
yces pombe 
21 Escherichia coli 5 Xenopus laevis 3 






in top 10 
species 
Rickettsia prowazekii 28 
Arabidopsis 
thaliana 
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   Thermotoga maritima 28 
Caenorhabditis 
elegans 










4   Rattus norvegicus 2
Borrelia burgdorferi 28 Rattus norvegicus 14 Helicobacter pylori 4 Arabidopsis thaliana 2 
Buchnera aphidicola 28 
Nicotiana 
tabacum 
11 Campylobacter jejuni 4 Macropus eugenii 1 
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Not all of the protein sequences in each of the RNA-binding classes are specified as 
such in the protein sequence database. We have manually checked all the selected 
RNA-binding protein sequences to ensure the data quality. The number of known 
snRNA- and snoRNA-binding proteins is much lower than those in the other groups195, 
196 and it is substantially below the number of 80~100 sequences needed to properly 
train a SVM protein classification system. In order to evaluate the performance of SVM 
on classification of a small protein class, the classification of snRNA binding proteins 
was also studied in this work.  
All distinct members in each group are used to construct positive samples for training, 
testing and independent evaluation of SVM classification system. The negative 
samples for training and testing are selected from seed proteins of the curated protein 
families in the Pfam database169 excluding those that belong to the group of 
RNA-binding proteins under study. For each group of non-rRNA-, non-mRNA-, 
non-tRNA-, non-snRNA-binding proteins, distinct members in the other three groups 
are added to the negative samples of each of the training, testing and independent 
evaluation set. It is expected that the number of negative samples in each of these three 
groups may be higher than that in the group of negative samples for all RNA-binding 
proteins.  
4.2.2. Results and discussion 
The number of positive and negative samples for each of the training, testing and 
independent evaluation set for each group of RNA-binding proteins is given in Table 
4-5.  The training set is composed of 708 rRNA-binding and 972 non-rRNA-binding 
proteins, 277 mRNA-binding and 2106 non-mRNA-binding proteins, 94 
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tRNA-binding and 792 non-tRNA-binding proteins, 33 snRNA-binding proteins and 
1988 non-snRNA-binding proteins, and 2161 RNA-binding proteins and 2965 
non-RNA-binding proteins. The testing set is comprised of 1245 rRNA-binding and 
9044 non-rRNA-binding proteins, 129 mRNA-binding and 10164 non-mRNA-binding 
proteins, 114 tRNA-binding and 9297 non-tRNA-binding proteins, and 1850 
RNA-binding proteins and 6816 non-RNA-binding proteins. The independent 
evaluation set is made of 101 rRNA-binding and 4997 non-rRNA-binding proteins, 164 
mRNA-binding and 6046 non-mRNA-binding proteins, 51 tRNA-binding and 5033 
non-tRNA-binding proteins, 20 snRNA-binding and 6151 non-snRNA-binding 
proteins, and 447 RNA-binding proteins and 4881 non-RNA-binding proteins. 
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Table 4-5 Prediction accuracies and number of positive and negative samples in the 
training, testing, and independent evaluation set of rRNA-, mRNA-, tRNA-, and 
snRNA-binding proteins and of all RNA-binding proteins respectively. Predicted 
results are given in TP (true positive), FN (false negative), TN (true negative), FP 
(false positive), sensitivity SE=TP/(TP+FN), specificity SP=TN/(TN+FP), and Q 
(overall accuracy, Q=(TN+TP)/(TP+FN+TN+FP)). Number of positive or negative 
samples in the testing and independent evaluation sets is TP+FN or TN+FP 
respectively. 
 
Training set Testing set Independent evaluation set 
positive negative positive negative 
Protein 
family positive negative 
TP FN TN FP TP FN SE (%) TN FP SP (%) 
Q(%)
RNA 
-binding 2161 2965 1844 6 6802 14 437 10 97.8 4685 196 96.0 96.1
rRNA 
-binding 708 972 1243 2 9031 13 95 6 94.1 4931 66 98.7 98.6
mRNA 
-binding 277 2106 129 0 10164 0 130 34 79.3 5833 213 96.5 96.0
tRNA 
-binding 94 792 114 0 9295 2 48 3 94.1 5028 5 99.9 99.8
snRNA 
-binding 33 1988 7 0 10373 1 9 11 41.0 6133 18 99.7 99.5
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The numbers and prediction results of specific class of RNA-binding proteins and 
non-class-members are given in Table 4-5. In this table, TP stands for true positive 
(correctly predicted RNA-binding proteins of specific class), FN stands for false 
negative (specific class of RNA-binding proteins incorrectly predicted as 
non-class-members), TN stands for true negative (correctly predicted 
non-class-members), and FP stands for false positive (non-class-members incorrectly 
predicted as specific class of RNA-binding proteins). The predicted sensitivity SE for 
rRNA-, mRNA-, tRNA-, snRNA-binding proteins and all RNA-binding proteins, 
which measures the overall prediction accuracy for each class of RNA-binding proteins, 
is 94.1%, 79.3%, 94.1%, 41.0% and 97.8% respectively. The predicted specificity SP 
for non-rRNA-, non-mRNA-, non-tRNA-, non-snRNA-binding proteins and all 
non-RNA-binding proteins, which measures prediction accuracy for each group of 
non-RNA-binding proteins, is 98.7%, 96.5%, 99.9% 99.7% and 96.0% respectively.  
4.2.2.1. Overall prediction accuracy 
A direct comparison with results from previous protein studies is inappropriate because 
of the differences in the specific aspects of proteins classified, dataset, descriptors and 
classification methods. Nevertheless, a tentative comparison may provide some crude 
estimate regarding the level of accuracy of our method with respect to those achieved 
by other studies of proteins. With the exception of snRNA-binding proteins, the range 
of accuracy for the prediction of each class of RNA-binding proteins from our study is 
from 79.3% to 97.8%, which is comparable to or better than the level of accuracy 




Chapter 4 Classification of the functional classes of proteins based on primary sequence 
Table 4-6. Performance of Support Vector Machines for predicting protein functional classes as reported in the literature. All of the 
data and results were collected from the original papers. N+, N- and N are the number of class members, non-members and all 
proteins (members + non-members) respectively, SE and SP are prediction accuracy for class members and non-members 

















Physicochemical properties 2247 (927/1320) Independent evaluation 95.6 98.1 97.4
43 All GPCRs 
Dipeptide composition 3302(778/2524) 5-fold CV 98.6 99.8 99.5 197 
Gi/o binding type 132(61/71) 4-fold CV 77.0 78.3  




Gs binding type 
Structural characteristics 
(extra cellular loops, 
intracellular loops etc) 
132(24/108)   4-fold CV 83.3 95.2
198 
Amino acid composition 282 5-fold CV   82.6
Dipeptide composition 282 5-fold CV   97.5
32 
Nuclear receptors 
Physicochemical properties 872(334/538) Independent evaluation 89.5 97.6  
43 
Amino acid composition, 
limited range correlation of 
hydrophobicity, solvent 
accessible surface area 
12507 (7739/4768) 10-fold CV 92.8 77.1 86.8 44 
5-fold CV 89.1 82.1 93.9 
DNA-binding proteins 
Surface and overall 
composition, overall charge 
and positive potential 
patches on the protein 
359 (121/238) 
Jackknife    90.5 81.8 94.9
199 
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surface 
 leave 1-pair 
holdout  
86.3   80.6 87.5
jackknife test   86.3
independent 




cy   93.9
200 
jackknife test   82.4
independent 




cy   99.9
201 
Transmembrane proteins 
Physicochemical properties 4668(2105/2563) Independent evaluation 90.1 86.7 86.7
43 
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As a statistical learning method, sufficient number of samples is needed in order to 
properly train and test a SVM classification system. The total number of available 
snRNA-binding protein sequences is only 60, from which a very small training set of 
33 sequences is used in this work. As less positive examples tends to be less adequate or 
not enough in representing all types of proteins in a class, it is thus not surprising to find 
that the prediction accuracy for this RNA-binding class is at a very low level of 40%, in 
contrast to the level of 79.3% to 97.8% for other RNA-binding classes. 
The prediction accuracy for each group of non-RNA-binding proteins appears to be 
better than that for the corresponding group of RNA-binding proteins. The higher 
prediction accuracy for non-RNA-binding proteins likely results from the availability 
of sufficiently diverse set of non-RNA-binding proteins than that of RNA-binding 
proteins, which enables SVM to perform a better statistical learning for recognition of 
non-RNA-binding proteins. Based on the statistics provided on the webpage of Pfam 
database, there are more than 7,000 families of proteins, from which one can generate a 
diverse set of non-RNA-binding proteins.  
Inspection of individual misclassified protein sequences of different RNA-binding and 
non-RNA-binding classes, including those false negatives and false positives in the 
independent evaluation data sets, shows that a significant portion of these wrongly 
predicted protein sequences are either protein fragment or described as hypothetical, 
probable, or putative. Sequence incompleteness likely contributes to some of the 
prediction errors in this work. Many of the hypothetical, probable, and putative proteins 
are described primarily based on some form of distant sequence similarity relationship 
with existing proteins of known functions. 
The accuracy measures of the SVM prediction suggested that the prediction on 
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RNA-binding proteins is less accurate than that of non-RNA-binding proteins. One 
possible reason is that SVM based on an unbalanced datasets tends to produce feature 
vectors that push the hyperplane towards the side with smaller number of data 202, that 
can lead to a reduced accuracy for the set either with a smaller number of samples or of 
less diversity.  It is however inappropriate to simply reduce the size of 
non-RNA-binding proteins to artificially match that of RNA-binding proteins, since 
this compromises the diversity needed to fully represent all non-RNA-binding proteins. 
Computational methods for re-adjusting biased shift of hyperplane have been 
introduced166. Application of these methods may help improving SVM prediction 
accuracy in this and other cases involving unbalanced data. 
 
4.2.2.2. Classification of proteins with specific characteristics 
A number of RNA-binding proteins have a molecular structure and contain 
RNA-binding domains of 70-150 amino acids that mediate RNA recognition 203, 204. 
Three classes of RNA-binding domains have been documented to bind RNA in a 
sequence independent manner, and these domains are RNA-recognition motif (RRM), 
double-stranded RNA-binding motif (dsRM), and K-homology (KH) domain204. A 
fourth class of RNA-binding domain, S1 RNA-binding domain, has also been found in 
a number of RNA-associated proteins205. These domains have distinguished structural 
features responsible for RNA recognition and binding. Thus the performance of SVM 
classification of RNA-binding proteins can be evaluated by examining whether or not 




Chapter 4 Classification of the functional classes of proteins based on primary sequence 
A search of protein family and sequence databases shows that there are a total of 260, 
74, 190, and 41 RNA-binding protein sequences known to contain RRM, dsRM, KH 
and S1 RNA-binding domain respectively. The majority of these sequences are 
included in the training and testing set of all RNA-binding proteins. In the 
corresponding independent evaluation set, there are 35, 16, 93, and 10 sequences 
containing RRM, dsRM, KH, and S1 RNA-binding domain respectively. The 
prediction status and examples of these protein sequences are given in Table 4-7. All 
but one protein sequence are correctly classified as RNA-binding by SVM, which 
shows the capability of our trained SVM classification system. The only incorrectly 
predicted protein sequence is HnRNP-E2 protein fragment in the group that contains 
KH domain. The incompleteness of this sequence might partially contribute to its 
incorrect prediction by SVM. Thus, it is suggested that one must be aware of the pitfalls 
in statistical analysis of prediction accuracies of testing data. 
 
Some RNA-binding proteins are in a primarily sequence-specific manner. Typical 
examples are ribosomal proteins187 and a U8 snoRNA-specific binding protein196. 
Majority of the ribosomal protein entries are correctly predicted as rRNA-binding 
proteins. Inspection of the ribosomal protein entries that are incorrectly predicted as a 
non-rRNA-binding protein shows that some of these entries are protein fragment and 
some are described as hypothetical, probable, or putative. The prediction error for some 
of these sequences may be partly due to sequence incompleteness or low sequence 
similarity to those of other protein sequences in each class. Some ribosomal proteins 
are known to bind to mRNA and tRNA as well as rRNA, examples of these proteins are 
30S ribosomal protein S1, S3, S4. The multiple binding natures of these proteins likely 
makes it more difficult for a statistical classification system such as SVM to 
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Some proteins, such as dihydrofolate reductase and thymidylate synthase, are known to 
bind to their own mRNA206. Not all of these proteins are listed as RNA binding proteins 
in protein sequence databases. As a result, these mRNA-binding proteins may not be 
included in the right protein group, which likely affects prediction accuracy on these 
proteins. Hence, additional work is needed to search for these proteins and include 
them in the group of mRNA-binding proteins. 
 
unambiguously distinguish the features between rRNA-binding, mRNA-binding and 
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Table 4-7 Prediction statistics, examples and host species of RNA-binding protein sequences known to contain one of the 
RNA-recognition motif (RRM), double-stranded RNA-binding motif (dsRM), K-homology (KH), and S1 RNA-binding domain. Only 
those RNA-binding proteins in the independent evaluation sets are included. Host species of some protein sequences are not provided 
because the relevant information is not yet available in the protein sequence database. The only incorrectly predicted protein sequence 
with KH domain is HnRNP-E2 protein fragment. 
 
















RRM 35  35
CUG triplet repeat RNA-binding protein 1 (Homo sapiens) 
ELAV-like protein 2 (Mus musculus) 
ELAV-like protein 4 (Homo sapiens, Rattus norvegicus) 
Heterogeneous nuclear ribonucleoprotein A1 (Mus musculus) 
Heterogeneous nuclear ribonucleoprotein A3 (Homo sapiens, Xenopus laevis) 
Heterogeneous nuclear ribonucleoprotein H (Homo sapiens) 
Matrin 3 (Rattus norvegicus) 
Nuclear polyadenylated RNA-binding protein NAB4 (Candida albicans) 
Polypyrimidine tract-binding protein 1 (Rattus norvegicus) 
RNA-binding protein FUS (Mus musculus) 
RNA-binding region containing protein 2 (Mus musculus) 
Splicing factor, arginine/serine-rich 4 (Mus musculus) 
Splicing factor, arginine/serine-rich 5 (Homo sapiens) 
Splicing factor U2AF 65 kDa subunit (Mus musculus, Caenorhabditis elegans) 
100% 
dsRM 16  16
ATP-dependent RNA helicase A (Bos taurus) 
Interleukin enhancer-binding factor 3 (Mus musculus, Rattus norvegicus) 
Ribonuclease III (Escherichia coli, Ralstonia solanacearum, Brucella melitensis, Salmonella typhi, 
Yersinia pestis, Rhizobium meliloti, Staphylococcus aureus (strain N315), Neisseria meningitidis 
(serogroup A), Neisseria meningitidis (serogroup B), Chlamydia muridarum, Helicobacter pylori J99) 
100% 
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SON protein (Mus musculus) 
KH 94  93
30S ribosomal protein S3 (Mycobacterium bovis, Escherichia coli, Mycoplasma pneumoniae, Buchnera 
aphidicola (subsp. Acyrthosiphon kondoi), Acholeplasma florum, Buchnera aphidicola (subsp. 
Acyrthosiphon pisum), Synechocystis sp. (strain PCC 6803), Thermus thermophilus, Phytoplasma sp. 
(strain STRAWB2), Mycoplasma capricolum, Acholeplasma sp. (strain ATCC J233), Fusobacterium 
nucleatum (subsp. nucleatum), etc.) 
A kinase anchor protein 1 (Homo sapiens, Mus musculus) 
GTP-binding protein era homolog (Streptococcus pyogenes (serotype M3), Streptococcus pneumoniae, 
Fusobacterium nucleatum (subsp. nucleatum), Clostridium perfringens, Anabaena sp. (strain PCC 
7120), Mycoplasma pulmonis, Staphylococcus aureus (strain Mu50 / ATCC 700699), Neisseria 
meningitidis (serogroup A), Neisseria meningitidis (serogroup B), Bacillus halodurans, Lactococcus 
lactis (subsp. lactis), Helicobacter pylori J99) 
Hypothetical UPF0109 protein TC0030 (Chlamydia muridarum) 
N utilization substance protein A homolog (Bacillus halodurans, Rickettsia conorii) 
Poly(rC)-binding protein 1 (Oryctolagus cuniculus) 
Poly(rC)-binding protein 2 (Homo sapiens) 
Poly(rC)-binding protein 3 (Mus musculus) 
Poly(rC)-binding protein 4 (Mus musculus) 
Polyribonucleotide nucleotidyltransferase (Bacillus subtilis, Buchnera aphidicola (subsp. Schizaphis 
graminum)) 
Probable exosome complex RNA-binding protein 1 (Methanosarcina mazei, Thermoplasma 
acidophilum, Pyrococcus abyssi) 
Heterogeneous nuclear ribonucleoprotein K (Oryctolagus cuniculus) 
Vigilin (Gallus gallus) 






30S ribosomal protein S1 (Chlamydia trachomatis, Chlamydia pneumoniae) 
Eukaryotic translation initiation factor 2 (Rattus norvegicus) 
N utilization substance protein A homolog (Buchnera aphidicola (subsp. Schizaphis graminum)) 
Probable translation initiation factor 2 alpha subunit (Methanopyrus kandleri, Pyrococcus furiosus, 
Sulfolobus tokodaii, Pyrococcus abyssi) 
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4.2.2.3. Contribution of feature properties to the classification of 
RNA-binding proteins 
 
We choose a total of nine feature properties  for describing physicochemical 
characteristics of each protein, which have been routinely used in previous studies of 
proteins 14, 43, 47, 168, 182. However, not all feature vectors contribute equally to the 
classification of proteins, some have been found to play relatively more prominent role 
than others in specific aspects of proteins 47. It is therefore of interest to examine which 
feature properties play more prominent role in classification of RNA-binding proteins.  
The contribution of individual feature property to protein classification is investigated 
by separately conducting classification using each feature property. Our analysis on the 
classification of all RNA-binding proteins suggests that, in order of prominence, the 
amino acid composition, charge, polarity, hydrophobicity play more prominent role 
than other feature properties. Amino acid composition and hydrophobicity are 
important factors for the interaction of a protein with other biomolecules as well as for 
structural folding. On the other hand, charge and polarity is important for electrostatic 
interactions and hydrogen-bonding to RNA. As the backbone of RNA is charged, 
charge and polarity are expected to be particularly important feature properties for the 
binding of a protein with its RNA-substrate. A recent study of the dynamics of 
protein-RNA interfaces showed that actions condensed around RNA affect the binding 
of protein to RNA 207, which is indicative of the strong effect of charges and polarity. 
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4.3. Classification of Transporters (Paper III) 
Transporters play key roles in transporting cellular molecules across cell and cellular 
compartment boundaries, mediating the absorption and removal of various molecules, 
and regulating the concentration of metabolites and ionic species 208-210. Specific 
transporters have been explored as therapeutic targets 211-213 and a variety of 
transporters are responsible for the absorption, distribution and excretion of drugs 214, 
215. Functional assignment of transporters is important for facilitating functional study 
of genomes, for probing molecular mechanism of cellular processes and diseases, and 
for searching new therapeutic targets and pharmacologically relevant transporters.  
 
There are active and passive transporters. Active transporters couple solute transport to 
the input of energy and these can be divided into two classes: ion-coupled and 
ATP-dependent transporters. Ion-coupled transporters link uphill solute transport to 
downhill electrochemical ion gradients. ATP-dependent transporters are directly 
energized by the hydrolysis of ATP and they transport a heterogeneous set of substrates. 
Passive transporters include facilitated transporters and channels, which allow the 
diffusion of solutes across membranes. These transporters evolve from common 
themes into families of different architectures 208, 216, 217.  
 
Functional families of transporters are described by the transporter classification (TC) 
system (http://www-biology.ucsd.edu/msaier/transport/) based on their mode of 
transport, energy coupling mechanism, molecular phylogeny and substrate specificity 
217. In particular, transport mode and the energy coupling mechanism have been used as 
the primary basis for transporter family classification due to their relatively stable 
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characteristics 217. Therefore, transporters in a TC family share common transport 
modes and mechanisms. In cases that the precise function of a transporter is unknown, 
prediction of its TC family provides useful hint about its broad transportation role, 
mode of action and substrate classes.  
 
TC families are classified at four levels (TC class, TC sub-class, TC family, and TC 
sub-family) as indicated by a specific TC number TC I.X.J.K.L. Here I=1, …, 9 
represents each of the 9 TC classes, X=A, B, C, D, E, … represents each of the TC 
sub-classes that belong to a TC class, J=1, … represents each of the TC families that 
belong to a TC sub-class, K=1, … represents each of the TC sub-families that belong to 
a TC family, and L=1, … represents individual transporters under a sub-family.  
So far, sequence alignment and clustering are used widely for predicting the TC family 
as well as the function of transporters 218, 219. Some transporters are known to have no or 
low homology to other proteins of known function 220-223. Substantial portions of 
transporters in different TC families have very low sequence identity to other family 
members. For instance, a member of the multidrug transporter family, bmr3, has only 
7% sequence identity and 17% similarity to another family member blt 223. A K+ 
channel, TASK-2, has 18-22% sequence identity to other members of the two pore 
domain K+ channel family such as TWIK-1, TREK-1, TASK-1, and TRAAK 224. Two 
members of the major facilitator family, GlpT and LacY, are 21% identical to each 
other 225. Thus the function of some of these transporters may be difficult to assign 
based solely on homology 16, 226, and methods that predict protein function without the 
use of sequence similarity are needed.  
Several methods have been developed for predicting protein function without sequence 
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alignment and clustering. Some of these explore structural features 10, interaction 
profiles 13, 14, and protein/gene fusion data 11, 12. Others conduct functional family 
assignment by using statistical learning methods including neural networks and SVM 31, 
34, 43, 45, 46. These methods have been tested by using a variety of proteins including 
enzymes, receptors and transmembrane proteins. While these methods have not been 
specifically tested for transporters, some of these methods are expected to be applicable 
to transporters. 
 
One approach for protein functional classification has shown useful capability for 
functional family assignment of distantly related proteins as well as homologous 
proteins at high accuracy rates 43, 227, 228. Some SVM systems have been developed to 
classify proteins into functional families defined from activities and physicochemical 
properties rather than sequence similarity 14, 31, 43, 45, 46. In training a SVM classification 
system, proteins represented by their sequence-derived physicochemical properties are 
projected onto a hyperspace where proteins in a family are separated from those outside 
the family by a hyperplane. By projecting a new sequence onto this hyperspace, the 
SVM system can determine whether the corresponding protein belongs to the family 
based on its location with respect to the hyperplane. To some extent, no sequence 
similarity is required in this process.  The overall accuracy of functional family 
prediction is 87%, based on the test of 34,582 proteins. The accuracy for the correct 
assignment of non-family-members is 97%, based on the test of 310,000 proteins 43, 45, 
46. Thus SVM appears to be a useful alternative approach for predicting the TC family 
of transporters irrespective of sequence similarity. 
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So far, SVM and other statistical learning methods have not been explored for 
predicting transporter families, due in large part to the limited information about 
transporters. The relevant data in the transporter databases 229, 230 has now reached to a 
level useful for using SVM to predict transporter families. A survey of the transporter 
databases 229, 230 finds that the number of known transporters in each of the 13 TC 
sub-classes and 8 TC families is no less than 80-100, which is  typically needed for 
properly training a SVM protein classification system 43. Thus, in this work, transporter 
family classification is conducted at the sub-class level for the 13 TC sub-classes and at 
the family level for the 8 TC families. 
 
4.3.1. Selection of transports and non-members of TC sub-classes and TC 
families 
The seed transporters for each of the 20 known TC sub-class are from the TCDB 
database 230. A BLAST search is conducted to scan the Swissprot database 231 for 
finding additional transporters in each sub-class. There is no seed transporter for the 
TC1.D, TC2.B  and TC9.C sub-classes, and the number of collected transporters in the 
TC3.B, TC3.C, TC5.A and TC5.B sub-classes are substantially less than the number of 
80-100 typically needed for properly training a SVM protein classification system 43. 
Moreover, there are 8 TC families found to have more than 80 transporters. Thus 13 TC 
sub-classes with a combined number of 14,987 transporters, and 8 TC families with a 
combined number of 2684 transporters are studied in this work. All distinct members in 
each sub-class are used to construct positive samples for training, testing and 
independent evaluation of the SVM classification system. 
 
The negative samples of each TC sub-class/family for training and testing our SVM 
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classification systems refer to those proteins outside this sub-class/family which 
include both non-transporter proteins and transporters of other sub-classes and families. 
These negative samples are selected from seed proteins of the 7,316 curated protein 
families in the Pfam database 232 that have no protein as a member of that sub-class. 
Each negative set contains at least one randomly selected seed protein from each of the 
7,316 Pfam families. For the group of negative samples of a sub-class, distinct 
members in the other sub-classes are added to the group of each of the training, testing 
and independent evaluation set. It is expected that the number of negative samples in 
each of these groups may be higher than that of non-transporter proteins.  
 
The performance of SVM classification is further evaluated by using an independent 
evaluation set, which is composed of all of the proteins in each sub-class/family and 
those outside the sub-class/family that have not been used in the training and 
optimization the SVM system. No duplicate protein entry is used in the training, testing 
and independent evaluation set for each group. The number of positive and negative 
samples for each of the training, testing and independent evaluation set for each of the 
13 transporter sub-classes is given in Appendix A, as indicated in “Protein family” as 
transporters. 
4.3.2. Results and Discussion 
 
Statistics of the datasets and prediction results of each of the 13 TC sub-classes of 
transporters and those of the 8 TC families are given in Appendix Table A(as indicated 
in “Protein family” as transporters). The computed TP, TN, FP, FN, Qp and Qn and C 
for each TC sub-class and family by using the respective testing and independent 
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evaluation sets are also given respectively. The computed Qp,, Qn and C for the 13 TC 
sub-classes is in the range of 70.7% to 96.1%, 97.6% to 99.9% and 69.7% to 96.5% 
respectively, and those for the 8 TC families is in the range of 60.6%~97.1% and 
91.5%~99.4% respectively. The overall accuracies for the assignment of 4,351 and 770 
transporters into their respective TC sub-class and TC family are 83.4% and 88.0% 
respectively, and those for the correct assignment of 83,151 and 57, 951 non-members 
of TC sub-classes and families are 99.3% and 96.6% respectively. These accuracies are 
comparable to the overall accuracy of 86% for the SVM assignment of the enzymes 
classification previously in section 4.1. 
 
In order to evaluate the capability of SVM classification systems for distinguishing 
between transporters of a particular TC sub-class and transmembrane proteins outside 
that sub-class, all of the transmembrane proteins known to not belong to each of the 13 
investigated TC sub-classes are collected and used to test the corresponding SVM 
classifier. A total of 26,139 such transmembrane proteins are found from the SwissProt 
database231. The number of transmembrane proteins outside each of the 13 TC 
sub-classes and the SVM prediction results are given in Table 4-8. It is shown that 
90.4% to 99.6% of the transmembrane proteins outside each TC sub-class are correctly 
predicted to be non-members of that sub-class, suggesting that our SVM classification 
systems have certain level of capability for separating transporter members and 
transmembrane non-members of transporter families. 
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Table 4-8 Transmembrane proteins outside each of the TC families and SVM 













TC 1.A α-Type channels 25456 24599 857 96.6% 
TC 1.B β-Barrel porins 26011 25816 195 99.3% 
TC 1.C Pore-forming toxins 26061 23565 2496 90.4% 
TC 1.E Holins 26101 26001 100 99.6% 
TC 2.A Porters (uniporters, 
symporters, and antiporters) 25439 24321 1118 95.6% 
TC 2.C Ion gradient-driven 
energizers 26100 26049 51 99.8% 
TC 3.A Diphosphate bond 
hydrolysis-driven transporters  25559 23244 2315 90.9% 
TC 3.D Oxidoreduction-driven 
transporters 24266 23498 768 96.8% 
TC 3.E Light absorption-driven 
transporters 24929 24684 245 99.0% 
TC 4.A Phosphotransfer-driven 
group translocators 26062 25753 309 98.8% 
TC 8.A Auxiliary transport 
proteins 26053 25915 138 99.5% 
TC 9.A Transporters of unknown 
biochemical mechanism 26085 25647 438 98.3% 
TC 9.B Putative but 
uncharacterized transport 
proteins  
25815 24246 1569 93.9% 
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The prediction accuracy for the non-members of each TC sub-class/family appears to 
be higher than that for the transporters in the sub-class/family. It is likely resulting from 
the availability of a significantly more diverse set of non-transporter proteins than that 
of transporters, which enables the training of a system with higher capability for 
recognizing non-members of a TC sub-class or family. There are over 7,316 families of 
proteins Pfam database 232,  from which a diverse set of non-members for each TC 
sub-class or family can be generated.  
 
Examples of the predicted true positive, false negative, true negative and false positive 
protein sequences of each of the 13 sub-classes are given in Table 4-9.  Inspection of 
the false negative transporters and the false positive non-members of each sub-class 
show that a substantial percentage of these incorrectly predicted proteins are actually 
sequence fragment entries of the corresponding protein, which likely contributes to 
some of the prediction errors in this work.  
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Table 4-9 Examples of the predicted true positive (TP), true negative (TN), false 
positive (FP), false negative (FN) protein entries of different TC sub-classes. Only 
proteins in the independent evaluation sets are included in this Table. Host species of 
some protein sequences are not provided because the relevant information is not yet 
available in the protein sequence database. 
Protein class Prediction
category
Example of predicted proteins 
TP Cyclic-nucleotide-gated cation channel 
Calcium transporter CaT1 
Transient receptor potential cation channel protein 
P2X purinoceptor 1 
Glycine receptor alpha-1 chain precursor 
Glutamate-gated chloride channel 
Outwardly rectifying chloride channel 
CLC-Nt2 protein 
Urea transporter; Structural polyprotein P130 
Magnesium and cobalt transport protein corA 
VPU protein 
TN V1A arginine vasopressin receptor 
ATP-binding protein of ABC transporter 
Chorionic gonadotropin beta subunit (Fragment) 
16 kDa heat shock protein A 




NADH gehydrogenase 8 subunit (Fragment) 
TC 1.A α-Type 
channels 
FP Probable G-protein-coupled receptor Mth-like 10 
precursor 
CG18678 protein 
Envelope glycoprotein (Fragment) 
Sulfonylurea receptor-1 (Fragment) 
Hfq protein; Short transient receptor potential channel 
2  




Dentatorubro-pallidoluysian atrophy protein 
(Fragment) 
RNA replicase beta chain (Fragment) 
C14orf1-like protein  
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FN PBCV-1 K+ ion channel protein 
Melastatin 1 
Channel protein (Hypothetical protein) 
Calcium-activated chloride channel protein 2 
Non-selective cation channel 
NADPH thyroid oxidase 2 
BspA protein precursor 
YKUT protein. 
TP Outer membrane protein C precursor 
Sucrose porin precursor 
Voltage-dependent anion-selective channel protein 3 
Long-chain fatty acid transport protein precursor 
Hemoglobin receptor 
Lactoferrin-binding protein B precursor  
Cation efflux system protein cusC precursor 
Porin B precursor 
TN GRH receptor-2 
Putative pheromone receptor 
ATPase alpha subunit (Fragment) 
Translation elongation factor 1-alpha (Fragment) 
Chaperone protein dnaK 
Decoy TNF receptor 
ADP-ribosylation factor-like protein 
Cytochrome b (Fragment) 
Cytochrome b. 
FP R09B5.5 protein. 
Hypothetical 21.7 kDa protein. 
Photosystem II reaction center X protein. 
PAR-1a protein 




Putative nitrate-induced protein. 
Homeodomain protein vaamana. 
Probable soluble cytochrome b562 2 precursor 
TC 1.B β-Barrel porins 
FN GnRH receptor-2. 
Putative pheromone receptor. 
ATPase alpha subunit (Fragment). 
Ribulose 1,5-bisphosphate carboxylase large subunit 
(fagment). 
2010109I03Rik protein. 
Hypothetical protein All2748. 
Blastomere-cadherin precursor 
Cytochrome c. 
Ribonuclease III  
TC 1.C Pore-forming 
toxins 
TP Alpha-toxin. 
Bifunctional hemolysin-adenylate cyclase precursor  
Plantaricin S beta protein precursor. 
Mastoparan B. 
Crabrolin. 
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TN Re6 receptor long splice variant. 
Cell division protein FTSE 
ATP synthase beta subunit (Fragment). 
Translation elongation factor 1 alpha (Fragment). 
Methyl-accepting chemotaxis protein. 
Tumor necrosis factor receptor superfamily member 
11B precursor 
Matrix metalloproteinase 9 precursor 
Hemoglobin alpha chain. 
FP NAD-glycohydrolase. 
Apolipophorin-III precursor  
Photosystem I reaction centre subunit XII precursor. 
Steroid receptor coactivator 1a 
Bll2849 protein. 
Probable spore cortex-lytic enzyme. 
Hypothetical protein NMA0089. 
FN Enterocin P precursor. 
Myeloid secondary granule protein. 
Countin. 
Lactococcin 972 precursor. 
Hemolysin BL lytic component L2. 
Beta2-toxin. 
TP Lysis protein S. 
Extracellular secretory protein. 
Holin. 
LrgA family protein. 
TN Long-wavelength opsin (Fragment). 
G-protein-coupled receptor Mth2 precursor  
Hypothetical protein CBU1189. 
ABC transporter ATP-binding protein-oligopeptide 
transport. 
ATP synthase beta subunit (Fragment). 
Glycoprotein hormone beta 5 precursor  
CG14207-PB. 
NADP-dependent malate dehydrogenase (Fragment). 
GRAAL2 protein precursor. 
LDL receptor-related protein 6. 
FP NADH dehydrogenase. 
YVLD. 
Cytochrome c oxidase, cbb3-type, CcoQ subunit. 
Probable transmembrane protein. 
TC 1.E Holins 
FN Long-wavelength opsin (Fragment). 
G-protein-coupled receptor Mth2 precursor  
Hypothetical protein CBU1189. 
ABC transporter ATP-binding protein-oligopeptide 
transport. 
ATP synthase beta subunit (Fragment). 
Glycoprotein hormone beta 5 precursor  
CG14207-PB. 
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TP Hexose transporter 1. 
Metabolite transport protein. 
Integral membrane protein. 
Inorganic phosphate transporter 1. 
Organic cation transporter. 
Feline leukemia virus subgroup C receptor FLVCR. 
Aromatic amino acid and leucine permease. 
TN Orphan G protein-coupled receptor Ren 1. 
Glucagon receptor. 
Thyrotropin beta subunit precursor. 
Elongation factor 1a (Fragment). 




FP Glutamate receptor 3.1 precursor  
NADH-ubiquinone oxidoreductase chain 1  
Manganese transport system membrane protein mntC. 
Iron ABC transporter, permease protein. 
NADH dehydrogenase subunit 4. 
Pollen coat oleosin. 
G-protein coupled receptor GPR110. 




FN Carboxypeptidase II (Fragment). 
Glucose uptake protein. 
Lysine and histidine specific transporter. 
Sodium proton exchanger NHX1 (Fragment). 
KtrB protein. 
Purine nucleoside permease. 
MNHG NA+/H+ antiporter subunit 
Bilitranslocase. 
Threonine export carrier. 
TP TonB protein 
Biopolymer transport exbB protein 
TolQ protein 
TolR protein 
TN Olfactory receptor-like protein 42-2 (Fragment). 
Metabotropic glutamate receptor 7 variant 3. 
Tat-binding homolog 7, AAA ATPase family protein. 
Transcription termination factor Rho. 
Thyroptin beta chain (Fragment). 
C901 protein. 
Phospholipase A2-3 (Fragment). 
Coenzyme A disulfide reductase. 
Ras-related protein Rab-12 (Fragment). 
TC 2.C Ion 
gradient-driven 
energizers 
FP TAU-1a (Fragment). 
S164 (Fragment). 
F22F1.3 protein. 
Outer-membrane lipoproteins carrier protein precursor. 
CG13097 protein (SD02943p). 
46-kDa surface lipoprotein (Fragment). 
Hypothetical protein XAC3753. 
Complexin 2 (Synaphin 1) (921-L). 
Conserved hypothetical protein. 
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FN Peptidoglycan-associated lipoprotein [Precursor] 
TolA protein 
TolB protein precursor. 
TP ABC transporter ATP-binding subunit. 
Bacitracin export permease protein bceB. 
P-type ATPase. 
Copper-transporting ATPase, P-type  
Plasma membrane calcium-transporting ATPase 1  
TN Olfactory receptor (Fragment). 
Bovine growth hormone-releasing hormone receptor 
(Fragment). 
Seven transmembrane helix receptor. 
Gonadotropin beta-II chain precursor  
Atonal-like protein 3. 
Inhibin alpha subunit (Fragment). 
UL144 protein. 
Ras-like small monomeric GTP-binding protein. 
FP Chemotaxis sensory transducer protein. 
Putative signal peptidase IB. 
Hydrogenase expression/formation protein HypE 
(Fragment). 
Major outer membrane protein OmpA. 
PugilistDominant (Fragment). 
Ribosomal small subunit pseudouridine synthase A. 
Inward rectifier potassium channel 4  
NADH dehydrogenase subunit 4  (Fragment). 
TC 3.A Diphosphate 
bond hydrolysis-driven 
transporters 
FN DNA translocase ftsK 
Tra protein 
Gene I protein 
ComG operon protein 1 
Putative mitochondrial F0-ATPase, mammalian 
subunit b 
TP Cytochrome c oxidase polypeptide IVB  
Ubiquinol oxidase polypeptide I  
Cytochrome O ubiquinol oxidase subunit III  
Protoheme IX farnesyltransferase  
TN SH3P13S. 




Similar to ankyrin-like protein 
CG7802 protein  
Aspartic protease Bla g 2 precursor  
Cyclic nucleotide-gated channel 2b. 
TC 3. D 
Oxidoreduction-driven 
transporters 
FP Flagella-related protein G. 




Putative membrane protein MMPS2. 
Chromosome IV reading frame ORF YDL072C. 
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FN NADH-quinone oxidoreductase chain 2  
Mbh12 membrane bound hydrogenase alpha  
Hypothetical protein PF1431. 
Protoheme IX farnesyltransferase  
Ubiquinol oxidase polypeptide II precursor  
TP Cytochrome b.  
Photosystem Q(B) protein.  
Cytochrome B6-F complex iron-sulfur subunit 
Photosystem II 44 kDa reaction center protein  
TN G protein-coupled receptor 119  
Glucagon receptor. 
Metabotropic glutamate receptor 2 precursor  
ClpB protein. 
ATP synthase beta subunit (Fragment). 
Gonadotropin beta-II chain precursor  
Sugar transport related protein. 
Coagulation factor XIII, beta subunit. 
FP Cytochrome oxidase 1 (Cox1 protein) (Fragment). 
Beta polypeptide. 
NAS-20 protein (Fragment). 
Glycine betaine transporter (Fragment). 
Lysosomal-associated transmembrane protein 4A  
Conserved hypothetical protein. 




FN Photosystem II 44 kDa reaction center protein 
Photosystem Q(B) protein 
Cytochrome b6-f complex subunit 4 
TP PTS system, glucose-specific IIBC component  
PTS system, fructose-specific IIBC component  
PTS system, mannitol-specific IIABC component  
PTS system, lactose-specific IIA component  
PTS system, N,N'-diacetylchitobiose-specific IIC 
component  
AgaC. 
TN Opsin Rh6  
Bride of sevenless protein precursor. 
ATP-dependent Clp protease subunit. 
Hemin transport system ATP-binding protein hmuV. 
FSH beta-subunit. 






FP PsbA protein. 
Hypothetical protein SAV2534  
Ammonia permease. 
DNA-directed RNA polymerase subunit K (EC 
2.7.7.6). 
Transporter. 
Integral membrane protein. 
Carbon starvation protein. 
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FN PtsC1 protein. 
PTS system, lichenan-specific IIB component  
Putative phosphotransferase D-arabitol specific 
component IIC (Fragment). 
AgaW. 
Putative PTS system, glucitol/sorbitol-specific enzyme 
II  
TP Tyrosine-protein kinase etk  
Voltage-gated potassium channel beta-1 subunit  
Large conductance calcium-dependent potassium ion 
channel beta 4subunit. 
Sodium channel beta-1 subunit precursor. 
Phosphocarrier protein HPr  
TN Olfactory receptor MOR256-1  
Latrophilin 2 splice variant bbabe. 
Calcium-sensing receptor related protein 4 (Fragment). 
ATP-dependent Clp protease ATP-binding subunit 
clpX. 
ATP synthase beta subunit (Fragment). 
Luteinizing hormone beta subunit. 
Ovomucoid (Fragment). 
Hepatocyte growth factor precursor  
Alpha 3B chain of laminin-5 (Fragment). 
FP Ebh protein. 
HapP1 protein precursor. 
Similarity to late embryogenesis abundant protein. 
Prospero-related homeobox 1 (Fragment). 
DNA helicase-primase complex component. 
Protein F14. 
Conserved hypothetical protein. 
TC 8.A Auxiliary 
transport proteins 
FN Chromosome XII COSMID 9449. 
Potassium voltage-gated channel subfamily E member 
1  
Cardiac phospholamban  
Transport accessory protein. 
Pediocin PA-1 biosynthesis protein pedC  
TP MerC. 
Peroxisomal targeting signal 1 receptor. 
IRON(II) transport protein  
High-affinity iron permease CaFTR2. 




TC 9.A Transporters of 
unknown biochemical 
mechanism 
TN Muscarinic acetylcholine receptor M1. 
Latrophilin 3 splice variant bbbh. 
Nuclear valosin-containing protein-like  
ABC transporter (Fragment). 
ATP synthase beta chain  
Thyrotropin beta subunit. 
Fibrillin 1 precursor  
88 
Chapter 4 Classification of the functional classes of proteins based on primary sequence 
FP NADH dehydrogenase subunit I  
Phosphoenolpyruvate carboxylase, isoform 1 
(Fragment). 
MHBs protein 
DNA-repair protein complementing XP-G cells 
homolog  
Calsequestrin 1. 
Lysosomal amino acid transporter 1. 
FN Ubiquitin-conjugating enzyme E2-21 kDa  
PbrT protein. 
ComC. 
Putative mercuric ion binding protein. 
Probable tryptophan transport protein. 
TP Galectin-9. 
Cytochrome c-type biogenesis protein ccl1. 
Long-chain-fatty-acid--CoA ligase. 
Putative chloroquine resistance transporter. 
Bax inhibitor-1  
Magnesium and cobalt efflux protein corC. 
TN Olfactory receptor MOR114-5  
Bovine growth hormone-releasing hormone receptor 
(Fragment). 
Gamma-aminobutyric acid type B receptor, subunit 1 
precursor  
Endopeptidase Clp ATP-binding chain B. 
ATP synthase alpha chain, sodium ion specific  
Thyroptin beta chain (Fragment). 
Fibrillin-1 (Fragment). 





Similar to C-14 sterol reductase. 
19kD alpha zein B5 (Fragment). 
TC 9.B Putative but 
uncharacterized 
transport proteins 
FN Very-long-chain acyl-CoA synthetase 
Probable crotonobetaine/carnitine-CoA ligase 
Retrograde regulation protein 3 
Beta-(1-3)-glucosyl transferase. 
Conserved hypothetical protein. 
Hemolysin-related protein, containing CBS domain. 
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Because the number of transporters is significantly less than that of non-members, there 
is an unbalance between the positive and negative training dataset for each sub-class 
and family. SVM based on an imbalanced dataset tends to generate a hyper-plane closer 
to the side with smaller number of samples 202, which can lead to a lower prediction 
accuracy for these samples compared to those on the other side of hyper-plane. This 
partly explains why the accuracy for assigning the sub-class of transporters is lower 
than that for the non-members.  It is however inappropriate to simply reduce the size 
of non-members of each sub-class to artificially match that of transporters in the same 
sub-class, since this compromises the diversity needed to fully represent all 
non-members. Computational methods for re-adjusting biased shift of the hyper-plane 
are being developed and evaluated 233. These methods, when sufficiently developed, 
may help improving SVM prediction accuracy in this and other cases involving 
unbalanced data. 
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5. Prediction of the functional class of novel 
proteins - Specific Case Studies 
The work in this chapter has been published in: 
IV) Predicting Functional Family of Novel Enzymes Irrespective of Sequence 
Similarity: A Statistical Learning Approach. L.Y.Han, C.Z.Cai, Z.L.Ji, 
Z.W.Cao,J.Cui, Y.Z.Chen Nucleic Acids Res.32(21): 6437-6444(2004). 
V) Prediction of Functional Class of Novel Viral Proteins by a Statistical Learning 
Method Irrespective of Sequence Similarity. L.Y.Han, C.Z Cai, Z. L. Ji, Y.Z. 
Chen. Virology 331(1):136-143 (2005). 
VI) Prediction of Functional Class of Novel Plant Proteins by a Statistical Learning 
Method. L. Y. Han, C. J. Zheng, H. H. Lin, J. Cui, H. Li, H. L. Zhang, Z. Q. 
Tang, and Y. Z. Chen, New Phytologist. 168:109-121(2005) 
VII) Prediction of Functional Class of Novel Bacterial Proteins without the Use of 
Sequence Similarity by a Statistical Learning Method.J. Cui, L. Y. Han, C. Z. 
Cai, C.J.Zheng, Z. L. Ji, and Y. Z. Chen.J. Mol. Microbiol. Biotech. 9 (2): 
86-100 (2005) 
 
A fundamental understanding of how biological systems work requires knowledge of 
protein functions as well as protein interactions. Finding clues of functions is becoming 
an increasingly important means for better understanding in biological process. For 
example, exploring functions of certain novel sequences of some bacterial species 
could help elucidate their pathogenesis potential and reveal novel pathways for drug 
intervention; large DNA viruses such as poxviruses encode for a variety of proteins that 
can specifically manipulate the function of host immune factors/messengers, e.g. 
interferon, interleukins and chemokines. Hints of these novel viral proteins functions 
are very important for interpreting how the viruses use to interact with their hosts and 
for searching molecular targets of antiviral therapeutics. 
The gap between the large amounts of sequences information resulting from large- 
scale genome sequencing projects and their function characterization is continuously 
increasing. In the completely sequenced genome of Arabidopsis, the function of 30% of 
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the putative protein-coding open reading frames (ORFs) is unknown 234, 235. Similar 
percentage of unknown ORFs is expected in other plant genomes. The function of a 
substantial percentage (17-20%) of the putative protein-coding open reading frames 
(ORFs) in many bacterial genomes is unknown 236, 237. There is also a substantial 
percentage of the unknown ORFs in the recently determined genomes of Fer-de-lance 
virus238, Grapevine fleck virus239, Indian citrus ringspot virus240, and SARS 
coronavirus 241 etc. The same problem arisen when we shift the visual angle from the 
aspect of taxonomy to the aspect of the protein functional group. There is a large 
amount of proteins that could perform a specific function or could play a certain 
biological role haven’t been discovered. Thus, increasing efforts have been directed to 
development of methods for probing protein functions. However, as the sequence of 
these ORFs mentioned above has no significant similarity to those of known proteins, 
their functions are difficult to formulate by using sequence alignment and clustering 
methods. In addition, approaches building upon direct sequence comparisons were 
lacking of sensitivity and were even unable to identify those novel proteins with remote 
homologous. 
Since our approach for protein function prediction is based on the statistical learning 
from the physico-chemical properties derived from the primary sequence instead of the 
sequence comparison, it is possible to predict protein functional class irrespective of 
sequence similarities. In order to extensively evaluate the potential and usefulness of 
the protein functional class prediction system ‘SVMProt’ developed in this study, novel 
proteins that are distinctly related to other known functional proteins, diversely covered 
novel enzymes, novel viral ORFs, novel bacterial ORFs, as well as novel protein in 
plants are selected to examine the usefulness of our prediction system.  
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5.1. Prediction of Functional Family of Novel Enzymes 
(Paper IV) 
Enzymes are proteins that act as catalysts that could affect the rate of chemical 
reactions. As Enzymes play a central role in every aspect of life involves in chemical 
reactions, as well as they provided a means for regulating the reactions in the metabolic 
pathways of the body242, the knowledge on enzymes is highly in demand for facilitating 
the understanding of biological processes.  
Enzymes have been systematically classified by the International Commission on 
Enzymes 178 into six major groups: oxidoreductases, transferases, hydrolases, lyases, 
isomerases, and ligases. These six major groups are further subdivided according to the 
more specific type of reactions that these enzymes involve. By classifying a protein into 
a specific enzyme family, one can get the hints of the enzyme function as well as the 
type of reactions that the enzyme may catalyze.  
Large amount of proteins that perform an enzymatic function have not been discovered. 
Thus, it is essential to interpret biological process at a deep level, especially when we 
consider discovering or even developing new therapeutic strategies. As mentioned 
previously, the function of an enzyme that has low sequence similarities of known 
function is difficult to assign based on their sequence similarity. The same problem 
may arise for homologous enzymes with different functions. In order to evaluate the 
capability of our developed prediction system for assignment of distantly related 
enzymes and homologous enzymes with different functions, two different groups of 
enzymes were tested for their functional class assignment.  
5.1.1. Methods 
In this work, two groups of enzymes, obtained from protein databases and literatures 
and subsequently verified by PSI-BLAST38, are used to assess the capability of SVM 
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for predicting the functional family of novel enzymes.  
One group includes enzymes that are without a homolog in protein database based on 
PSI-BLAST search of these databases. A similarity threshold E-value of 0.05 is used 
for protein sequence similarity searching. Those novel enzymes are firstly searched 
from the Swiss-Prot database 180 by using the key word “novel”, “distinct”, or 
“unrelated” combined with “enzyme”. The next step is to eliminate those with at least 
one homolog of known function (except for hypothetical proteins) by conducting a 
PSI-BLAST38 search against the NR databases that include all non-redundant GenBank, 
CDS translations, PDB, SwissProt, PIR, and PRF databases. This ensures that only 
those truly having no homolog in protein databases are selected. While the selected 
enzymes from this process are without a homolog, their function has been determined 
experimentally and these were reported in the literature and subsequently described in 
the Swiss-Prot database. The last step is to remove the redundancy. 
The second group contains pairs of homologous enzymes of different families. A low 
similarity E-value threshold of 10-6 is used for selecting these enzyme pairs to ensure 
the high sequence similarities. In a hypothetical situation that one enzyme in a pair of 
homologous enzymes of different families is newly discovered and the other is the only 
known protein of similar sequence, the function of the first enzyme can be incorrectly 
assigned to that of the second enzyme by using sequence similarity methods. Thus, it is 
of interest to examine to what extent SVM can be used as an alternative approach for 
facilitating functional assignment for these enzymes. These enzymes are further 
checked to remove the redundancy. 
5.1.2. Results and Discussion 
As shown in Table 5-1, 12 enzymes without a homolog in the NR databases (group NR) 
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and additional 38 enzymes without a homolog in the SwissProt database (group SP) are 
selected from the process introduced in 5.1.1 methods section. None of them is in the 
SVM training sets. SVMProt correctly assigns 8 out of 12 (67%) enzymes in the group 
“NR” and 28 out of 38 (73.7%) enzymes in the group “SP” to the respective family. The 
overall accuracy is 72%, which is comparable to the average sensitivity for the enzyme 
families, and it is consistent with the sequence-similarity-independent nature of SVM 
functional assignment.  
These 8 pairs of homologous enzymes of different families from previous publications 
45, 243 that satisfy the low E-value criterion, which together with SVMProt predicted top 
family for each enzyme are given in Table 5-2.  It is found that 5 or 62% of these 
enzyme pairs are correctly assigned by SVMProt, such accuracy is comparable to the 
average sensitivity for the enzyme families and indicative of the 
sequence-similarity-independent nature of SVM functional assignment. 
These results suggest that our prediction system has the capability for functional family 
assignment of novel enzymes without any sequence similarities in protein database, 
and for distinguishing homologous enzymes of different functions. The overall 
accuracy of SVM prediction system is not yet at the same level of that of sequence 
alignment for homologous proteins. One reason is the imbalance between the number 
of positive and negative samples. The total number of distinct enzymes in some 
families is less than 200, which is significantly smaller than that of a few thousand 
representative proteins used as the negative samples of the respective family. Such a 
large data imbalance is known to affect the accuracy of a SVM classification system 
and methods for solving these problems are being developed 233. It is likely that not all 
possible types of proteins, particularly those of distantly related members, are 
adequately represented in some families. This can be improved along with the 
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availability of more protein data. Not all distantly related proteins from one functional 
families have similar structural and chemical features due to the flexibility at the active 
site 26. These improvements will enable the development of SVM into a useful tool for 
facilitating functional study of novel proteins.  
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Table 5-1 List of enzymes without a homolog in the NR and SwissProt databases and 
the results of SVM functional family assignment. The symbol +, *, and – represent 
the cases that the predicted family with highest ranking, one of the predicted families, 













beta subunit (EC 3.5.5.8) 
[O66186]. 
NR 
EC 3.5 Hydrolase of non-Peptide Carbon-Nitrogen 
Bonds (98.9%) 




protein avrPpiC2 (EC 
3.4.22.-) [Q9F3T4]. 
NR 
EC 4.2 Carbon-Oxygen Lyase (93.6%) 
EC 2.3 Acyltransferase  (83.9%) 
EC 4.1 Carbon-Carbon Lyase (71.3%) 





NR EC 3.1 Hydrolase of Ester Bonds (98.7%) + 
Cytochrome c oxidase 
polypeptide IV, 
mitochondrial precursor 
(EC 1.9.3.1) [P30815]. 
NR EC 1.9 Oxidoreductase of a heme group of donors (99.0%) + 
Cytochrome c oxidase 
polypeptide VI (EC 
1.9.3.1) [P26310]. 
NR 
EC 1.9 Oxidoreductase of a heme group of donors 
(98.4%) 
Transmembrane (98.3%) 
EC 3.1 Hydrolase of Ester Bonds  (62.2%) 
+ 
Alginate lyase precursor  
(EC4.2.2.3)  [P39049]. NR 
Transmembrane (65.4%) 
Outer membrane (58.6%) 




e  (EC 2.4.1.26) 
[P04519] 
NR 
EC 2.4 Glycosyltransferase (80.4%); 




(EC 3.1.21.4 [P31117] NR EC 3.1 Hydrolase of Ester Bonds (99.0%) + 
Type II restriction 
enzyme CviJI (EC 
3.1.21.4) [P52283] 
NR 
EC 3.1 Hydrolase of Ester Bonds (99.0%);  
rRNA-binding Proteins (98.8%) ; 
EC 3.4 Peptidase (68.5%) 
+ 
DNA-directed RNA 
polymerase, subunit 10 
homolog (EC 2.7.7.6) 
[P42488] 
NR 
EC 2.7 Transferase of Phosphorus-Containing Groups 
(99.0%) 
7 transmembrane receptor metabotropic glutamate 
family (58.6%)  
+ 
Endonuclease IV (EC 
3.1.21.-) [P39250] NR No function predicted - 
Beta-agarase precursor  
(EC3.2.1.81) [P13734]. NR 
EC 4.1 Carbon-Carbon Lyase (96.7%) 
EC 2.4 Glycosyltransferase (71.3%) - 
Phenylacetaldoxime 




EC 3.4 Peptidase (96.4%) 
EC 3.3 Hydrolase of Ether Bonds (80.4%) 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (73.8%) 
- 
ATP synthase H chain, 
mitochondrial precursor  
(EC3.6.3.14) [ Q12349]. 
SwissProt EC 3.6 Hydrolase of Acid Anhydrides (99.0%) RNA-binding Protein (58.6%) + 
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Peptide-N(4)-(N-acetyl-b
eta-D-glucosaminyl)aspa
ragine amidase F 
precursor  (EC 
3.5.1.52) [P21163] 
SwissProt 
EC 3.5 Hydrolase of non-Peptide Carbon-Nitrogen 
Bonds (99.0%) 
Beta-Barrel porin (58.6%) 
+ 
S-adenosyl-L-methionin
e hydrolase (EC 3.3.1.2) 
[P07693] 
SwissProt 
EC 3.3 Hydrolase of Ether Bonds (99.0%) 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (71.3%) 
DNA-binding Protein (65.4%) 
+ 
Hypothetical 52.8 kDa 
protein in VPS15-YMC2 
intergenic region .(EC 
3.1.22.-) [P38257] 





EC 2.7 Transferase of Phosphorus-Containing 
Groups (88.1%) 
EC 3.4 Peptidase (86.8%) 
EC 2.3 Acyltransferase (71.3%) 
EC 4.1 Carbon-Carbon Lyase (65.4%) 
- 
Telomere elongation 
protein   (EC2.7.7.-)  
[P17214]. 
SwissProt 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (99.1%) 




(EC 2.7.7.30) [O14772] 
SwissProt 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (99.1%) 




polymerase I 14 kDa 
polypeptide   (EC 
2.7.7.6) [P50106]. 
SwissProt 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (99%) 
DNA-binding Protein (62.2%) 
Beta-Barrel porin (58.6%) 
EC 3.4 Peptidase (58.6%) 
+ 
DNA polymerase III, 
theta subunit (EC 
2.7.7.7) [P28689]. 
SwissProt 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (99.0%) 
EC 4.2 Carbon-Oxygen Lyase (58.6%) 
+ 
Cytochrome c oxidase 
polypeptide IV (EC 
1.9.3.1) [P77921] 
SwissProt 
EC 1.9 Oxidoreductase of a heme group of donors  
(97.0%) 
Envelope protein (58.6%) 
Transmembrane (58.6%) 
+ 
Cytochrome c oxidase 
polypeptide VII (EC 
1.9.3.1) [P10174]. 
SwissProt 




Cytochrome c oxidase 
polypeptide VIII, 
mitochondrial precursor 
(EC 1.9.3.1) [P04039]. 
SwissProt 
EC 1.9 Oxidoreductase of a heme group of donors 
(99.0%) 
Transmembrane (58.6%) 
RNA-binding Protein (58.6%) 
+ 





EC 1.9 Oxidoreductase of a heme group of donors 
(97.8%) 
Transmembrane (93.8%) 
EC 1.10 Oxidoreductase of diphenols and related 
substances as donors (58.6%) 
Alpha-Type channel (58.6%) 
+ 
Heme-copper oxidase 
subunit IV (EC 1.9.3.-) 
[Q9YDX4]. 
SwissProt 






(EC 2.3.1.-) [P95219] 
SwissProt 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (78.4%) 
EC 4.2 Carbon-Oxygen Lyase (58.6%) 
- 
Glycosyl transferase alg8 
(EC2.4.1.-) [Q887P9]. SwissProt 
Transmembrane (99.0%) 
EC 2.4 Glycosyltransferase (98.6%) * 
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Beta-agarase B  (EC 
3.2.1.81) [P48840]. SwissProt 
Outer membrane (58.6%) 
Beta-Barrel porin (58.6%) - 
CM (EC 5.4.99.5)  
[P19080] SwissProt 
EC 5.4. Intramolecular Transferase (99.0%) 
EC 4.2. Carbon-Oxygen Lyase (58.6%) 




(EC 2.4.1.27) [P04547] 
SwissProt 
EC 2.4 Glycosyltransferases (95.7%); 
EC 2.5 Transferase of Alkyl or Aryl Groups, Other 
than Methyl Groups (80.4%) 
+ 
dNMPkinase (EC 
2.7.4.13) [P04531] SwissProt 
EC 2.7 Transferase of Phosphorus-Containing Groups 
(99.0%);  
EC 2.4 Glycosyltransferase (96.4%);  
EC 1.1 Oxidoreductase of the CH-OH group of 
donors (71.3%)  
+ 
Endonuclease II (EC 
3.1.21.1) [P07059] SwissProt EC 3.1 Hydrolase of Ester Bonds (99.0%) + 
Endonuclease V (EC 
3.1.25.1) [P04418] SwissProt EC 3.1 Hydrolase of Ester Bonds (99.0%) + 
Exonuclease (EC 
3.1.11.3) [P03697] SwissProt 
EC 3.1 Hydrolase of Ester Bonds (99.0%);  
EC 4.1 Carbon-Carbon Lyases (88.1%);  
EC 2.7 Transferase of Phosphorus-Containing Groups 
(68.5%);  




3.1.-.-)[P13312] SwissProt EC 3.1 Hydrolase of Ester Bonds (99.0%) + 
Intron-associated 
endonuclease 1 (EC 
3.1.-.-) [P13299] 
SwissProt EC 3.1 Hydrolase of Ester Bonds (99.0%);  DNA-binding Protein (83.9%) + 
Intron-associated 
endonuclease 2 (EC 
3.1.-.-) [P07072] 
SwissProt EC 3.1 Hydrolase of Ester Bonds (99.0%) + 
Putative adenine-specific 
methylase (EC 2.1.1.72) 
[P51715] 
SwissProt 
EC 2.1 Transferase of One-Carbon Groups (99.0%) 
Outer membrane (58.6%) 
mRNA-binding Protein (58.6%) 
+ 
Protein kinase (EC 
2.7.1.37) [P00513] SwissProt 
EC 2.7 Transferase of Phosphorus-Containing 
Groups (99.0 %) + 
Slt35 (EC 3.2.1.-)  
[P41052] SwissProt 
Outer membrane (99.0%) 
EC 1.1. Oxidoreductase acting on the CH-OH group 
of donors (89.3%) 




1.13.12.- )[ Q04508] 
SwissProt 
EC 1.13. oxygenase  (99.0%) 
Transmembrane  (99.0%) 
EC 2.4. Glycosyltransferases (83.9%) 
+ 
2-aminomuconate 
deaminase (EC 3.5.99.5) 
[P81593] 
SwissProt 
EC 3.5. Hydrolase acting on Carbon-Nitrogen Bonds, 
other than Peptide bonds (99.0%) 
EC 3.4. Peptidase (58.6%) 
+ 
ADP-ribosyltransferase 
(EC2.4.2.37) [P14299] SwissProt 
Transmembrane (92.9%) 
EC 2.4. Glycosyltransferase (90.3%) 
Outer membrane (58.6%) 
* 
Alpha-N-AFase II (EC 
3.2.1.55 ) [P82594] SwissProt EC 3.4. Peptidase (91.3%) _ 
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Aminopeptidase G (EC 
3.4.11.-) [Q54340] SwissProt 
EC 3.4. Peptidase (99.0%)  
TC 1.C. Pore-forming toxins (proteins and peptides) 
(58.6%)  
+ 





EC 3.1.-.-: Hydrolases - Acting on Ester Bonds 
(78.4%)  
Outer membrane (58.6%) 
_ 
ATPE_YEAST (EC 





EC 3.1. Hydrolase acting on Ester Bonds (82.2%) 





Table 5-2 List of pairs of homologous enzymes of different families and the results of 
SVM functional family assignment. E1Æ F1 or E2 Æ F2 indicates that enzyme E1 or 
E2 is assigned into family F1 and F2 respectively. E1Æ W or E2 Æ W indicates that 
enzyme E1 or E2 is assigned into a wrong family respectively. The symbol + or - 
represents the cases that SVM is able or unable to distinguish the two enzymes and 
exclusively assign them into the respective family.  



























5.3 3.00E-07 E1ÆF1;E2ÆF2 + 


























4.4 1.00E-12 E1ÆW;E2ÆF2 - 
Maleylacetoacetate 





class  (P57108) 
EC 



























4.2 1.60E-96 E1ÆF1;E2ÆF2 + 
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5.2. Prediction of Functional Class of Novel Viral Proteins 
(Paper V) 
5.2.1. Introduction of exploring knowledge of novel viral proteins 
The need to explore functions of novel viral proteins is required for better 
understanding of how viruses interact with their host. For example, large DNA viruses 
such as poxviruses encode for a unique variety of proteins that can specifically 
manipulate the function of important host immune factors/messengers, e.g. interferon, 
interleukins and chemokines. The complete genomes of 1,536 viruses have been 
sequenced (Viral genomes at NCBI244 as of September 2004). Knowledge of these 
genomes is very important for mechanistic study of viral infections and identification 
of molecular targets of antiviral therapeutics 245-247. However, the function of over 15% 
of the putative protein-coding open reading frames (ORFs) in these viral genomes is 
unknown 245, 247, 248. Determination of the function of these unknown ORFs is important 
for a more comprehensive understanding of the molecular mechanism of specific virus 
and for searching novel targets for antiviral drug development.  
The sequence of many of these unknown ORFs has no significant similarity to proteins 
of known functions, and their functions are difficult to predict based on sequence 
similarity. For instance, 50%, 100%, 20% and 67% of the unknown ORFs in the 
recently determined genomes of Fer-de-lance virus238, Grapevine fleck virus239, Indian 
citrus ringspot virus240, and SARS coronavirus241 are without a homolog in Swissprot 
database180 based on BLAST search against Swiss-Prot database180 as of September 
2004. This suggests that a large number of new viral proteins are likely to have no 
known sequence homolog.  
In the absence of clear sequence or structural similarities, the criteria for comparison of 
distantly-related proteins become increasingly difficult to formulate 16. Moreover, not 
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all homologous proteins have analogous functions 8. The presence of shared domain 
within a group of proteins does not necessarily imply that these proteins perform the 
same function21. Therefore, careful evaluation is required to determine whether method 
is useful for facilitating functional study of novel viral proteins with no homology to 
proteins of known function. 
This work evaluates the usefulness of SVMProt for predicting the functional class of 
viral ORFs of unknown function. It is assessed by using novel viral proteins that (1) 
have no homology in the Swissprot database180 based on sequence similarity search; (2) 
have a clear function indication described in the literature and (3) were not in the 
training set of SVMProt. These proteins are collected from an unbiased search of 
Medline 244 and Swiss-Prot database 180. The SVMProt predicted functional classes of 
these proteins are compared with the function described in the literature and databases 
to evaluate to what extent SVMProt are useful for functional class assignment of novel 
viral proteins. The prediction accuracy for assignment of these novel proteins is 
compared with the overall accuracy of the SVMProt assignment of a large number of 
proteins to examine the level of sequence similarity independence of SVMProt 
classification. 
5.2.2. Methods 
The key words, “novel protein virus” or “novel viral protein”, are used to search the 
Medline 244 and the Swissprot database 180 for finding viral proteins that are both 
described as novel and with their precise function provided. As the search of the 
Medline is confined to the abstracts, those proteins whose function is not explicitly 
mentioned in an abstract are excluded. Thus, the selected proteins likely account for a 
portion of the known novel viral proteins with available functional information.  
PSI_BLAST38 sequence analysis is subsequently conducted on each of these novel 
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viral proteins against all SwissProt entries in the SwissProt protein database 180 so that 
those with at least one sequence homolog of known function (including that of the same 
protein in different species) are removed. The commonly-used criterion38 for homologs, 
the similarity score e-value < the inclusion threshold value of 0.005, is used in this work. 
Finally, those proteins that are in the training sets of SVMProt are removed. 25 novel 
viral proteins are identified in this process. These protein and their protein accession 
number, literature-described functional indications and related references are given in 
Table 5-3. 
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Table 5-3 Novel viral proteins, literature-described functional indications as suggested from experiment and/or sequence analysis, and SVMProt 
predicted functions. The SVMProt predicted functions are categorized in one of the four classes: The first class is M (matched), in which all of 
the literature-described functional indications are predicted. The second is PM (partially matched), in which some of the literature-described 
functional indications are predicted. The third is WC (weakly consistent), in which some of the predicted functions can be considered to be 
consistent with literature-described functional indications on an inconclusive basis. The fourth is NM (not matched), in which No function 
predicted of the literature-described functions matched or consistent with a predicted function. 
Protein 
(SwissProt or 
NCBI  accession 
number) 
Virus Literature Described Function  (reference) 
Function characterized  by SVMProt (probability of 





Adenosylmethionine hydrolase (EC 
3.3.1.2) 249 
EC 3.3: Hydrolase of Ether Bonds  (99.0%); 
EC 2.7: Transferase of  Phosphorus-Containing Groups 
(71.3%); 
DNA-binding Proteins ( 65.4%);  
M 
AGT (P04519) Enterobacteria phage T4 
DNA alpha-glucosyltransferase  (EC 
2.4.1.26) 246 
EC 2.4 Glycosyltransferase (80.4%); 
EC 2.7 Transferase of Phosphorus-Containing Groups (68.5%) M 
BGT (P04547) Enterobacteria phage T4 
DNA beta-glucosyltransferase  (EC 
2.4.1.27) 246, 250 
EC 2.4 Glycosyltransferases (95.7%); 
EC 2.5 Transferase of Alkyl or Aryl Groups, Other than Methyl 
Groups (80.4 %) 
M 
DNA-directed 
RNA polymerase  
(P42488) 
African swine 
fever virus (strain 
BA71V) 
DNA-directed RNA polymerase, 
subunit 10 homolog (EC 2.7.7.6) 251. EC 2.7 Transferase of Phosphorus-Containing Groups (99.0%); M 
DNK (P04531) Enterobacteria phage T4 dNMPkinase (EC 2.7.4.13) 
252 
EC 2.7 Transferase of Phosphorus-Containing Groups (99.0%); 
EC 2.4 Glycosyltransferase (96.4%);  
EC 1.1 Oxidoreductase of  the CH-OH group of donors 
(71.3%)  
M 
Endonuclease II  
(P07059) 
Enterobacteria 
phage T4 Endonuclease II (EC 3.1.21.1) 




phage T4 Endonuclease IV (EC 3.1.21.-) 
246 No function predicted NM 
Endonuclease V  
(P04418) 
Enterobacteria 
phage T4 Endonuclease V (EC 3.1.25.1) 
254 EC 3.1 Hydrolase of Ester Bonds(99.0%) M 
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lambda Exonuclease (EC 3.1.11.3) 
255. 
EC 3.1 Hydrolase of  Ester Bonds(99.0%);  
EC 4.1 Carbon-Carbon Lyases (88.1%);  
EC 2.7 Transferase of Phosphorus-Containing Groups(68.5%); 







Associated with unique cytoplasmic 
structures, filament-associated protein  
256 
No function predicted NM 
Gp61.9 (P13312) Enterobacteria phage T4 Ribonuclease (EC 3.1.-.-) 





Intron-associated endonuclease 1 (EC 
3.1.-.-) 258 
EC 3.1 Hydrolase of Ester Bonds(99.0 %);  
DNA-binding Protein (83.9%)  M 
I-TevII (P07072) Enterobacteria phage T4 
Intron-associated endonuclease 2 (EC 
3.1.-.-) 259 EC 3.1 Hydrolase of Ester Bonds(99.0%) M 
MotA protein  
(P22915) bacteriophage T4 
DNA-binding, transcription regulation 
260 
DNA-binding Proteins (99.0 %); 
EC 3.1: Hydrolase - Acting on Ester Bonds (68.5%) M 
ORF13 (P51715) Haemophilus phage HP1 
Putative adenine-specific methylase 
(EC 2.1.1.72) 261 
EC 2.1 Transferase of One-Carbon Groups (99.0%); 
Outer membrane (58.6%);  






(serotype 10 / 
strain B223) 





herpesvirus 6 chemokine like  
263 No function predicted NM 
Protein kinase  
(P00513) 
Enterobacteria 
phage T7 Protein kinase (EC 2.7.1.37) 






Membrane associated and encodes 
three arginin-rich motifs of 
RNA-binding properties 265 






Endonuclease CviAII (EC 3.1.21.4) 266 EC 3.1 Hydrolase of Ester Bonds (99.0%)  M 
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Type II restriction enzyme CviJI (EC 
3.1.21.4) 267 
EC 3.1  Hydrolase of Ester Bonds (99.0%);  
rRNA-binding Proteins(98.8%) ; 









Transferase 268 No function predicted NM 
SPLT137 
(NP_258405) SpLtMNPV virus A noval envelope protein 






Structural envelop glycoprotein 270   Transmembrane (98.2%) NM
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5.2.3. Results and Discussion 
SVMProt predicted functional classes for each of the 25 novel viral proteins together with 
their literature-described function are given in Table 5-3. SVMProt may characterize more 
than one class for each protein and the probability of correct prediction for each class is 
given in the table. There are 18 proteins with the top hit of the SVMProt assigned functional 
class matching their functions described in the literature, representing 72% of the novel viral 
proteins studied in this work. These proteins are MotA protein of bacteriophage T4 260, outer 
capsid protein VP4 of bovine rotavirus (serotype 10 / strain B223) 262, ADOMetase of 
bacteriophage T3 249, R.CviJI of chlorella virus IL3A 267, exonuclease of bacteriophage 
lambda 255, R.CviAII of paramecium bursaria chlorella virus 1 266, ORF13 of haemophilus 
phage HP1 261, Protein kinase of enterobacteria phage T7 264, DNA-directed RNA 
polymerase of African swine fever virus (strain BA71V)251, AGT 246, BGT 248, 250, DNK 252, 
Endonuclease II 253, Endonuclease V 254, Gp61.9 257, IRF protein 258, and I-TevII 259 of 
enterobacteria phage T4. 
 
MotA protein of bacteriophage T4 has been found to be a transcription activator that binds to 
DNA 260 and the far-C-terminal region of the sigma70 subunit of Escherichia coli RNA 
polymerase 271. The top hit of SVMProt predicted functional class for this protein is the 
DNA-binding, which matches with literature-described functions. Bovine rotavirus is a 
double-stranded RNA virus which is naked. Thus the outer capsid protein VP4 of bovine 
rotavirus (serotype 10 / strain B223) is located at the viral surface acting as part of the viral 
coat 262. This protein is predicted by SVMProt as a coat protein, which is consistent with 
literature-described function. The other 14 proteins are enzymes and SVMProt correctly 
assigns all these to the respective enzyme EC class. 
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Because these proteins have no homolog of known function in the SwissProt entries of 
Swissprot database based on PSI-BLAST search, our study suggests that SVMProt has 
certain level of capability for providing useful hint about the functional class of novel 
proteins with no or low homology to known proteins, and this capability is not based on 
sequence similarity or clustering. The overall accuracy of 72% for the assignment of 
the novel viral proteins is smaller than that of 87% for SVMProt functional class 
assignment of 34,582 proteins.  This indicates certain level of the 
sequence-similarity-independent nature of SVM protein classification.  
 
Several factors may affect the accuracy of SVMProt for functional characterization of 
novel plant proteins. One is the diversity of protein samples used for training SVMProt. 
It is likely that not all possible types of proteins, particularly those of distantly related 
members, are adequately represented in some protein classes. This can be improved 
along with the availability of more protein data. Not all distantly related proteins of the 
same function have similar structural and chemical features. There are cases in which 
different functional groups, un-conserved with respect to position in the primary 
sequence, mediate the same mechanistic role, due to the flexibility at the active site 272. 
This plasticity is unlikely to be sufficiently described by the physicochemical 
descriptors currently used in SVMProt. Therefore, SVMProt in the present form is not 
expected to be capable of classification of these types of distantly related enzymes.  
 
Some of the SVMProt functional classes are at the level of families and superfamilies 
that may include a broad spectrum of proteins. It has been shown that, SVM works not 
as well as HMM for distinguishing proteins in a superfamily, but may be more accurate 
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with subfamily discrimination 31. Thus, the use of some large families and 
superfamilies as the basis for classification may affect the prediction accuracy of 
SVMProt to some extent. 
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5.3. Prediction of functional class of novel plant proteins 
(Paper VI) 
5.3.1. Introduction of probing function of unknown ORFs in plant 
Plants have the well known advantages for the production of clinically-useful, 
therapeutic proteins, such as low-cost, large-scale production of safe and biologically 
active mammalian proteins273. In the completely sequenced genome of Arabidopsis, the 
function of 30% of the putative protein-coding open reading frames (ORFs) remain 
uncovered 234, 235. Similar percentage of unknown ORFs is expected in other plant 
genomes. The sequence of these ORFs has no significant similarity to those of known 
proteins, and their functions are difficult to probe by using sequence alignment and 
clustering methods. It is thus desirable to explore complementary methods or 
combination of methods for providing useful hint about the function of unknown 
ORFs.  
Various methods for probing protein function have been developed. These include 
evolutionary analysis 8, 9, hidden Markov models 274, structural consideration 10, 27, 
protein/gene fusion 11, 12, protein-protein interactions 14, motifs 19, family 
classification by sequence clustering 12, and functional family prediction by statistical 
learning methods 31, 34, 43, 45, 46. In the absence of clear sequence or structural 
similarities, the criteria for comparison of distantly-related proteins become 
increasingly difficult to formulate 16. Moreover, not all homologous proteins have 
analogous functions 8. The presence of shared domain within a group of proteins does 
not necessarily imply that these proteins perform the same function 21. Therefore 
careful evaluation is needed to determine which method or combination of methods is 
useful for facilitating functional study of novel proteins with no homology to proteins 
of known function. 
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In this work, SVMProt is assessed for its capability in prediction of the functional 
class of a number of literature-described novel plant proteins that have no homolog in 
the SwissProt entries of the SwissProt database based on PSI-BLAST search and with 
their functional indications provided in the literature. There are 49 plant proteins 
selected from a comprehensive search of Medline abstracts and SwissProt databases 
in 1999-2004 to test SVMProt. These proteins are selected based on 1) no sequence 
similar proteins in Swissprot protein database, 3) not in our dataset for training 
SVMProt and 3) with precise functional indications provided by the literature. These 
proteins represent unique proteins whose functions cannot be confidently predicted by 
sequence alignment and clustering methods at present. The predicted functional class 
of 31 proteins is consistent, and that of 4 other proteins is weakly consistent with 
literature-described functions. Overall, the functional class of 71.4% of these proteins 
is consistent or weakly consistent with literature described functional indications. 
SVMProt shows certain level of capability for providing useful hint about the 
function of novel plant proteins un-similar to known proteins. 
5.3.2.  Methods of novel plant proteins selection 
The key words “novel plant protein” is used to search two sources for finding plant 
proteins that were both described as novel and with their precise functional 
indications provided. One is the abstracts of Medline 244 published during 1999-2004. 
The sequences of these proteins are obtained by querying the protein database. As the 
search is confined to the abstracts, those proteins whose functional indication is not 
apparently hinted in an abstract are excluded. Thus, the selected proteins likely 
account for a portion of the known novel plant proteins with available functional 
indications. The second source is the SwissProt database180. The key words “novel 
plant” is used to search the description field of the plant protein entries to find those 
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with precise functional indications provided. There are 413 proteins selected from 
these two search procedures. 
 
Some of these selected proteins may become less novel than originally described 
because of the subsequent findings of additional proteins. Thus PSI_BLAST 38 search 
is conducted for each of these proteins against all SwissProt entries in the SwissProt 
protein database 180 to determine whether it has a sequence homolog (including that 
of the same protein of different species). The commonly-used criterion for homologs, 
the similarity score e-value < the inclusion threshold value of 0.005 38, is used in this 
work. Based on PSI-BLAST analysis, 49 of these proteins have no sequence homolog 
in the SwissProt entries of SwissProt database and they are not in the training sets of 
SVMProt.  
 
These 49 proteins, along with their NCBI protein accession number, or Swiss-Prot 
accession number, literature-described functional indications and related references, 
are given in Table 5-4. Only a few proteins published before 2001 are selected 
primarily because more proteins published in earlier years tend to have their homologs 
available than those published more recently. Because of the lack of a sequence 
homolog, sequence alignment and clustering tools would not confidently predict the 
function of these proteins. They are thus ideal for testing the feasibility of using 
SVMProt for facilitating functional characterization of novel plant proteins. 
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5.3.3. Prediction results and discussions 
 
Table 5-4 gives SVMProt ascribed functional classes for each of the 49 novel plant 
proteins together with their literature described functional indications. SVMProt may 
characterize more than one functional class and the probabilities of correct prediction 
for each class are given in Table 5-4. There are 31 proteins with SVMProt predicted 
class to be consistent with literature-described functional indications, 20 of which are 
enzymes with their enzyme classification (EC) number assigned in the literature. The 
predicted functional class of these enzymes can thus be confirmed based on the 
comparison with their respective EC number. These enzymes are SPP of Aegilops 
speltoides 275, CPDase276 and GddR of Arabidopsis thaliana, Cucumisin of Cucumis 
melo var reticulates277,  AOC  of Hordeum vulgare, Spp of Hordeum vulgare var 
distichum 275, AOC278 and RdRP279 of Lycopersicon esculentum, 
Beta-1,2-xylosyltransferase and AOC of Oryza sativa, GrG of Phaseolus angularis 280, 
PAT1 and rfs of Pisum sativum, Sucrose-phosphatase of  Secale cereale 275, CR6 of 
Solanum tuberosum 281, CPDase, SPP1,SPP2,SPP3 and fut12  of Triticum aestivum. 
Some of these enzymes do not yet  have a reference because they have been submitted 
to Swissprot database prior to their publications 180. 
 
Four proteins are predicted as transmembrane and another one as a DNA-binding 
protein by SVMProt, which can be directly compared with their respective literature 
described functional indications. PSI-O of Arabidopsis thaliana is known to have two 
transmembrane helices 282. PM19 of Hordeum vulgare has been described as a putative 
plasma membrane protein 283. OsBLE2 of Oryza sativa has been suggested to contain 
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nine possible transmembrane regions 284. NEC1 of Petunia x hybrida has been found to 
be reminiscent of a transmembrane protein with possible role in sugar metabolism and 
nectar secretion 285. MYB-related transcription factor EPR1 of Arabidopsis thaliana is 
part of a regulatory feedback loop that suppresses its own expression, and it is known to 
specifically recognizes the DNA sequence 5'-YAAC[GT]G-3' 286. The SVMProt 
predicted transmembrane or DNA-binding property for each of these proteins appears 
to be consistent with literature descriptions. 
 
The predicted functional class of the other four proteins also appears to be consistent 
with literature described functional indications based on our analysis. NCP1 of 
Lycopersicon esculentum has been described as a nuclear matrix protein and a 
candidate for a plant-specific structural protein with a function both in the nucleus and 
cytoplasm 287. The top hit of SVMProt predicted functional classes for this protein is 
the structural protein class that includes matrix proteins, core proteins, viral occlusion 
body, and keratins. This prediction is consistent with literature-described function. 
Antimicrobial peptide 2, 3 and 4 of Pinus sylvestris are known to interfere with cell 
wall synthesis 288. The top hit of SVMProt predicted class for each of these proteins is 
EC3.4 peptidase enzyme family. It is known that members of peptidase family such as 
penicillin-binding protein 5 (EC 3.4.16.4) polymerize and modify peptidoglycan, the 
stress-bearing component of the bacterial cell wall, thereby helping to create the 
morphology of the peptidoglycan exoskeleton together with cytoskeleton proteins that 
regulate septum formation and cell shape 289. While other mechanisms cannot be ruled 
out yet, EC3.4 peptidase enzymatic activity is certainly an interesting possibility for the 
observed interference of each of these proteins with cell wall synthesis. 
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There are 4 proteins whose SVMProt predicted function may possibly explain literature 
described functional indications non-conclusively. The predicted functional class of 
each of these proteins is thus considered to be weakly consistent with literature 
descriptions pending further studies. PLATZ1 of Pisum sativum has been found to be 
responsible for A/T-rich sequence-mediated transcriptional repression 290. The top 
ranked SVMProt predicted class for this protein is the nuclear receptor class. Nuclear 
receptors such as thyroid hormone T3 receptor have been known to be involved in 
transcriptional repression 291. Thus, there is a possibility that PLATZ1 is a nuclear 
receptor. SPA15 of Ipomoea batatas, has been found to be specifically associated with 
the cell wall and involved in oligogalacturonides signaling during leaf senescence 292. 
SVMProt predicts this protein as an outer membrane protein, which is possible to 
possess both properties.  
 
SVMProt predicts three of these proteins as DNA-binding protein. OsGRF1 of 
Arabidopsis thaliana has been described as a putative transcription factor possibly 
playing a regulatory role in stem elongation 293. bnKCP1 of  Brassica napus contains a 
putative kinase-inducible domain and it may function as a transcription factor 294. 
Transcription factors primarily exert their function through DNA-binding295, thus these 
two proteins are likely DNA-binding proteins.  HvS40 of Hordeum vulgare subsp. 
Vulgare has been described as a novel nucleus-targeted protein 296. The nuclear HvS40 
protein belongs to the group of nuclear proteins that possess two putative NLSs, one 
belonging to the SV40 class, the other to the class of bipartite NLSs. In the case of the 
maize transcription factor opaque 2, the bipartite NLS has an additional function in 
DNA binding 296. Although there is no other evidence, it is possible that HvS40 of 
Hordeum vulgare subsp. Vulgare is a DNA-binding protein like the other of bipartite 
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NLS containing proteins such as the maize transcription factor opaque 2. 
 
Another protein, HvCaBP1 of Hordeum vulgare, has been described as a putative 
calcium binding protein 297. One of the SVMProt predicted classes for this protein is 
outer membrane class. It is known that some outer membrane proteins, such as the 40 
kDa outer membrane protein, form spheroplast at a high rate in an isotonic medium in 
the presence of calcium and the calcium-protein complex helps maintaining the 
structural integrity of the cell wall 298. Thus, there is some possibility that HvCaBP1 is a 
calcium-binding outer membrane protein. 
 
Overall, SVMProt characterized functions of 71.4% of the 49 novel plant proteins 
studied in this work are found to be consistent or weakly consistent with the 
functional indications described in the literature. Because all of these proteins have no 
homolog in the SwissProt entries of Swissprot database based on PSI-BLAST search, 
our study suggests that SVMProt has certain level of capability for probing the 
functional class of novel plant proteins with no or low homology to known proteins, 
and this capability is not based on sequence similarity or clustering. 
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Table 5-4 Novel plant proteins, literature-described functional indications as suggested by the literature and SVMProt predicted functional 
classes. The SVMProt predicted functional classes are categorized in one of the four classes: The first class is C (consistent with 
literature-described functional indications), the second is WC (weakly consistent with literature-described functional indications, i.e., the 
predicted functional class can be considered to be consistent to the literature-described functions on an inconclusive basis.), the third is NC (not 
consistent with literature-described functional indications), and the fourth is represented by a question mark “?” (Currently available information 
is insufficient to determine prediction status). 
Host Plant 
Protein (NCBI or 
SwissProt Accession
number) 




speltoides SPP(AAO33156) Sucrose-phosphatase (EC 3.1.3.24) 
275 
EC 3.1  Hydrolases - Acting on Ester 
Bonds(94.7%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (76.2%); 
TC 1.C  Channels/Pores - Pore-forming toxins 
(proteins and peptides) (58.6%) 
C 
MYB-related transcription 
factor EPR1 (BAC98462) 
DNA-binding protein, specifically recognizes the 
sequence 5'-YAAC[GT]G-3' 286 DNA-binding Protein (98.8%) C 
OsGRF1 (AAM52876) putative transcription factor playing a regulatory role in stem elongation293 DNA-binding Protein (97.0%) WC 
PSI-O (CAD37939) contains two transmembrane helices 282 Transmembrane (68.5%); EC 5.3 Intramolecular Oxidoreductase (58.6%) C 
ERN1 (CAA75349) a novel ethylene-regulated nuclear protein, putative transcription factor 299 
EC 4.2 Carbon-Oxygen Lyase (58.6%); 
7 transmembrane receptor metabotropic glutamate 
family (58.6%) 
NC 





 Glutathione dependent dehydroascorbate
reductase (EC 1.8.5.1) * 
 
EC 1.8  Oxidoreductases - Acting on a sulfur group 
of donors(99.0%); 
Transmembrane(58.6%); 
TC 1.C Channels/Pores - Pore-forming toxins 
(proteins and peptides) (58.6%) 
C 
Brassica napus bnKCP1 (AAO53442) contains a putative kinase-inducible domain,  may function as a transcription factor 294 DNA-binding Protein (68.5%) WC 
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Cucumis melo var 
reticulatus Cucumisin (Q940D5) serine protease(EC 3.4.21.25)
277 
EC 3.4  Hydrolases - Acting on peptide bonds 
(Peptidases) (99.0%); 
EC 3.1  Hydrolases - Acting on Ester Bonds(78.4%)
C 
CPP1 (CAA09028) 
DNA-binding protein interacting with the 
promoter of the soybean leghemoglobin gene 
Gmlbc3 300 
No function predicted NC 
Glycine max 
GmN6L (AAL86737) 
both as a soluble protein and as a peripheral 
membrane protein bound to the peribacteroid 
membrane, a late nodulin 301 
EC 1.1 Oxidoreductase acting on CH-OH group of 
donors (73.8%); 
EC 3.6 Hydrolase Acting on Acid Anhydrides 
(71.3%); 
? 
Lem1 (AAK58425) possibly associated with membranes, may play a role in organ development 302 
EC 3.4 Peptidase (58.6%); 
Lectin (58.6%) NC 
HvCaBP1 (AAK92225) putative calcium binding protein 297 
EC 1.3 Oxidoreductase acting on CH-CH group of 
donors (85.4%); 
EC 4.1 Carbon-Carbon Lyase (62.2%); 
Outer membrane (58.6%) 
WC 
PM19 (AAF29532) putative plasma membrane protein 283   Transmembrane (68.5%) C
Hordeum vulgare
AOC  (Q711R0) Allene oxide cyclase precursor (EC 5.3.99.6)* 
EC 5.3  Isomerases - Intramolecular 
Oxidoreductases (95.7%); 
EC 1.10  Oxidoreductases - Acting on diphenols 
and related substances as donors (65.4%) 
C 
HvS40 (CAC36956) a novel nucleus-targeted protein with connection to the degeneration of chloroplasts 296 
DNA-binding Protein (78.4%); 
Nuclear Receptor (65.4%); 
EC 2.1 Transferase of One-Carbon Groups (58.6%); 




SnIP1 (CAB97356) interacts with SNF1-related protein kinase 303 
EC 3.4 Peptidase (71.3%); 
EC 5.3 Intramolecular Oxidoreductase (68.5%); 
EC 1.3 Oxidoreductase acting on CH-CH group of 
donors (65.4%); 
EC 3.5 Hydrolase acting on Carbon-Nitrogen Bonds 
other than Peptide Bonds (62.2%); 
7 transmembrane receptor secretin family (58.6%) 
NC 
Hordeum vulgare 
var distichum Spp (Q84ZX7) Sucrose-phosphatase (EC 3.1.3.24) 
275 
EC 3.1  Hydrolases - Acting on Ester Bonds 
(97.7%); 
EC 2.4  Transferases - Glycosyltransferases(91.3%)
C 
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Ipomoea batatas SPA15 (AAK08655) specifically associated with the cell wall 292   Outer membrane (58.6%) C
Lilium 
longiflorum LlSCL (BAC77269) strong activity of transcriptional activation 
304 No function predicted NC 
NCP1 (AAK83083) Nuclear Matrix Protein, structural protein with a function both in the nucleus and cytoplasm 287 
Structural protein (99.0%) 
EC 5.4 Intramolecular Transferase (85.4%) 
DNA-binding Proteins (65.4%) 
C 
AOC (Q9LEG5) Allene oxide cyclase precursor (EC 5.3.99.6) 278 
EC 5.3  Isomerases - Intramolecular 
Oxidoreductases (99.0%); 
EC 4.1  Lyases - Carbon-Carbon Lyases(58.6%) 
C 
RdRP (Q9ZR58) RNA-directed RNA polymerase(EC 2.7.7.48) 279 EC 2.7  Transferases - Transferring Phosphorus-Containing Groups (99.1%) C 
LeMan3 (Q9FUQ6) Endo-beta-mannanase precursor(EC 3.2.1.78) * 
EC 2.4  Transferases - 
Glycosyltransferases(95.2%) ; 




MAN5 (Q6YM50) Mannan endo-1,4-beta-mannanase precursor (EC 3.2.1.78)305 EC 2.3  Transferases - Acyltransferases (68.5%) NC 
Oenothera 
bertiana A6L (P07513) ATP synthase protein 8(EC 3.6.3.14) 
180 






contains nine possible transmembrane regions, 
involved in BL-regulated growth and 
development processes 306 
Transmembrane (99.1%) Alpha-Type channel 
(58.6%) C 
OsMYBS2 (AAN63153) 
trans-activates a promoter containing the 
TATCCA element, interacts with other protein 
factors 307 
Transmembrane (71.3%); 
7 transmembrane receptor secretin family (58.6%) NC 
Beta-1,2-xylosyltransferas
e (Q703H1) Beta-1,2-xylosyltransferase (EC 2.4.2.38)* 
EC 2.4  Transferases - Glycosyltransferases 
(98.8%) ; 
EC 4.2  Lyases - Carbon-Oxygen Lyases (58.6%); 
Outer membrane (58.6%) 
C 
Oryza sativa 
AOC(Q8L6H4) Allene oxide cyclase (EC 5.3.99.6) * 
EC 5.3  Isomerases - Intramolecular 
Oxidoreductases(99.0%); 
EC 1.10  Oxidoreductases - Acting on diphenols 
and related substances as donors (58.6%) 
C 
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Aspartate aminotransferase (EC 2.6.1.1) * 
TC 1.C Channels/Pores - Pore-forming toxins 
(proteins and peptides) (58.6%); 
RNA-binding Proteins (58.6%) 
NC 
Petunia x hybrida NEC1 (AAG34696) reminiscent of a transmembrane protein, possible role in sugar metabolism and nectar secretion 285 Transmembrane (97.3%) C 
Phaseolus 
angularis GrG (Q9SBZ0) 
Galactinol-raffinose galactosyltransferase (EC 
2.4.1.67) 280 
EC 2.4  Transferases - Glycosyltransferases 
(96.4%); EC 4.2  Lyases - Carbon-Oxygen Lyases 
(78.4%) 
C 
antimicrobial peptide 1 
(AAL05052) Interferes with cell wall synthesis 
288   Transmembrane (58.6%) NC
antimicrobial peptide 2 
(AAL05053) interferes with cell wall synthesis 
288 EC 3.4 Peptidase (58.6%); EC 4.1 Carbon-Carbon Lyase (58.6%) C 
antimicrobial peptide 3 
(AAL05054) interferes with cell wall synthesis 
288 EC 3.4 Peptidase (58.6%) C 
Pinus sylvestris 
antimicrobial peptide 4 
(AAL05055) interferes with cell wall synthesis 
288 EC 3.4 Peptidase (58.6%); EC 4.1 Carbon-Carbon Lyase (58.6%) C 
PLATZ1 (BAB69816) 
zinc-dependent DNA-binding protein responsible 
for A/T-rich sequence-mediated transcriptional 
repression 290 
Nuclear Receptor (68.5%); 
EC 3.1 Hydrolase Acting on Ester Bonds (62.2%); 
EC 4.1 Carbon-Carbon Lyase (58.6%) 
C 
PAT1 (Q43085) Phosphoribosylanthranilate transferase (EC 2.4.2.18) * 
EC 2.4  Transferases - Glycosyltransferases 
(99.1%); Transmembrane (96.1%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (76.2%) ; 
7 transmembrane receptor (Secretin family) 
(58.6%) ; 
7 transmembrane receptor (metabotropic glutamate 
family) (58.6%) 
C Pisum sativum 
rfs (Q8VWN6) Raffinose synthase (EC 2.4.1.82) * 
EC 2.4  Transferases - Glycosyltransferases 
(98.6%); Aptamer-binding protein (98.0%); 
EC 4.2  Lyases - Carbon-Oxygen Lyases (78.4%) 
C 
Secale cereale Sucrose-phosphatase (Q84ZX9) Sucrose-phosphatase (EC 3.1.3.24) 
275 
EC 3.1  Hydrolases - Acting on Ester Bonds 
(86.8%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (62.2%) 
C 
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Solanum 
tuberosum CR6(P48505) 
Ubiquinol-cytochrome C reductase complex 6.7 
kDa protein (EC 1.10.2.2) 281 
EC 1.10  Oxidoreductases - Acting on diphenols 
and related substances as donors (99.0%); 
EC 3.4  Hydrolases - Acting on peptide bonds 
(Peptidases) (58.6%) 
C 
CPDase (P62809) Cyclic phosphodiesterase (EC 3.1.4.-) 308 
EC 1.9  Oxidoreductases - Acting on a heme group 
of donors (58.6%); 
EC 3.1  Hydrolases - Acting on Ester Bonds 
(58.6%); 
EC 3.4  Hydrolases - Acting on peptide bonds 
(Peptidases) (58.6%); 
Transmembrane (58.6%) ; 
Aptamer-binding protein (58.6%) 
C 
SPP3 (Q9ARG8) Sucrose-6F-phosphate phosphohydrolase SPP3 (EC 3.1.3.24) *
EC 3.1  Hydrolases - Acting on Ester Bonds 
(96.4%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (92.1%); 
TC 1.C. Channels/Pores - Pore-forming toxins 
(proteins and peptides) (58.6%) 
C 
SPP2 (Q9AXK5) Sucrose-6F-phosphate phosphohydrolase SPP2 (EC 3.1.3.24) * 
EC 3.1  Hydrolases - Acting on Ester Bonds 
(93.6%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (68.5%); 
TC 1.C. Channels/Pores - Pore-forming toxins 
(proteins and peptides) (58.6%) 
C 
Triticum aestivum
SPP1 (Q9AXK6) Sucrose-6F-phosphate phosphohydrolase SPP1 (EC 3.1.3.24) * 
EC 3.1  Hydrolases - Acting on Ester Bonds 
(96.4%); 
EC 2.1  Transferases - Transferring One-Carbon 
Groups (58.6%); 
TC 1.C.Channels/Pores - Pore-forming toxins 
(proteins and peptides) (58.6%) 
C 
                                                        
* NOTE: Some of these enzymes do not yet have a reference because they have been submitted to Swissprot database prior to their publications
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fut12 (Q7XAG0) GDP-fucose protein-O-fucosyltransferase 1 (EC 2.4.1.221) * 
EC 2.4  Transferases - Glycosyltransferases 
(98.4%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (96.7%) 
C 
Vigna 
unguiculata  FGARAT (Q8W160) 
Formylglycinamide ribonucleotide
amidotransferase  (EC 6.3.5.3) * 
 
EC 2.4  Transferases - Glycosyltransferases 
(95.2%); 
DNA-binding Proteins (73.8%); 
EC 2.7  Transferases - Transferring 
Phosphorus-Containing Groups (62.2%) 
NC 
Zea mays ATPase (Q6V916) Putative AAA-type ATPase (EC 3.6.4.8) * EC 2.4  Transferases - Glycosyltransferases (71.3%) NC 
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5.4. Prediction of the functional class of novel bacterial 
proteins (Paper VII) 
5.4.1. Overview of function prediction of novel bacterial ORFs  
The complete genomes of a growing number of bacteria have been sequenced. The total 
number of distinct complete genomes in the bacterial genome database at NCBI 
(http://www.ncbi.nlm.nih.gov/genomes/static/eub_g.html) has reached 202. 
Knowledge of these genomes has facilitated the mechanistic study of bacterial growth 
and infections 309, 310, and the search of antibacterial targets 311-314. The function of a 
substantial percentage (17-20%) of the putative protein-coding open reading frames 
(ORFs) in these genomes is unknown 236, 237. Determination of the function of these 
ORFs is important for a more comprehensive understanding of the molecular 
mechanism of bacterial growth and infections and for searching novel antibacterial 
targets.  
The sequence of these ORFs has no significant similarity to proteins of known 
functions. As a result, their functions are difficult to probe based on sequence similarity 
alone. The system developed in this work has shown some potential for assignment of a 
functional class of distantly related proteins and homologous proteins of different 
functions as well as homologous proteins of similar functions43, 45, 46, 227. It classifies 
proteins into functional classes defined based on activities or physico-chemical 
properties rather than sequence similarity 14, 31, 43, 45, 228.  This work is intended to 
further evaluate the capability of SVMProt for predicting the functional class of 
bacterial proteins of unknown function. It is assessed by using novel bacterial proteins 
that are without a single homolog in the Swiss-Prot database 180 and not included in the 
training sets of SVMProt. The precise functions of these proteins are described in the 
literature. These proteins are collected from an unbiased search of Medline 244 and 
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Swiss-Prot database 180. The SVMProt predicted functional classes of these proteins are 
compared with the reported function to evaluate to what extent SVMProt is useful for 
the functional class assignment of these proteins. The prediction accuracy for the 
assignment of these novel proteins is compared with the overall accuracy of the 
SVMProt assignment of a large number of proteins to examine to which extent that 
sequence similarity affects the prediction accuracy of SVMProt. 
5.4.2.  Selection of novel bacterial proteins 
The key words, “novel protein bacterium” or “novel bacterial protein”, are used to 
search the Medline 244 and the Swiss-Prot database 180 for finding bacterial proteins that 
are both described as novel and with their precise function provided. As the search of 
the Medline is confined to the abstracts, those proteins whose function is not explicitly 
hinted in an abstract are not selected. Thus the selected proteins likely account for a 
portion of the known novel viral proteins with available functional information.  
PSI-BLAST38 sequence analysis is subsequently conducted on each of these novel viral 
proteins against all Swiss-Prot entries in the Swiss-Prot protein database 180 so that 
those with at least one sequence homolog of known function (including that of the same 
protein in different species) are removed. The commonly-used criterion for homologs, 
the similarity score e-value less than the inclusion threshold value of 0.005 38, is used in 
this work. Finally, those proteins that are in the training sets of SVMProt are removed. 
46 novel bacterial proteins are identified in this process, which together with their 
protein accession number and literature-described functional indications and related 
references are given in Table 5-5. 
5.4.3. Results and discussion of functional class prediction of novel bacterial 
proteins 
Table 5-5 gives SVMProt ascribed functional classes for each of the 46 novel bacterial 
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proteins together with their literature-described function. As shown in Table 5-5, there 
are 26 proteins with the top hit and 5 proteins with one of the hits of the SVMProt 
assigned functional classes matching the reported function, representing 67.4% of the 
novel bacterial proteins studied in this work. The 26 top-hit-matching proteins are Nhe 
of Bacillus cereus 315, AAC(6') of Enterobacter aerogenes 316, alpha-clostripain of 
Clostridium histolyticum 317, AMDASE of Bordetella bronchiseptica 318, 
aminopeptidase G of Streptomyces lividans 319, 2-aminomuconate deaminase of 
Pseudomonas pseudoalcaligenes 320, ammonia monooxygenase of Nitrosomonas 
europaea 321 , AmpE protein of  Escherichia coli 322, esterase precursor of 
Streptomyces scabies 323, CM of Bacillus subtilis 324, cytochrome c oxidase polypeptide 
IV  of Paracoccus denitrificans 325, 2-dehydro-3-deoxygalactonokinase of  
Escherichia coli 326, DNA polymerase III theta subunit  of Escherichia coli 327, 
Extracellular lipase of Aeromonas hydrophila 328, Extracellular serine protease of 
Bacteroides nodosus 329, flp-1 of Actinobacillus actinomycetemcomitans 330, Histidine 
protein kinase of Lactobacillus plantarum 331, Monofunctional chorismate mutase 
precurs of Erwinia herbicola 332, PNGase F Glycopeptide N-glycosidase N-glycanase  
of Flavobacterium meningosepticum 333, Precorrin-6A reductase of Pseudomonas 
denitrificans 334, Putative cytochrome P450 128 of Mycobacterium tuberculosis 335, 
Thiocyanate hydrolase beta subunit  of Thiobacillus thioparus 336, Thiaminase I 
[Precursor] of Paenibacillus thiaminolyticus 337, DNA alpha-glucosyltransferase of 
Bacteriophage T4 246, Type II restriction enzyme ScaI of Streptomyces caespitosus 338, 
and ATP synthase C chain  of Rhodospirillum rubrum, Paenibacillus thiaminolyticus 
339. 
 
Flp-1 protein of Actinobacillus actinomycetemcomitans has been found to be 
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associated with the bacterial cell surface and smaller structures, involved in fibril 
formation and cell adherence 330. The top hit of SVMProt predicted functional class for 
this protein is the cell adhesion class, which matches with the literature-described 
functions. AmpE protein of Escherichia coli has been reported to be an integral 
membrane protein with a likely ATP-binding site between the second and third putative 
transmembrane region 340. This protein is predicted as a transmembrane protein by 
SVMProt, which is consistent with the reported function. The other 28 correctly 
assigned proteins are enzymes and their SVMProt predicted EC class matches with the 
corresponding EC number. 
 
Because these proteins have no homolog of known function in Swiss-Prot database 
based on PSI-BLAST search, our study suggests that SVMProt has a certain capability 
for providing useful hint about the functional class of novel proteins with no or low 
homology to known proteins, and this capability is not based on sequence similarity or 
clustering. The overall accuracy of 67.4% for the assignment of the novel bacterial 
proteins is smaller than that of 87% for the SVMProt functional class assignment of 
34,582 proteins that have at least one homolog of known function.  This indicates the 
sequence-similarity-independent nature of SVM protein classification.  
 
Several factors may affect the accuracy of SVMProt for functional characterization of 
novel bacterial proteins. One is the diversity of protein samples used for training 
SVMProt. It is likely that not all possible types of proteins, particularly those of 
distantly related members, are adequately represented in some protein classes. This can 
be improved along with the availability of more protein data. Not all distantly related 
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proteins of the same function have similar structural and chemical features. There are 
cases in which different functional groups, un-conserved with respect to position in the 
primary sequence, mediate the same mechanistic role, due to the flexibility at the active 
site 272. This plasticity is unlikely to be sufficiently described by the physicochemical 
descriptors currently used in SVMProt. Therefore, SVMProt in the present form is not 
expected to be capable of classification of these types of distantly related proteins.  
 
Some of the SVMProt functional classes are at the level of families and superfamilies 
that may include a broad spectrum of proteins. It has been shown that performance of 
SVM may not better than  HMM for distinguishing proteins in a superfamily, but may 
be more accurate with subfamily discrimination 31. Thus, the use of some large families 
and superfamilies as the basis for classification may affect the prediction accuracy of 
SVMProt to some extent. 
 
In this evaluation work, SVMProt shows a certain level of capability for predicting the 
functional class of a number of novel bacterial proteins. This suggests that SVMProt is 
potentially useful to a certain extent for providing useful hints about the function of 
distantly related proteins in the genomes of bacteria as well as in other organisms. 
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Table 5-5 Novel bacterial proteins, literature-described functional indications as suggested from experiment and/or sequence analysis, and 
SVMProt predicted functions. The SVMProt predicted functions are categorized in one of the three classes: The first class is M (matched), in 
which all of the literature-described functional indications are predicted. The second is PM (partially matched), in which some of the 
literature-described functional indications are predicted. The third is NM (not matched), in which No function predicted of the 













Aminoglycoside 2'-N-acetyltransferase (EC 2.3.1.-) 
341 
EC 2.7 Transferase of Phosphorus-Containing Groups 
(78.4%) 
EC 4.2 Carbon-Oxygen Lyase (58.6%) 
NM 
Nhe [P81242] Bacillus cereus. Non-hemolytic enterotoxin 105 kDa component (EC 3.4.24.-) 315 
EC 3.4. Hydrolases - Acting on peptide bonds 
(Peptidases) (99.0%) 








Aminoglycoside N(6')-acetyltransferase type 1 
(EC 2.3.1.82) 316. 
EC 2.3 Acyltransferases (99.0%) 
EC 3.1.Hydrolases - Acting on Ester Bonds(86.8% ) 
EC2.7.Transferases-Transferring Phosphorus-Containing 
Groups (68.5%) 
EC 4.2. Carbon-Oxygen Lyases(62.2%) 
EC 4.1. Carbon-Carbon Lyases(58.6%) 





rubrum ADP-ribosyltransferase(EC 2.4.2.37) 
342 
Transmembrane (92.9%) 
EC 2.4. Glycosyltransferase (90.3%) 







erythropolis.. Limonene-1,2-epoxide hydrolase (EC 3.3.2.8)
343 
EC 3.3 Hydrolases - Acting on Ether Bonds (99.0%) 
EC 4.2. Carbon-Oxygen Lyases (71.3%) 
Transmembrane (62.2%) 
Outer membrane (58.6%) 
M 
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strain P2 a salicylate 1-hydroxylase (EC 1.14.-.-)
344 
EC 3.1. Hydrolase acting on Ester Bonds (82.2%) 






pneumoniae Alginate lyase(EC 4.2.2.3)
345 
Transmembrane (96.4 %) 
EC 3.1. Hydrolases - Acting on Ester Bonds (78.4%) 





histolyticum Clostridiopeptidase B (EC3.4.22.8 )




chartreusis Arabinosidase II (EC 3.2.1.55) 







Arylmalonate decarboxylase (EC 4.1.1.76) 318 
EC 4.1. Carbon-Carbon Lyases (99.0%) 
Transmembrane (93.6%) 
EC 1.1. Oxidoreductases - Acting on the CH-OH group 
of donors (68.5%) 
EC 4.2. Carbon-Oxygen Lyases (62.2%) 
M 
Aminopeptidase 
G [Q54340] Streptomyces lividans Aminopeptidase G(EC 3.4.11.-)
319 
EC 3.4. Hydrolases - Acting on peptide bonds 
(Peptidases) (99.0%) 







A novel aminopeptidase with unique substrate 
specificity, no significant homology to any known 
aminopeptidases  (EC3.4.-.-)347 
EC 3.5. Hydrolase acting on Carbon-Nitrogen Bonds, 
other than Peptide Bonds (78.4%) 
EC 1.1. Oxidoreductase acting on the CH-OH group of 
donors (76.2%) 
Outer membrane (58.6%) 
TC 1.B. Beta-Barrel porins (58.6%) 
NM 
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pseudoalcaligenes 2-aminomuconate deaminase (EC 3.5.99.5) 
320 
EC 3.5. Hydrolase acting on Carbon-Nitrogen Bonds, 
other than Peptide bonds (99.0%) 






europaea Ammonia monooxygenase(EC 1.13.12.-)
321 
EC 1.13. Oxidoreductases - Acting on single donors with 
incorporation of molecular oxygen (oxygenases) (99.0%)
Transmembrane(99.0%) 





radiodurans. Ribonuclease P protein component(EC 3.1.26.5 ) 
348 
EC 3.1.Hydrolases - Acting on Ester Bonds (99.0%) 
RNA-binding Proteins (99.0%) 
rRNA-binding Proteins (78.4%) 
DNA-binding Proteins (62.2%) 
mRNA-binding Proteins (58.6%) 




Escherichia coli ;  
Shigella flexneri 
an integral membrane protein with a likely 
ATP-binding site between the second and third 
putative transmembrane region 340 
Transmembrane (99.0%) 





scabies. Esterase precursor (EC 3.1.1.-)
323 
EC 3.1. Hydrolases - Acting on Ester Bonds (99.0%) 
Transmembrane (86.8%) 





Vibrio sp. (strain 
JT0107) Beta-agarase B (EC 3.2.1.81)
349 Outer membrane (58.6%) TC 1.B. Beta-Barrel porin (58.6%) NM 
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cehA  
[BAB85626.1] 
Rhizobium sp. strain 
AC100 a novel carbaryl hydrolase (EC 3.5.1.-)
350 
EC 1.4. Oxidoreductases - Acting on the CH-NH2 group 
of donors (85.4%) 
Transmembrane (82.2%) 
EC 2.7. Transferases - Transferring 
Phosphorus-Containing Groups (73.8%) 
EC 6.4. Ligases - Forming Carbon-Carbon Bonds 
(65.4%) 
NM 
CM [P19080] Bacillus subtilis CM(EC 5.4.99.5)324 
EC 5.4. Intramolecular Transferase (99.0%) 
EC 4.2. Carbon-Oxygen Lyase (58.6%) 







Escherichia coli Curlin genes transcriptional activatory protein351 EC 2.7. Transferases - Transferring Phosphorus-Containing Groups (78.4%) NM 
Cytochrome c 
oxidase 
polypeptide IV  
[P30815] 
Paracoccus 
denitrificans Cytochrome c oxidase polypeptide IV (EC 1.9.3.1)
325 
EC 1.9 Oxidoreductase of a heme group of donors 
(97.0%) 






Escherichia coli 2-dehydro-3-deoxygalactonokinase (EC 2.7.1.58)327 
EC 2.7. Transferases - Transferring 
Phosphorus-Containing Groups (99.1%) 
EC 2.3. Transferases - Acyltransferases (76.2%) 
EC 4.1. Carbon-Carbon Lyases(65.4% ) 







Shigella flexneri DNA polymerase III, theta subunit (EC 2.7.7.7)
326 
EC 2.7 Transferase of Phosphorus-Containing Groups 
(99.0%) 





hydrophila Triacylglycerol lipase (EC 3.1.1.3)
328 
EC 3.1. Hydrolase acting on Ester Bonds (99.0%) 
EC 1.3. Oxidoreductase acting on the CH-CH group of 
donors (65.4%) 
Outer membrane (58.6%) 
TC 1.B. Beta-Barrel porin (58.6%) 
M 
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Extracellular 











Associated with the bacterial cell surface and smaller 
structures, involved in fibril formation and cell 
adherence330 
Cell adhesion (58.6%) 
Outer membrane (58.6%) 






syringae (pv. tomato) Glycosyl transferase alg8 (EC 2.4.1.-)
352 Transmembrane (99.0%) EC 2.4 Glycosyltransferase (98.6%) M 
HbpA  
[AAK68926.1] Treponema denticola
iron-regulated 44-kDa outer membrane protein 
(HbpA) with hemin binding ability353 
EC 3.4. Peptidase (86.8%) 
EC 3.1. Hydrolase acting on Ester Bonds (62.2%) 
EC 1.7. Oxidoreductase acting on other nitrogenous 





plantarum Histidine protein kinase (EC 2.7.3.-)
331 
EC 2.7. Transferases - Transferring 
Phosphorus-Containing Groups (91.3%) 
TC 2.C.Electrochemical Potential-driven transporters - 
Ion-gradient-driven energizers (73.8%) 
TC 3.A.Primary Active Transporters - 








Hypothetical protein BBB03 (EC 3.1.22.-)354 
EC 2.7 Transferase of Phosphorus-Containing Groups 
(88.1%) 
EC 3.4 Peptidase (86.8%) 
EC 2.3 Acyltransferase (71.3%) 




mutase precurs  
[P42517] 
Erwinia herbicola Monofunctional chorismate mutase precursor (EC 5.4.99.5)332 





gingivalis outer membrane protein




polysaccharea outer membrane protein
356 
EC 3.1 Hydrolase acting on Ester Bonds (82.2%) 
EC 4.2 Carbon-Oxygen Lyase (62.2%) 
Outer membrane (58.6%) 
TC1.B Beta-Barrel porin (58.6%) 
M 
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Phenol 2-monooxygenase P4 component 
(EC 1.14.13.7 )357 
EC 1.9. Oxidoreductase acting on a heme group of 
donors (78.4%) 
EC 3.4. Peptidase (58.6%) 





Bacillus sp. (strain 
OxB-1) Phenylacetaldoxime dehydratase (EC 4.2.1.-)
358 
Transmembrane (98.2%) 
EC 3.4 Peptidase (96.4%) 
EC 3.3 Hydrolase of Ether Bonds (80.4%) 













ine amidase F precursor  (EC 3.5.1.52)333 
EC 3.5 Hydrolase of non-Peptide Carbon-Nitrogen 
Bonds (99.0%) 






denitrificans Precorrin-6A reductase (EC 1.3.1.54)
334 
EC 1.3. Oxidoreductases - Acting on the CH-CH group 
of donors (99.0%) 
EC 3.5. Hydrolases - Acting on Carbon-Nitrogen Bonds, 
other than Peptide Bonds (58.6%) 







tuberculosis Putative cytochrome P450 128 (EC 1.14.-.-)
335 
EC 1.14. Oxidoreductases - Acting on paired donors with 
incorporation or reduction of molecular oxygen (99.0%) 
EC 2.3. Transferases – Acyltransferases(86.8%) 
EC 4.1. Carbon-Carbon Lyases(85.4% ) 
EC 4.2. Carbon-Oxygen Lyases (83.9%) 
M 
Slt35  
[P41052] Escherichia coli 
Membrane-bound lytic murein transglycosylase B 
(EC 3.2.1.-) 359 
Outer membrane (99.0%) 
EC 1.1. Oxidoreductase acting on the CH-OH group of 
donors (89.3%) 







thioparus Thiocyanate hydrolase beta subunit (EC 3.5.5.8)
336 
EC 3.5 Hydrolase of non-Peptide Carbon-Nitrogen 
Bonds (98.9%) 
EC 2.6 Transferases of Nitrogenous Groups (62.2%) 
M 
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Thiaminase I precursor  (Thiamine 
pyridinylase)( EC 2.5.1.2) 337 
EC 2.5. Transferases - Transferring Alkyl or Aryl 
Groups, Other than Methyl Groups (99.0%) 





[P04519] Bacteriophage T4. DNA alpha-glucosyltransferase  (EC 2.4.1.26) 
246 
EC 2.4. Glycosyltransferases (80.4%) 
EC 2.7. Transferases - Transferring 













Type II restriction enzyme ScaI  (Endonuclease 
ScaI) (EC 3.1.21.4) 338 
EC 3.1. Hydrolases acting on Ester Bonds (99.0%) 
TC 1.C Pore-forming toxins(proteins and peptides) 
(58.6%) 
M 




ATP synthase C chain (Lipid-binding protein) 
(EC 3.6.3.14) 339 
EC 3.6. Hydrolases acting on Acid Anhydrides (99.0%) 
Transmembrane (58.6%) M 
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6. Prediction of Protein Inhibitors by Statistical 
Learning Approach, HIV-1 Protease as a case 
study 
The in depth understanding of the drug-target interaction mechanism and rapid 
advances in biochemistry and organic chemistry lead to the advent of computer aided 
drug design52-55, 361-364, which aims to help the rapid and efficient discovery of drug 
leads. Existing computational investigations mostly focused on how to improve the 
interaction between protease and inhibitor. One approach is to simulate HIV-1 protease 
with a substrate by finding if there is a stable energy minimum by molecular 
dynamics365-367 or docking368. Another method to speed up the PI development process 
is the identification of PIs in the early stage of drug discovery using statistical learning 
methods. As such, drug candidates that are not involved in protease inhibition can be 
eliminated earlier and the cost effectiveness of the drug discovery process can be 
improved. In a study by Patankar and Jurs58, radial basis function neural networks were 
used for classify HIV-PI. The model was trained with a limited set of only 123 
compounds and tested using 12 compounds. Although the predictive ability was in the 
high 80% range for the external prediction set, the model is not robust due to the small 
representation of compounds and statistically insignificant prediction set.  
In this study, support vector machine is implemented for HIV-1 protease inhibitors 
exploration by using new strategy and more comprehensive data set. 
6.1. Methods 
6.1.1. HIV-1 Protease Inhibitors 
An accurate SVM classification model requires large number of examples for both 
protease inhibitors and non-inhibitors. In this study, HIV-1 PIs are selected from the 
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HIV/OI Enzyme Inhibition Database of the National Institute of Allergy and Infectious 
Diseases (National Institutes of Health). The diversity analysis is based on the chemical 
family information that is obtained from the same data source. In our collected HIV 
protease inhibitors, 76.57% of them are peptide-based inhibitors and only 23.43% are 
non-peptide-based inhibitors. Among these peptide-based inhibitors, about 66%of 
them are peptidomimetics that are made up of a wide variety of compounds, and only 
about 5% are symmetry-based inhibitors.  
Peptidomimetics can be described as compounds derived from peptides and proteins 
and are obtained by structural modification using unnatural amino acids, 
conformational restraints, isosteric replacement, cyclisation etc. The peptidomimetics 
bridge the gap between simple peptides and the nonpeptide synthetic structures and 
may be useful in delineating pharmacophores and in helping to translate peptides into 
small non-peptide compounds. Peptidomimetic is sometimes used in a broad sense to 
designate organic molecules mimicking some properties of peptide ligands369.They are 
the most common starting point for HIV-1 inhibitor drug development and have been 
designed to mimic the tetrahedral transition-state intermediate formed during the 
HIV-1 protease catalysis event. In this study, 57.18% of the total positive samples 
found were peptidomimetics. 
Although there is currently no non-peptide-based inhibitors reaching clinical trials, but 
there has been considerable interest in using non-peptide based compounds in HIV 
drug development. Thus, we also consider these non-peptidic inhibitors in this study. 
 
6.1.2. HIV-1 Protease non-Inhibitors 
 
The supervised statistical learning requires both substantial positive and negative 
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examples to develop a prediction model with a certain generalization potential. Thus, 
the selection of effective negative example should be considered seriously in terms of 
the distribution and effectiveness. 
In this work, Hierarchal Clustering is employed to analyze the compound distribution 
according to their descriptors. The comprehensive negative examples are chosen from 
the following conditions based on the distribution of positive examples: (1) They 
allocate in the chemical space not occupied by positive examples, (2) their structures 
must be sufficiently distinct from the positive samples, and (3) the distribution of the 
selected negative examples should be diverse enough to form an effective 
representation of negative examples within the chemical space.  To simulate the entire 
chemical space and figure out the distribution of positive examples within this space, a 
compound database* composed of 85,000 entries is constructed.  In this work, a total 
number of 12453 negative samples were selected to ensure data balance in the binary 
classification SVM model.  
6.1.3. Positive and negative samples quantity 
 
The use of comprehensive dataset for model training is required for developing a robust 
and reliable prediction system, in turn, a small sample size and range is inadequate in 
representing all chemical families of HIV-1 PIs and non-PIs, leading to biased learning 
and eventually poor accuracies.  
In terms of robustness, reliability and statistical significance, the SVM model 
developed in this work is a significant improvement from the previously reported work 
for the prediction of HIV protease inhibitor using radial basis function neural 
                                                        
* These compounds are selected from MDDR, ACD and ChemIDPlus, ChemFinder databases with 
available 3D structures
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networks58 due to the notably larger, and more diversified dataset size for both positive 
and negative samples. The number and distribution of data used in each set are shown 
in Figure 6-1. 
 
Figure 6-1 The distribution and number of samples in each set 
 




























6.2. Results and Discussion 
6.2.1. Self- consistence testing accuracy 
As shown in Table 6-1, The prediction sensitivity, specify and overall accuracy of the 
testing set are 80.7%, 94.1% and 92.7%respectively, which suggest the self consistency 
of the model. 
It is noticed that the prediction accuracy of HIV-1 PIs (sensitivity) is lower than the 
prediction accuracy of non-HIV-1 PIs (specificity) as shown in Table 6-1.  This may 
be explained by the smaller size of the positive sample dataset compared to that of the 
negative dataset. It has been known that SVM model based on unbalanced data  set 
tends to produce feature vectors that push the hyperplane towards the side with a 
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smaller number of data370. This can lead to reduced accuracy for the set either with a 
smaller number of samples or of less diversity. The higher prediction accuracy for 
non-PIs is likely the result of the availability of a more numerous and diverse set of 
samples as compared to the HIV-1 PIs due to the selection of one or few chemicals 
from each super family from the database. This enables SVM to perform a better 
statistical learning for recognition.  
 
Table 6-1 The prediction accuracy of the testing set. Predicted results are given in TP 
(true positive), FN (false negative), TN (true negative), FP (false positive), HIV-PIs 
prediction accuracy (TP/(TP+FN)), and Non-HIV-PIs prediction accuracy 
(TN/(TN+FP)). Number of positive or negative samples in the testing sets is TP+FN 
or TN+FP respectively. 
 
No.HIV-PIs No.Non-HIV-PIs examples Accuracies 
TP FN TN FP HIV-PIs Non-HIV-PIs Overall Accuracy 
638 153 6118 382 80.66% 94.12% 92.66% 
 
A direct comparison with results from an earlier study is impractical because of 
differences in the quantity and quality of data, molecular descriptors and classification 
methods and algorithms used. Nonetheless, a rough comparison with Patankar and 
Jurs’s work58 on HIV PI prediction by using neural networks shows that our approach 
improved the testing accuracy from the 80% to 92%. 
6.2.2. Independent evaluation 
The optimal separating hyperplane was constructed after the training process and it was 
subjected to further evaluation using an independent dataset that does not overlap with 
that which was used for model training and testing. The independent evaluation is 
aimed to show the potential of the model’s generalization abilities. The independent 
evaluation results are as summarized in Table 6-2. 
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Table 6-2 The results of independent evaluation. Predicted results are given in TP 
(true positive), FN (false negative), TN (true negative), FP (false positive), HIV-PIs 
prediction accuracy (TP/(TP+FN)), and Non-HIV-PIs prediction accuracy 
(TN/(TN+FP)). Number of positive or negative samples in the testing sets is TP+FN 
or TN+FP respectively. 
 
No.HIV-PIs No.Non-HIV-PIs examples Accuracies 
TP FN TN FP HIV-PIs Non-HIV-PIs Overall Accuracy 
989 11 2334 90 98.90% 96.29% 97.05% 
 
The prediction accuracies for positive samples, negative samples and overall sample set 
are in the range from 96.29% to 98.90%. This suggests that the classification model is 
quite reliable in terms of the prediction accuracies.  
The positive sample prediction accuracy (sensitivity) of the independent evaluation set 
was 98.90%, where only 11 samples were incorrectly predicted out of 1000. One of the 
possible reasons is that not all individual compound sub-groups have the same 
accuracies, and further knowledge of this might be of help to provide a way to improve 
the overall accuracy of the model. The prediction accuracy for each chemical family is 
shown in Table 6-3. It was found that there are indeed a few groups that have good 
accuracies, such as amines, peptides, peptidomimetics and inhibitors without any 
specified class have precision of 100.00%. The prediction accuracy of non-peptides is 
also at the high-value rage between 90% and 97.30%. The groups with the lowest 
sensitivities are amides and symmetry-based inhibitors, with only 80.00% and 93.48% 
respectively. It was noted that the sample size for amides is small, and this sensitivity 
may not be representative of the true prediction power of the model when more samples 
are given. The sensitivity of the amides group in the testing set is 62.96% (18/27). The 
amides make up only 3.25% of the total positive sample size used. The relative lack of 
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samples in this group may be inadequate to represent all compound subtypes in the 
family, leading to biased learning and poor accuracies eventually. The future inclusion 
of newly found amide protease inhibitors in SVM model training is likely to increase 
the accuracy. The same reason applies to the symmetry-based inhibitors, which only 
make up 3.84% of the training sample. 
 
 
Table 6-3 The sensitivity of individual groups of compounds in the independent 
evaluation set 
Chemical class Sensitivity (Number of true positive/total number of compound) 
Amides 80.00% (4/5) 
Amines 100.00% (10/10) 
Non-peptides 97.30% (252/259) 
Peptides 100.00% (15/15) 
Peptidomimetics 100.00% (658/658) 
Symmetry-based 
inhibitors 93.48% (43/46) 
Unspecified 100.00% (7/7) 
Overall average 98.90% (989/1000) 
 
6.2.3. Recursive Feature Elimination 
As introduced previously in Chapter 1.4, the feature selection provides the insight for 
discriminating the positive and negative examples. In this study, the non-linear 
recursive feature elimination (RFE) method was used to select the 20 predominant 
features for discriminating HIV PIs and non-HIV PIs. 
6.2.3.1. Selected significant features by RFE 
Table 6-4 gives the list of RFE-selected descriptors for HIV-1 PI classification in the 
order of importance, with the most significant feature on top.  
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As shown in Table 6-4, half of the important features selected by RFE methods are 
simple molecular connectivity chi indices, such as topological descriptors, which 
represent how constituent atoms are interconnected in the molecule. Three other 
molecular shape kappa indices quantitative the molecular structure from its shape. 
Besides, simple molecular properties related to electrostatic interaction such as the 
number of hydrogen atoms and the number of H-bond donors and acceptors are also 
show certain importance. The remaining dominant features are molecular weight, Kier 
molecular flexibility index, number of rotatable bonds and the number of rings – which 
dictates the rigidity of the inhibitors. This is consistent with a previous comparative 
quantitative structure activity relationship (QSAR) study371 of inhibitory activity of 
HIV-1 protease inhibitor model. They suggested that topological, molecular 
connectivity, and kappa shape indices were important for binding. These features were 
interpretable as hydrogen bond donating ability, non-polar groups, skeletal branching, 
and molecular globularity.  
Table 6-4 Molecular descriptors selected by the RFE method for the classification of 
HIV-1 PIs 
Descriptor 
selected Description Class 
3χCH
Simple molecular connectivity chi indices for cycles 
of 3 atoms 
Connectivity and shape 
1κ 
 
Molecular shape kappa indices for one bond fragment Connectivity and shape 
0χ Simple molecular connectivity chi indices for path order 0 
Connectivity and shape 
3χC Simple molecular connectivity chi indices for cluster Connectivity and shape 
nrot Number of rotatable bonds Simple molecular properties
1χ Simple molecular connectivity chi indices for path order 1 
Connectivity and shape 
5χCH
Simple molecular connectivity chi indices for cycles 
of 5 atoms 
Connectivity and shape 
2χ Simple molecular connectivity chi indices for path order 2 
Connectivity and shape 
ndonr Number of H-bond donors Simple molecular properties
4χCH
Simple molecular connectivity chi indices for cycles 
of 4 atoms 
Connectivity and shape 
3κ Molecular shape kappa indices for 3 bond fragments Connectivity and shape 
4χPC
Simple molecular connectivity chi indices for 
path/cluster 
Connectivity and shape 
6χCH Simple molecular connectivity chi indices for cycles Simple molecular properties
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of 6 atoms 
nhyd Count of hydrogen atoms Simple molecular properties
phi Kier molecular flexibility index Connectivity and shape 
naccr Number of H-bond acceptors Simple molecular properties
W mol Molecular weight Simple molecular properties
3χP
Simple molecular connectivity chi indices for path 
order 3 
Connectivity and shape 
2κ Molecular shape kappa indices for 2 bond fragments Connectivity and shape 
nring Numbers of rings Simple molecular properties
 
 
From the RFE study, the absence of electrophilicity descriptors in the dominant feature 
list indicated that the importance of hydrophobicity is superseded by that of simple 
molecular properties, molecular connectivity, and kappa shape interactions. Our results 
suggest that the count of hydrogen atoms, the number of H-bond donors and acceptors 
are important to distinguish molecular descriptors of HIV-1 PIs.  These molecular 
properties contribute directly to the properties of quantum chemical descriptors such as 
electrophilicity, polarizability and molecular dipole moment. This is consistent with the 
finding that hydrogen bonding is extremely crucial in the enzyme-inhibitor 
interaction372. 
 
In this study, all topological descriptors found to be significant features are simple 
molecular chi indices.  The key concept in chi indices is the decomposition of the 
molecular graph into fragments of different size and complexity373. As half of the 
significant features obtained by REF are molecular connectivity descriptors, simple 
molecular connectivity chi indices for cycles of 3 atoms, path order 0, cluster, path 
order 1, cycles of 5 atoms, path order 2, cycles of 4 atoms, path/cluster, cycles of 6 
atoms, and path order 3 are shown to be important to discriminateHIV-1 PIs and 
non-PIs. This is as understandable because the peptide-based inhibitors form a major 
group compounds which are typically heavy, long chain, complex molecules with 
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many branch points and ring structures. Besides, the molecular topology for 
non-peptidic inhibitors is also intricate, such as carbohydrates, nucleoside conjugates, 
natural product and symmetry-based inhibitors have complicated structures with 
numerous rings and branch points. The difference in the complexity of molecules might 
cause the significant difference in their distinctive indices. 
Apart from the molecular connectivity descriptors, molecular shape kappa indices for 
one, two, and three bonded fragments are found in the RFE-selected feature list. The 
kappa shape indices are the basis of a method of molecular structure quantization. In 
this study, the importance of Kier molecular shape indices suggests that HIV-1 protease 
is highly specific for their substrate in terms of their shape. The inhibitors of an enzyme 
should be of similar shape and chemical nature as the substrate in order to align 
properly with the active site and bind tightly to it. This approach has been widely used 
to design inhibitors for diverse enzymatic targets, including HIV-1 protease374.  
Our results also revealed that the number of rotatable bonds, number of rings, Kier 
molecular flexibility index, and molecular weight have important contributions to 
discriminated PIs and non-PIs. The Kier molecular flexibility index is a descriptor 
based on structural properties that restrict a molecule from being "infinitely flexible", 
the model for which is an endless chain of C (sp3) atoms. The structural features 
considered to prevent a molecule from attaining infinite flexibility are: (a) fewer atoms, 
(b) the presence of rings, (c) branching, and (d) the presence of atoms with covalent 
radii smaller than those of C (sp3)375.  
6.2.3.2. Prediction accuracy by using selected significant features 
The elimination of irrelevant molecular descriptors greatly reduced the computation 
costs. More importantly, the removal of noise-generating features could improve the 
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accuracy of SVM models in some cases376. In this work, the testing sensitivity is 
improved from 80.66% to 84.70% by using the selected 20 features. The specificity and 
overall accuracy are comparable to that utilizing all of the features, with a slight 
decrease from 94.12% to 93.40% and 92.66% to 92.40% respectively.  
6.3. Conclusion remark 
This work has lead to a robust and intelligent classification system for predicting 
HIV-PIs with accuracies in the range of 90%s. As the basis of a statistical learning 
method, the significant number and diversity of the positive and negative datasets 
confer statistical significance to the results. Recursive feature elimination coupled 
Support Vector Machines was successfully employed in the automated selection of 
relevant molecular descriptors and noise reduction. 
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7. Conclusion 
7.1. Protein functional class prediction  
As the gap between the large amounts of sequences information and their function 
characterization is continuously increasing3, 4, efforts has been directed in development 
of methods for probing protein functions. It is difficult to predict protein functions 
solely based on the sequence similarity if the protein sequence is dissimilar to the 
sequence. Moreover, the sequence similarity may not able to distinguish the protein 
functions for homologous proteins with different functions. Thus, it is desirable to 
explore methods that are not based on sequence similarity.  
One of the main purposes of this study is to develop a prediction system that is able to 
classify proteins into functional classes based on primary sequence by statistical 
learning approach – Support Vector Machines. The classification system is designed to 
be able to assign functional families from proteins’ primary sequence irrespective 
sequence similarity. Protein classification problems such as enzymes classification, 
transporters classification and RNA-binding proteins classification are studied and the 
classification models are further evaluated by using independent evaluation sets.  
The SVMProt protein functional class prediction system was build on the basis of 
above described optimized classifiers. SVMProt has increased to 97 protein functional 
classes as listed in Appendix Table A. The functional classes of SVMProt include 46 
enzyme families, 9 channel/transporter families, 21 transporter families, 4 
RNA-binding protein families, DNA-binding proteins, 5 G-protein coupled receptors, 
nuclear receptors, Tyrosine receptor kinases, cell adhesion proteins, coat proteins, 
envelope proteins, outer membrane proteins, structural proteins, and growth factors.  
The independent evaluation of the functional classes in SVMProt showed that the 
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prediction accuracy for proteins belonging to a functional family was greater than 70% 
for 53 families, and 53%~70% for the remaining 19 families. The accuracy for proteins 
outside the given functional family was 82%~100% for all families. These accuracies 
are comparable to that from other SVM studies of proteins in terms of accuracies 
obtained in evaluation, such as G-protein coupled receptor classification31 and Protein 
fold prediction 47. The results of this work either revealed that substantial portions of 
misclassified proteins are with low similarity to most members in its family, or 
described as hypothetical, probable and putative. These findings indicate that sequence 
distance and novelty have some influence on prediction accuracy. Besides, limited 
diversity of proteins for some families may also affect the prediction accuracies.  
 
Novel proteins such as novel enzymes, novel bacterial proteins, viral proteins and novel 
plant proteins are selected and evaluated by our developed protein function prediction 
system.  The evaluation accuracy is in the range of 67~ 85%, it is suggested that the 
prediction system is useful for protein functional family assignment of distantly related 
proteins in the genomes of bacteria, virus as well as in other organisms and major 
functional groups such as enzymes. 
 
The approach employed in this work is to classify proteins into functional classes. 
Some of functional classes are at the level of families and super families that may 
include a broad spectrum of proteins. Although the results of this study showed that the 
SVM prediction system may not work as well as HMM for distinguishing proteins in a 
super family, it may be more accurate with subfamily discrimination 31. Thus, the use of 
some large families and super families as the basis for classification may affect the 
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prediction accuracy of SVMProt to some extent. The prediction accuracy and 
prediction confidence level could be further improved by incorporating the domain 
based or multiple sequence alignment based approach with the SVM approach outlined 
in this study. Because the advantages of SVM in predicting function of novel proteins 
and advantages of sequence similarity based methods in probing functions from 
homology proteins could complement each other, the new combined prediction system 
may be an improvement in terms of prediction accuracy and prediction confidence. 
Another issue is that the development of classifier for each protein functional family 
needs a certain number of representative examples. Only those protein functional 
classes with enough positive examples could be implemented in the classification 
system developed in this work. Although one can still build the SVM classifier based 
on the limited positive examples, the problem of data imbalance may be critical as it 
would affect the accuracy of a SVM classification system233. Thus, approaches to solve 
the data imbalance problem properly are necessary for further improvements in protein 
functional family coverage. In addition, improvements in SVM algorithm, reliable 
protein sample collection, distribution analysis on both positive and negative examples, 
and a more comprehensive and refined set of protein descriptors may enable the 
development of this prediction system into a practical and mature tool for facilitating 
functional study of unknown function proteins. 
 
 
7.2. Prediction of protein inhibitors 
As the problem of rapid resistance development and physiological side effects remain 
in current use of HIV-1 protease inhibitors for anti-HIV therapies, methods for 
facilitating early elimination of potential HIV-1 protease inhibitors are useful for 
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speeding up new drug discovery in the battle with HIV infections. In this study, 
addition to the applications in functional families’ calcification and prediction, support 
vector machine also show the potential in the application of HIV-1 protease inhibitors 
exploration. A set of 4291 inhibitors and 10000 non-inhibitors are selected to train and 
test an SVM classification system. This gave a prediction accuracy of 97.05% for an 
independent evaluation set composed of 1000 PIs and 2424 non-PIs. This shows that 
the classification model developed during the training, testing and independent 
evaluation process is self-consistent and has certain capable in the selection of probable 
HIV-1 PI candidates for further experimentation and assay.  Recursive feature 
selection method is employed to select significant descriptors and it was shown that 
molecular connectivity and shape, flexibility and hydrogen bond interactions are 
among the most distinguishing features for discriminating HIV-1 protease inhibitors.  
In order to get the insight from the significant features for discriminating the PIs and 
non-PIs, Recursive feature selection method is employed. The results of feature 
elimination show that half of the important features sleeted by RFE methods are 
molecular topological descriptors, molecular properties related to electronic interaction 
such as the number of hydrogen atoms and the number of H-bond donors and acceptors, 
and some other global properties such as molecular weight, rigidity (Kier molecular 
flexibility, number of rotatable bonds and the number of rings etc). which is consistent 
with a previous comparative quantitative structure activity relationship (QSAR) study 
of inhibitory activity of HIV-1 protease inhibitor model 371.  
In conclusion, The results of this study indicated that the statistical learning approach 
was useful for protein inhibitors prediction, the methods implemented in this work 
could be extended to other fields in drug discovery and effort could be brought to the 
development new HIV PIs as well as new drug leads. 
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Future work entails further refinement of the SVM model through the inclusion of the 
most recently discovered HIV-PIs and the improvement of SVM algorithms, as well as 
compliment with other approaches for aiding in inhibitors prediction. As suggested in 
this study, SVM coupled with RFE is potentially useful as a classifier for facilitating 
the prediction of HIV-1 PIs. The introduction of weighted function into SVM-RFE is 
expected to improve the accuracy of the model. Moreover, a comprehensive collection 
of available compound is important for the compound diversity analysis. Qualified 
collection of positive examples and representative negative examples are the keys for 
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Appendix A：List of protein families currently covered by SVMProt, statistics of datasets and prediction results***.  
Training set Testing set Independent evaluation set 
positive negative positive negative Protein family positive negative
TP FN TN FP TP FN Sensitivity TN FP Specificity
EC1.1 Oxidoreductases acting on the CH-OH group of 
donors 1164 2324 1795 10 7594 14 494 105 82.5% 4760 192 96.1%
EC1.2 Oxidoreductases acting on the aldehyde or oxo 
group of donors 665 1960 705 14 8051 25 259 69 79.0% 4908 77 98.5%
EC1.3 Oxidoreductases acting on the CH-CH group of 
donors 491  1917 131 3 8090 17 73 37 66.4% 4941 57 98.9%
EC1.4 Oxidoreductases acting on the CH-NH2 group of 
donors 307     1869 92 2 8179 8 50 26 65.8% 4990 26 99.5%
EC1.5 Oxidoreductases acting on the CH-NH group of 
donors 276     1755 56 3 8278 5 41 29 58.6% 4985 21 99.6%
EC1.6 Oxidoreductases acting on NADH or NADPH 1333 2132 2189 21 7857 19 1118 65 94.5% 4901 88 98.2%
EC1.7 Oxidoreductases acting on other nitrogenous 
compounds as donors 170     1356 86 0 8703 2 29 15 65.9% 5005 13 99.7%
EC1.8 Oxidoreductases acting on a sulfur group of 
donors 299  1531 114 2 8500 13 40 28 58.8% 4989 20 99.6%
EC1.9 Oxidoreductases acting on a heme group of 
donors 561  807 9493 22 9246 24 4805 36 99.3% 4978 48 99.0%
EC1.10 Oxidoreductases acting on diphenols and 
related substances as donors 219     1348 88 0 8728 4 65 20 76.5% 4996 30 99.4%
EC1.11 Oxidoreductases acting on a peroxide as 
acceptor 344     1416 343 2 8664 5 146 22 86.9% 5009 22 99.6%
                                                        
*** Predicted results are given in TP (true positive), FN (false negative), TN (true negative), FP (false positive), Sensitivity (TP/(TP+FN)), and 
Specificity(TN/(TN+FP)). Number of positive or negative samples in testing and independent evaluation sets is TP+FN or TN+FP respectively 
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EC1.13 Oxidoreductases acting on single donors with 
incorporation of molecular oxygen (oxygenases) 152     1232 90 7 8832 4 29 23 55.8% 5009 13 99.7%
EC1.14 Oxidoreductases acting on paired donors with 
incorporation reduction of molecular oxygen 566     1896 786 0 8120 8 93 38 71.0% 4941 57 98.9%
EC1.15 Oxidoreductases acting on superoxide as 
acceptor 259      881 416 2 9214 7 222 18 92.5% 5019 20 99.6%
EC1.17 Oxidoreductases acting on CH2 groups 100 1308 109 4 8779 8 43 12 78.2% 5026 9 99.8%
EC1.18 Oxidoreductases acting on iron-sulfur proteins 
as donors 244     1229 232 1 8842 8 78 7 91.8% 5005 22 99.6%
EC2.1 Transferases transferring one-carbon groups 1509 2991 800 0 6903 2 190 89 68.1% 4194 740 85.0%
EC2.2 Transferases transferring aldehyde or ketone 
residues 35    1197 30 2 1121 0 26 5 83.9% 1005 3 99.7%
EC2.3 Acyltransferases  302 1001 246 0    1284 4 196 44 81.7% 966 27 97.3%
EC2.4 Glycosyltransferases 945 1896 1211 25 7940 41 203 85 70.5% 4640 286 94.2%
EC2.5 Transferases transferring alkyl or aryl groups, 
other than methyl groups 764 2174 519 24 7832 33 137 58 70.3% 4915 93 98.1%
EC2.6 Transferases transferring nitrogenous groups 343 1684 301 5 8395 6 75 32 70.1% 4982 49 99.0%
EC2.7 Transferases transferring phosphorus-containing 
groups 3892 5324 3761 4    6140 6 2463 553 81.7% 5082 625 89.0%
EC2.8 Transferases transferring sulfur-containing 
groups 203     1549 43 0 8531 7 20 10 66.7% 5021 11 99.8%
EC3.1 Hydrolases acting on ester bonds 2482 3859 1504 53 5677 100 379 154 71.1% 4355 452 90.6%
EC3.2 Glycosylases  337     867 379 2 1397 13 268 49 84.5% 939 51 94.8%
EC3.3 Hydrolases acting on ether bonds 97 1999 44 22 8053 49 32 22 59.3% 5007 32 99.4%
EC3.4 Hydrolases acting on peptide bonds (Peptidases) 2011 3402 1522 35 6207 29 264 90 74.6% 4528 279 94.2%
EC3.5 Hydrolases acting on carbon-nitrogen bonds, 
other than peptide bonds 1020 2498 440 2    7447 3 130 85 60.5% 4849 110 97.8%
EC3.6 Hydrolases acting on acid anhydrides     2195 2504 1449 1 7435 4 687 63 91.6% 4742 220 95.6%
EC4.1 Carbon-carbon lyases  546 1145 776 5   1113 17 547 62 89.8% 881 105 89.4%
EC4.2 Carbon-oxygen lyases       505 1231 382 1 1047 2 324 79 80.4% 915 77 92.2%
EC4.3 Carbon-nitrogen lyases  218     1068 194 2 9009 8 29 10 74.4% 4994 37 99.3%
EC4.4 Carbon-sulfur lyases  182 1999 53 23 8072 14 35 23 60.3% 5024 7 99.9%
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EC4.6 Phosphorus-oxygen lyases  200 1789 63 14 8250 7 55 27 67.1% 4112 899 82.1%
EC5.1 Racemases and Epimerases    379 1796 91 4 198249 35 31 53.0% 4990 30 99.4%
EC5.2 Cis-trans-Isomerases  35 1404 113 2 8671 11 72 36 66.7% 5008 24 99.5%
EC5.3 Intramolecular oxidoreductases       461 1122 92 3 1062 0 135 43 75.8% 4910 99 98.0%
EC5.4 Intramolecular transferases  329 1714 143 4 8337 16 42 35 54.5% 4991 31 99.4%
EC5.5 Intramolecular lyases  47 909 24 0 9196 0 75 32 70.1% 4982 49 99.0%
EC5.99 Other Isomerases  163 1038 393 8    9036 9 153 13 92.2% 5007 22 99.6%
EC6.1 Ligases forming carbon-oxygen bonds   281 1115 381 1 1185 28613 29 90.8% 980 27 97.3%
EC6.2 Ligases forming carbon-sulfur bonds 149     1233 154 4 8858 4 51 13 79.7% 5203 13 99.8%
EC6.3 Ligases forming carbon-nitrogen bonds      381 1133 358 2 1148 3 294 57 83.8% 946 45 95.5%
EC6.4 Ligases forming carbon-carbon bonds 99 1543 45 0     8548 8 28 16 63.6% 5033 4 99.9%
EC6.5 Ligases forming phosphoric ester bonds 94 1679 36 2 8408 3 22 9 71.0% 5027 6 99.9%
TC1.A alpha-type channels 381 1786 272 8 10425 7 164 25 86.8% 6037 44 99.3%
TC1.B beta-barrel porins 221 2008 58 0 12452 2 65 27 70.7% 7178 29 99.6%
TC1.C Pore-forming toxins (proteins and peptides) 357 2007 33 14 12371 0 100 27 78.7% 6452 15 99.8%
TC1.E Holins  100 513 55 5 11837 14 55 15 78.6% 6151 4 99.9%
TC2.A porters (symporters, uniporters, antiporters) 629 1175 781 4 10938 13 370 54 87.3% 5945 90 98.5%
TC2.C Ion-gradient-driven energizers 166 1014 86 2 11325 10 91 28 76.5% 6140 13 99.8%
TC3.A P-P-bond-hydrolysis-driven transporters 1220 2549 1301 20 9568 89715 243 78.7% 5895 143 97.6%
TC3.D Oxidoreduction-driven transporters 435 1529 981 1 12980 5 617 60 91.1% 7197 36 99.5%
TC3.E Light absorption-driven transporters 139 954 696 5 13648 2 395 16 96.1% 7267 11 99.8%
TC4.A Phosphotransfer-driven group translocators  197 887 212 8 11429 5 153 32 82.7% 6120 21 99.7%
TC8.A Auxiliary transport proteins 223 1388 169 5 10925 13 124 43 74.3% 6120 15 99.8%
TC9.A Recognized transporters of unknown biochemical 
mechanism  203 1034 188 1 11247 29 130 35 78.8% 6085 43 99.3%
TC9.B Putative uncharacterized transport proteins  869 2079 581 5 10153 5 469 116 80.2% 6002 98 98.4%
G protein coupled receptors 927 1320 4993 5 13212 4 2421 111 95.6% 7104 140 98.1%
7 transmembrane receptor (rhodopsin family & 
chemoreceptor ) 729 1061 4604 7 13535 3 2223 71 96.9% 7214 61 99.2%
7 transmembrane receptor (secretin family) 218 2007 71 0 12580 1 117 12 90.7% 6900 370 94.9%
7 transmembrane receptor (metabotropic glutamate 




7 transmembrane receptor (odorant receptor) 130 1999 11 0 12631 0 38 1 97.4% 7113 178 97.6%
DNA-binding proteins 3260 4251 4146 115 4914 73 2469 1114 68.9% 4065 464 89.8%
RNA-binding proteins 2161 2965 1844 6 6802 14 437 10 97.8% 4685 196 96.0%
mRNA-binding proteins 277 2106 129 0 10164 0 130 34 79.3% 5833 213 96.5%
rRNA-binding proteins 708 972 1243 2 9031 13 95 6 94.1% 4931 66 98.7%
tRNA-binding proteins 94 792 114 0 9295 2 48 3 94.1% 5028 5 99.9%
Structural proteins (Matrix protein,Core protein,Viral 
occlusion body,Keratin) 858 1353 4977 4 8512 12 2615 41 98.5% 4884 40 99.2%
Transmembrane 2105 2563 11135 1722 8237 1368 3054 335 90.1% 5254 809 86.7%
Outer membrane 602 1539 547 0 8384 1 318 25 92.7% 4276 672 86.4%
Cell adhesion 513 1678 322 1 8208 15 232 38 85.9% 4897 44 99.1%
Coat proteins 346 1474 297 8 8344 26 167 30 84.8% 4885 29 99.4%
Envelope proteins 177 1999 112 11 7904 28 135 15 90.0% 4927 25 99.5%
Nuclear receptors 334 538 601 7 1755 6 221 26 89.5% 962 24 97.6%
Tyrosine kinase receptors 14 1197 3 0 1121 0 5 2 71.4% 1006 2 99.8%
Growth factor 329 1320 205 5 8695 4 142 21 87.1% 4970 28 99.4%
Antigen 836 1867 1200 2 7786 8 720 29 96.1% 4747 74 98.5%
Chlorophyll 189 603 945 3 14630 10 515 14 97.4% 6965 11 99.8%
Chlorophyll biosynthesis 309 1742 109 0 13424 0 153 24 86.4% 6158 777 88.8%
Herbicide resistance 227 1999 205 7 13196 2 199 10 95.2% 6948 10 99.9%
Photoreceptor 354 1537 893 3 13611 11 548 42 92.9% 6896 26 99.6%
Photorespiration 368 1672 8197 4 13504 76 4257 13 99.7% 6955 24 99.7%
Photosynthesis 1054 1914 544 0 12950 47 613 44 93.3% 6664 132 98.1%
Photosystem I 264 1491 392 70 13726 1 326 8 97.6% 5900 1061 84.8%
Photosystem II 506 986 2018 4 14120 46 1192 31 97.5% 6890 36 99.5%
Plant defense 559 1830 456 5 13302 14 289 37 88.7% 6857 60 99.1%
 
List of Publications 
Appendix B: Distribution of RNA-binding proteins in different kingdoms and in 
top 10 host species of each kingdom. Not all protein sequences studied in this 
work are included because the host species information of some protein 
sequences is not yet available in the protein sequence database. 
 





986 1854 294 
Homo sapiens (168) Escherichia coli (75) 
Methanococcus 
jannaschii (22) 



























Xenopus laevis (30) Aquifex aeolicus (45) 
Sulfolobus solfataricus 
(18) 











proteins in  
each 
species 
Porphyra purpurea (19) Mycoplasma pneumoniae (43) 
Thermoplasma 
volcanium (14) 
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